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 Abstract 
The cell can be viewed as a miniature factory run by a large collection of molecular 
machines such as proteins and DNA that works together to perform complicated tasks, 
such as cell division, response to environmental stimuli, and energy production. 
Currently, nanotechnology research aims at reconstructing a fraction of complex 
functionality that exists in cell by designing novel systems to mimic cell properties and 
functions. The design of hybrid nanosystems based on biomacromolecules such as 
proteins, DNA, and synthetic molecules (polymers), brings science closer to achieving 
this target. The adaptability and mechanical properties of polymers allow for tailored 
designs that include various scaffolds for improved spatial-temporal connections to 
specific proteins, and DNA.  
In this thesis, two hybrid systems were established. First, tris-nitrilotriacetic acid (trisNTA) 
functionalized polymers (PNTs) for the specific conjugation of his-tagged molecules was 
designed and synthesized. For efficient binding to the His-tagged molecules, a chelating 
metal (Me2+) is introduced in the trisNTA site. The binding affinity of His-tagged 
molecules for the trisNTA-Me2+, and their interactions when bound were analyzed. 
These characteristics were dependent on the distance between the trisNTA binding sites 
and the size of his-tagged molecules. In addition to the distance between trisNTA 
binding sites on PNTs, the nature of the selected Me2+, connecting trisNTA and His tag, 
offers a way to tune the binding affinity of the protein for the polymer, and in this way 
the protein-protein interactions can also be modified to further tune the stability of the 
conjugates and their susceptibility to release under changing pH. The concept of 
polymers serving as models for combined geometric topology with size requirements is 
expected to show the real binding capacity of molecules to a complex targeting 
configuration, mimicing biological systems in details. In addition, PNTs fulfill the 
requirements as a great nanocarrier for protein delivery and can contribute to the 
development of protein therapy and other protein-related applications. 
Second, we applied DNA as the algorithm to regulate the self-organization of binary 
polymersomes to construct multicompartmentalized structures with spatial organization 
and connections. Polymersomes supply a robust and shielded encapsulation of active 
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entities, while DNA is capable to control the spatial organization and the spatial distance 
between compartments due to the rigid nature of double-strand DNA (<50 nm). The size 
of polymersomes as the second algorithm plays an important role in the assembly 
behavior and results in different architectures, including linear and satellite structures. 
The compartmentalized polymer network system described in this work offers a new 
perspective into the evolution from unitary (one component) to binary (two 
components) or polyphyletic (multiple components) systems with properties greater 
than the individual building blocks. 
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1. Introduction 
In Nature, two or more constituents are often combined and organized at the 
nanometer or molecular level to create various elaborate hybrid systems with 
remarkable functions and features. One of the most well-known examples is the cell. 
Lipids self-assemble to form a closed boundary separating the interior and exterior 
cellular environments. A large number of proteins, DNA and other molecules hosted 
inside of cells fulfill different functions, such as catalyzing metabolic reactions, DNA 
replication and transcription, signal transduction, etc, to implement the cell growth and 
division. The combination of dissimilar components has the opportunity to collect the 
characteristic properties for both components, and create complex systems with new 
functions and properties. This principle plays a major role in the development of 
advanced functional materials especially nanomaterials. 
Biomacromolecules, such as proteins, DNA, and synthetic polymers, are highly attractive 
for the design of smart and functional hybrid materials. Proteins and DNA are highly 
evolved biopolymers with remarkable properties and functions. Proteins are involved in 
many functions within living organisms, including catalyzing metabolic reactions, 
responding to stimuli, DNA replication, and transporting molecules from one location to 
another. DNA encodes the genetic information for the development and function of all 
known living organisms and many viruses. The powerful molecular recognition between 
DNA molecules makes them excellent candidates for the design of new materials for 
nanosciences.[1] Synthetic polymers offer many advantages compared to proteins and 
DNA, as the possibility to design the appropriate chemical structure with specific 
functional groups, length and physicochemical properties. The ideal hybrid systems 
would be to combine of the best of both worlds: the adaptability of synthetic polymers 
with the structural and the functional control ensured by biopolymers such as DNA or 
proteins.  
In addition, nature addresses the question how to organize dissimilar components to a 
whole structure. By elaborate design of the chemical structures in molecules such as ion 
coordination sites and hydrogen bond assays, it’s able to direct and drive the self-
organization of molecules to form complex structures and systems by the molecular 
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recognition events based on well-defined interaction patterns. It provides an approach 
to design diverse and elaborate hybrid systems based on proteins, DNA, and synthetic 
polymers by their self-organization through molecular recognition. The following 
sections provide an overview about the approaches for the construction of protein-
polymer and DNA-polymer hybrid systems, their applications, and the nanofabrication 
based on molecular recognition. 
1.1. Hybrid nanosystems based on polymers and proteins 
Proteins keep their irreplaceable role as new-emerging materials for applications in 
various domains, including catalysis, medicine, environmental science, electronics, 
nanodevices, etc. Proteins catalyze a vast array of metabolic reactions. They act as 
transport molecules, respond to specific stimuli, and convert ATP to thermal energy and 
mechanical energy. Protein-based therapeutics is highly successful in clinic and their 
potentials are well recognized. More than 100 modified therapeutic proteins are 
approved for clinical use in the European Union and the USA with 2010 sales of $108 
billion.[2] The best example of therapeutic protein application in clinics  is perhaps 
insulin, which has already been the major therapy for diabetes mellitus type I and type 
II.[3] Protein therapeutics have several advantages over small-molecule drugs, such as 
their high specificity , which reduces the interference with normal biological processes 
and side effects.[3] Because the body naturally produces many of the proteins that are 
used as therapeutics, these agents are well tolerated and are less likely to elicit immune 
responses. All of these features are hard to be reproduced by simple small molecular 
weight drugs. In addition, due to the development of chemical modification and site-
directed mutagenesis techniques for proteins, they are able to be modified with diverse 
functional groups and act as the selective connectors for the conjugation of various 
components while preserving their own functions, which is highly promising for 
nanoscale engineering and nanofabrication.[154]  For example, biotinylated F1-ATPase 
with his tag (His6) has been immobilized on the Ni substrate by the specific interactions 
between His6 and Ni
2+, and sequentially connected with streptavidin functionalized 
inorganic propeller by biotin-streptavidin interactions.[155] F1-ATPase preserved its 
functions during the engineering process and acted as the bimolecular motor, which 
initiates and maintains the rotation of the conjugated inorganic propeller (Figure 1-1). 
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Figure 1-1. Schematic of F1-ATPase-power nanopropeller.[155] Reproduced with 
permission from ref. 155. Copyright 1997 Rights Managed by Nature Publishing Group.   
On the other hand, proteins have their limitations for applications. First, proteins are 
macromolecules that fold into unique 3-dimensinal structures by covalent and non-
covalent interactions. Therefore, proteins are intrinsically unstable and highly influenced 
by the environments such as buffer concentration and working temperature. Another 
main drawback of proteins for in-vivo applications is their rapid clearance from the 
systemic circulation. They can be rapidly degraded by various proteolytic enzymes. Even 
though protein therapy has already been applied in clinic by injecting the proteins 
directly to the body, which is able to avoid the digestion by alimentary system. But the 
activity of proteins is still decreased in most of the cases and their efficacy is strongly 
reduced.[3] Therefore, engineering or protecting proteins to increase their stability is 
strongly demanded for different applications. In the following sections, we overviewed 
the approaches of protein engineering with polymers, targeting to stabilize the 
structures for the protein therapy and nanostructure fabrication.  
1.1.1. Protein-polymer conjugates 
 Conjugates are generally formed by either covalent or non-covalent bond between 
polymers and proteins. The highly flexible polymer chains generate a “conformational 
cloudʺ around the proteins, which prevents interactions with blood components and 
avoiding enzymatic degradation and opsonization (macrophage uptake) followed by 
uptake by the endothelial system.[6] The diminished interactions with the body result in 
protein-polymer conjugate showing less immunogenicity and antigenicity.     
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Conjugating polymers to proteins is the most used approach for the stabilization of 
proteins.[7, 153] The first protein-polymer conjugate brought to the market was 
SMANCS (Zinostatin stimalamer) in 1990. The conjugate contains two polymer chains of 
styrene-co-maleic anhydride (SMA) covalently bound to the anti-tumor protein 
neocarzinostatin (NCS).[7] The conjugation with polymers increases the lipid-solubility of 
NCS and enables the administration of SMANCS in the phase-contrast agent Lipiodol, 
increasing plasma half-life, allowing tumor visualization and improving the degree of 
tumor targeting. A remarkable tumor to blood ratio of ˃2500 was recorded using 
SMANCS. Furthermore, the treatment with SMANCS resulted in dramatic tumor 
shrinkage (95%) and decreased α-fetoprotein levels (86%), which is used as a tumor 
marker to detect and diagnose cancers. [7] 
Protein-polymer conjugates must be carefully designed for individual applications. They 
have a common tripartite structure, represented by the protein, the polymer and the 
linker, which connects them (Figure 1-2).  
 
Figure 1-2. Schematic representation of tripartite structure of protein-polymer 
conjugates. 
Proteins. Proteins are large biological macromolecules built from a series of up to 20 
different L-α-amino acids. Some of the amino acids such as lysine and cysteine have 
active groups, which are available for the polymer conjugation. A common approach to 
fabricate protein-polymer conjugates is to target the lysine or cysteine residues from 
protein structures by the polymers with either an amino group or a malemide group. 
This approach generally results in a random modification of proteins with polymer and 
the reduction of enzymatic or receptor-binding activity of the protein.[8] Unnatural 
amino acid mutagenesis enables the incorporation of site-specific linkers into both 
synthetic and recombinant proteins, and allow for complete control over the resulting 
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protein-polymer structures.[9, 10] More details are presented in the section describing 
site-specific protein-polymer conjugation. 
Polymers. It has been well accepted that the molecular weight and physico-chemical 
properties of polymer play a critical role for governing biodistribution, elimination, and 
metabolism of the conjugates.[11, 12] Therefore, the choice of a suitable polymer is 
crucial. In general, the polymer should be water-soluble, non-toxic, non-immunogenic, 
and biodegradable. The elimination of polymers can be done by choosing biodegradable 
polymers. For the non-biodegradable polymers, the molecular weight (MW) must be 
lower than 40kDa to avoid its accumulation in the body after repeated 
administrations.[12] In order to take full advantage of the enhanced permeability and 
retention effect (EPR effect) and increase retention into the tumor tissue, the polymers 
should have a MW ranging between 20-40 kDa.[12] The most widely tested polymers for 
protein conjugation include poly(ethyleneglycol) (PEG), poly(N-(2-
hydroxypropyl)methacrylamide) (PHPMA) and its copolymers, and poly(glutamic acid) 
(PGA).[6, 13] The structures of the commonly used polymers for protein conjugation are 
shown in Figure 1-3.  
 
Figure 1-3. Chemical structure of PEG, PHPMA and PGA. 
Linkers. The linker is the part connecting polymers and proteins. The design of the linker 
is dependent on the specific requirements of the application. Basically, the linker 
between polymers and proteins must be stable in bloodstream and non-toxic. In 
addition, because the conjugation of polymers can influence the function of proteins or 
even cause the total loss of its activity,[4] the ideal linker needs to be chemically or 
enzymatically cleavable in specific environments such as tumor tissue to avoid 
decreasing the activity of proteins by conjugation with polymers.[14, 15] More details 
about how to connect polymers with proteins are presented in the section describing 
the fabrication approaches for protein-polymer conjugation. 
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1.1.1.1. Methods to achieve protein-polymer conjugation 
Protein-polymer conjugates are obtained by two main methods (Figure 1-4): “grafting 
toʺ and “grafting fromʺ. The “Grafting toʺ approach is achieved by the active functional 
groups of polymers covalently or non-covalently conjugating to the corresponding 
amino acid side chains of proteins. “Grafting fromʺ is to use proteins as the macro-
initiator to process the polymerization. In this case, polymer chains can be grown 
directly from proteins. 
 
Figure 1-4. Methods to prepare protein-polymer conjugates.[16] Reproduced with 
permission from ref. 16. Copyright 2011 Royal Society of Chemistry.   
“Grafting toʺ is the first approach developed for the production of protein-polymer 
conjugates. The polymer generally has only one terminal end active group for the 
simplification of the system. The active end group from the structure of polymers is able 
to target active sites on the proteins and accomplish the conjugation with them.  
 Amino reactive polymers. Amino side chains of lysine residues and the N-
terminus amino acids are the most common sites for polymer conjugations. This 
approach is desirable for conjugate formation because these residues react with 
a variety of functional groups, including activated esters, thioimido esters, 
aldehydes, ketones, isocyanates and dichlorotriazines.[17-19] A disadvantage to 
this approach is that lysine residues are quite numerous on the proteins, 
rendering the conjugation between proteins and polymers uncontrollable and 
reducing the protein activity due to the hindrance of active sites and/or the 
denaturation of proteins. However, due to the facile synthesis, this approach is 
still extensively applied and results in materials with improved pharmacokinetics 
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over unmodified proteins. Some of commercial PEGylated protein drugs obtained 
by this approach have been previously reviewed .[127]  
 Thiol-reactive polymers. Cysteine residues are attractive targets for polymer 
conjugation to proteins, because surface-exposed, free cysteines are rare in 
native proteins. A large number of cysteine-reactive functional groups have been 
introduced into polymers (e.g. activated disulfides, maleimides, and vinyl 
sulfones).[21-23] Polymers with activated disulfides link to cysteine residues on 
proteins by thiol-disulfide exchange and the linker of disulfides between 
polymers and proteins is cleavable by reducing agents such as dithiothreitol (DTT) 
and 2-mercaptoethanol (BME). The linker formed between cysteine and 
maleimide/vinyl sulfones are much more stable in different environments. For 
example, Poly(Є-caprolactone)s functionalized with thioester end groups have 
been conjugated to bovine serum albumin (BSA) by simple thiol-disulfide 
exchange without the need of further reaction or activation steps (Figure 1-5).[22] 
The polymer can be cleaved by adding DTT or excess amount of cysteine. Poly(N-
isopropylacrylamide) (PolyNIPAM) with a single maleimide end group was 
attached to the cysteine residue on a T8C protein.[128] The obtained polymer-
protein conjugate allows selective precipitation above certain temperature due 
to the thermo-responsive property of conjugated PolyNIPAM.   
 
Figure 1-5. Polymer-protein conjugates obtained by thiol-disulfide exchange reaction.[22] 
Reproduced with permission from ref. 22. Copyright 2004 American Chemical Society.   
 Ligand binding polymers. Another route to produce well-defined protein-
polymer conjugates is to use polymers with specific ligands. The binding affinity 
between polymers and proteins is crucial for the stability of conjugates. Biotin 
and streptavidin with high binding affinity (Ka ≈ 1015 M
−1) are most exploited to 
prepare numerous conjugates.[21, 26] PolyNIPAM, PEG, PHEMA, and other 
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polymers have been conjugated to various proteins and substrates by the 
interactions between biotin and streptavidin.[129-131] As non-covalent 
interaction between biotin and streptavidin is highly stable and resistant to 
organic solvents, denaturants (e.g. guanidinium chloride), detergents (e.g. 
sodium dodecyl sulfate, Triton), proteolytic enzymes, and extreme temperature 
and pH, they have been used extensively. Streptavidin covalently bound with 
PolyNIPAM was shown to co-precipitate biotinylated immunoglobulin G (IgG) 
above 37 °C and used for the purification of biotinylated proteins.[30] 
Biotinylated poly(L-lysine)-graft-poly(ethylene glycol) was absorbed on the 
negatively charged surface and sequentially immobilized streptavidin and 
biotinylated goat antirabbit immunoglobulin (αRIgG-biotin) for the sensing of 
rabbit IgG target molecule.[132] Other non-covalent interactions are much less 
reported for protein-polymer conjugation. One of the example is to obtain 
PEGylated BSA protein-polymer conjugate by host–guest interaction between 
the macrocycle cucurbit[8]uri (CB[8]), viologen (MV7) and naphthalene (Np8), 
which form the CB[8] ternary complex with a good binding affinity (overall 
binding constant, Ka, of 1.5 × 10
9 M-2, Figure 1-6).[133] The interaction between 
NTA and His6 was used for the PEGylation of his-tagged tumor necrosis factor-
related apoptosis inducing ligand (TRAIL) while it failed to reach complete 
complexation of PEG and his-tagged TRAIL at any ratio. Charged polymers such as 
poly(amidoamine)s[134] and PEG with oligo-lysine or oligo-arginine side 
groups[135] were used for the conjugation of negatively charged proteins such 
as β-galactosidase[134] and insulin[135], while large excess of polymers are 
required for a full and stable complexation with targeted proteins and the 
binding between polymers and proteins is always poorly defined. Weak 
interactions between ligands on both polymers and proteins cause the instability 
of the protein polymer conjugates, which restricts the application of non-
covalent interactions for the construction of protein-polymer conjugates.  
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Figure 1-6. Polymer-protein conjugates obtained by the host–guest interaction between 
CB[8], MV7 and Np8.[133] Reproduced with permission from ref. 133. Copyright 2011 
Royal Society of Chemistry.   
“Grafting fromʺ strategy was first reported by the group of Prof. Heather D. Maynard’,  
and the general idea is to grow the polymer directly from the proteins.[35, 36] The 
advantage of “grafting fromʺ comparing to “grafting toʺ is that no purification of excess 
polymers is required and the polymer location can be easily identified. The “grafting 
fromʺ involves two steps: the synthesis of protein macroinitiators and polymerization. 
Protein macroinitiators are obtained by the covalent binding of maleimide and pyridyl 
disulfide initiators to the cysteine residues on the proteins or coupling initiators on the 
protein through molecular recognition.[36] For example, BSA and lysozyme were 
modified with pyridyl disulfide- and maleimide-functionalized initiators for atom transfer 
radical polymerization (ATRP). Polymerization of NIPAM from the protein 
macroinitiators resulted in thermosensitive BSA−PolyNIPAM and lysozyme−PolyNIPAM 
in greater than 65% yield.[36] Streptavidin was coupled with a biotinylated initiator for 
ATRP. Various polymers including PNIAM and poly(ethylene glycol) methyl ether 
methacrylate (PEGMA) were grown directly from modified streptavidin.[35] Narrow 
polydispersities (PDIs) of polymers can be obtained by using the grafting from approach 
and the proteins remain active after ATRP or (reversible addition−fragmentation chain-
transfer) RAFT polymerization.[35-38] The disadvantage of the “grafting fromʺ strategy 
is that it involves two step reactions and the steric hindrance of proteins will 
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dramatically influence the polymerization and the final conjugation efficiency. Both 
“grafting fromʺ and “grafting toʺ approaches require a careful determination of the 
suitable polymers with proper physico-chemical properties and the precise location on 
the proteins for the polymer conjugation, to maximally preserve the native structures of 
proteins and their activity. 
1.1.1.2. Site-specific protein-polymer conjugation  
As discussed above, the non-specific reaction of polymers with the lysine or cysteine 
residues on the proteins provide a heterogeneous mixture of proteins modified to a 
different extent and at variable location. Many PEGylated protein products are produced 
using this type of chemistry. The negative impact brought by the polymer conjugation 
can’t be underestimated. For example, the attachment of polymers induced an 
alteration of the protein structure and converted human growth hormone into a growth 
hormone receptor antagonist.[39] The development of unnatural amino acid 
mutagenesis and enzymatic catalysis enables the incorporation of unique functional 
groups, that are not found in natural amino acids, into intended modification sites. The 
protein-polymer conjugates produced by site-specific conjugation are well-characterized, 
homogenous and show high reproducibility.[8] 
There are two strategies for the site-specific polymer conjugation. One strategy is to 
mutate residues bearing an active group such as lysines into less reactive residues. For 
example, all the lysine residues of tumor necrosis factor-α (TNF-α) were replaced with 
other amino acids with the preservation of full bioactivity.[40] The resultant mutant was 
then site-specifically PEGylated at the N terminus. This mono-PEGylated TNF-α mutant 
showed higher bioactivity in vitro and greater antitumor therapeutic potency than non-
specifically mono-PEGylated wild-type TNF-α.   
Another strategy is to incorporate unique functional groups or linkers into intended 
modification sites for the polymer conjugation. The incorporation is mainly achieved by 
two approaches: chemical modification and unnatural amino acid mutagenesis.  
Chemical modification. The unique reactive properties of the N terminus have led to 
several strategies dedicating this location for site-selective protein modification.[41] N-
terminal amino groups have lower pKa values compared to that of lysine side chains, and 
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can be used for direct acylation reactions by selecting the appropriate pH value.[42] 
However, in most cases the selectivity of this reaction is limited due to the presence of 
the large number of competing lysine residues (10–40 on most proteins). Alternative 
strategies have targeted the N terminus in combination with specific amino acid side 
chains such as N-terminal cysteine, N-terminal aspartic acid, and other residues. In 
particular, the reaction of N-terminal cysteine residues with thioesters has shown a 
great success for site-specific protein conjugation.[43] N-terminal cysteine residues can 
be modified through thiazolidine formation by using aldehyde reagents (Figure 1-7).[44] 
Reactive aldehydes can be formed through periodate oxidation of N-terminal serine and 
threonine residues,[45] or though N-terminal aspartic acid residues reacted with 
glyoxylic acid and O-benzylhydroxylamine. N-terminal tryptophan residues can be 
modified through Pictet–Spengler reactions to get reactive aldehydes.[46]  
 
Figure 1-7. Conjugation of Polymer (R) with aldehyde group to N-terminal cysteine on 
the protein.   
An alternative strategy that does not depend on the nature of the amino acid side chain 
can be envisioned through the oxidation of the N-terminal amino group to an imine, 
followed by hydrolysis to a ketone or an aldehyde. However, reaction conditions are too 
harsh to maintain the folded structure of most proteins.[47]  
Unnatural amino acid mutagenesis. A variety of in vitro (cell-free) methods have been 
developed to incorporate unnatural amino acids into proteins by using the existing 
protein biosynthetic machinery of the cell with excellent translational fidelity.[10] As 
they do not represent the topic of this thesis, more details about this process will not be 
given. 
Another promising approach to fabricate protein-polymer conjugation is the recognition 
between certain ligands on the polymers and the existing tags on the proteins.[5] In 
general, recombinant proteins contain tags so that they can be purified from their crude 
biological source using an affinity technique. The location of the affinity tag on the 
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proteins is well known. They are therefore great candidates for site-specific protein-
polymer conjugation. However, up to now the application of affinity tags on the proteins 
is restricted to small molecular modification, such as site-specific fluorescent or 
radioactive labelling,[48-50] and very few publications are reported for the protein-
polymer conjugation.[5, 51] The problem is that most affinity tags recognize specific 
antibodies, which increases the difficulty of the synthesis. His6, which is the most used 
affinity tag for the protein purification, specifically binds nitrilotriacetic acid-Me2+ 
chelator (NTA-Me2+). However, relative low binding affinity between NTA-Me2+ and His6 
hinders the application as a linker for protein-polymer conjugation.[52] 
1.1.1.3. Conjugation of multiple proteins to polymers  
The polymers for protein conjugation are mostly end group active, therefore, the 
current protein-polymer conjugates have mainly two types of structures: one protein 
bearing a single polymer chain by site-specific protein-polymer conjugates, and one 
protein randomly bearing multiple polymer chains produced by non-specific protein-
polymer conjugation. However, polymers are able to build up more complicated 
structures with proteins, and one possibility is to conjugate multiple proteins on a single 
polymer chain. This strategy is inspired from viruses, with which interactions between 
multiple trimers of the hemagglutinin on the virus surface and multiple moieties of N-
acetylneuraminic acid on the surface of the target cell occurs.[53, 54] Now, polymers are 
designed with multiple ligands for the binding of viral surface proteins , which can inhibit 
the interaction of virus with healthy cells and consequently stop the virus infection.[55] 
However, the conjugation of polymers with multiple free proteins was rarely reported. 
Two publications from Prof. Laura L. Kiessling used polymers as scaffolds for protein 
oligomerization (Figure 1-8).[56, 57] Even though polymer-protein conjugates have been 
developed for more than 40 years, only few investigations have been dedicated to the 
conjugation of multiple proteins to a polymer, although previous studies already proved 
that the formation of protein cluster on polymers can enhance the protein activity.[57]  
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Figure 1-8. Schematic representation of concanavalin A clustering by multivalent ligands 
on polymers.[56] Reproduced with permission from ref. 56. Copyright 2002 American 
Chemical Society.   
1.1.2. Proteins in polymer self-assembled structures 
Polymer-protein conjugates have been largely used for various applications especially as 
therapeutics, which have been approved by the Food and Drug Administration 
(FDA).[136] However, the limitations of polymer conjugation as an approach for protein 
protection have also been described.[6] The polymers are able to efficiently protect 
proteins against the proteolysis in the body, but cannot stop the permeation of small 
molecules through the polymer shield and protect proteins from the change of 
conditions which can induce the inactivity of proteins, such as pH, ions strength, and 
solvents,.[137, 138] In addition, targeting molecules are required on the polymer shield 
for targeted delivery, but the modification of polymers with targeting molecules such as 
antibodies can be problematic and the reaction process has the risk to inactivate the 
proteins. To avoid all of these problems, polymer supramolecular structures with 
specific sealed reaction spaces at the nanoscale level were described for proteins.[61-63, 
66] The selective transport of molecules across the membrane can be achieved by the 
insertion of membrane proteins.[68, 69, 139, 140] Elaborate designs of polymer 
properties provide different physicochemical environments for the accommodation of 
proteins and preserves the characteristic of synthetic materials such as stability and 
mechanical robustness. The proteins can be encapsulated, inserted, or attached to the 
self-assembled structures based on the physicochemical properties of both proteins and 
polymers without affecting their functions.[67, 68, 70-72] For example, the water-
channel protein Aquaporin Z (AqpZ) was incorporated into the membrane of polymeric 
vesicles self-assembled by poly(2-methyloxazoline)-block-poly(dimethylsiloxane)-block-
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poly(2-methyloxazoline) (PMOXA-b-PDMS-b-PMOXA). A large enhancement in water 
productivity, up to 800 times compared with the one of vesicles without AqpZ, was 
observed.[69] Superoxide dismutase (SOD) and lactoperoxidase (LPO) were 
coencapsulated in polymeric vesicles formed by the self-assembly of PMOXA-b-PDMS-b-
PMOXA. The enzymes acted in tandem inside the polymeric cavities and converted 
reactive oxygen species O2
- to H2O2, which can further react with amplex red and 
produce fluorescent resorufin. In addition, the reconstituted outer membrane protein F 
(OmpF) in the polymer membrane allowed the passive diffusion of resorufin outside of 
the cavities (Figure 1-9).[68] The combination of proteins and amphiphilic block 
polymers (ABPs) will be further discussed. 
 
Figure 1-9. Enzymatic cascade reaction inside polymeric vesicles for detection and 
superoxide radical detoxification.[68] Copyright 2011 WILEY-VCH Verlag GmbH & Co. 
KGaA. 
ABPs are composed by a hydrophilic block (water-loving) and hydrophobic block (water-
repellent). Due to the dual affinity of the blocks, the polymers self-assemble into 
different morphologies in solution depending on molecular parameters (hydrophilic-to-
hydrophobic block length ratios, molecular weight, etc.) and external factors 
(preparation methods, concentration, buffer, etc.).[65,73] Spherical structures including 
micelles and vesicles are mostly used and investigated. In the following sessions, the 
combination of proteins with polymeric micelles and polymeric vesicles will be reviewed.  
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Figure 1-10. Schematic presentation of the structure of micelles (A) and vesicles (B).  
1.1.2.1. Proteins in polymeric micelles   
Polymeric micelles are obtained by self-assemby of ABPs in aqueous solutions at 
concentrations above the critical micelle concentration (cmc).[141] The hydrophilic 
block will orient towards aqueous environment while the hydrophobic block orients 
inward to shield it forming a core-shell structure. Compared with small molecular weight 
surfactant micelles, the cmc of polymeric micelles is much lower, resulting in a slower 
rate of dissociation. Therefore, polymeric micelles are more stable than surfactant 
micelles in different environments.[142]  
The size of polymeric micelles is usually in the range of 10-100 nm. In addition, the 
structures and physicochemical properties of polymeric micelles can be modulated by 
changing the internal factors (such as chemical nature of polymers, molecular weight, or 
hydrophilic-to-hydrophobic block length ratios) or external factors (such as temperature, 
ionic strength, solvents or preparation methods).[144] Increasing the temperature 
reduces the size of polymeric micelles due to the improved polymer solubility and raised 
CMC value.[144, 145] Even though polymeric micelles have proven their adaptabilities 
for different environments and applications, their combination with proteins is still 
challenging. Only hydrophobic cargo can be loaded into the polymeric micelles, while 
most proteins are hydrophilic and functional only in aqueous environments. To 
overcome this limitation, Khmelnitsky introduced polymeric reversed micelles, in which 
hydrophilic blocks aggregate to form the core while hydrophobic blocks extend away 
from the core.[146] Different enzymes such as laccase and α-chymotrypsin have been 
loaded into the micelles and used for synthetic, non-aqueous enzymology.[146-148] 
There are two main problems with this strategy: (1) enzymes are denatured and their 
specific activity is extremely low when working in organic solutions; (2) the restricted 
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working conditions (non-aqueous environment) limits the applications of protein-loaded 
polymeric reversed micelles in vitro or in vivo.       
1.1.2.2. Proteins in polymeric vesicles 
Polymeric vesicles are microscopic sacs formed by the self-assembly of ABPs in aqueous 
solution due to their amphiphilic nature.[64] The formation of either vesicular or 
micellar structures by ABPs is decided by internal and external factors as mentioned 
above.[64, 65, 73] A hydrophilic/hydrophobic ratio between 16% and 27% is desirable to 
obtain vesicular structures.[65] Increasing molecular weight of ABPs promotes the 
vesicle formation and enhances the stability of structures attributed to the increase of 
membrane thickness.[65]  
Polymeric vesicles can be regarded as higher molar mass homologues of conventional 
lipids, which are the basic components forming cell membranes of bilayer structure. The 
polymer membrane in vesicle structures plays the role to partition aqueous volumes of 
different compositions and concentrations. Therefore, vesicle structures are able to 
provide customized and isolated environments for the proteins and maximally preserve 
their activities.[70, 80] In addition, due to the presence of hydrophobic domain inside 
the membrane, hydrophobic proteins such as membrane proteins are able to insert into 
polymer membranes and maintain their functions such as active or passive transport of 
molecules.[69, 140]        
Various enzymes have been encapsulated in polymeric vesicles, acting as nanometer-
sized reaction compartments. By encapsulating enzymes inside polymer vesicles, 
enzymes preserve their activity, while being protected from the inhibition and the 
degradation induced by denaturing agents such as ethylenediaminetetraacetic acid 
(EDTA) and proteases. Due to the high thickness of polymer membranes and their low 
membrane fluidity compared with lipid membranes, generally only gases and oxidant 
species can pass through the membrane by passive diffusion. To achieve in situ reactions, 
selectively permeable polymer membranes capable of exchanging substrates and 
products are required to maintain the reactions. Principally, it is possible to create, by an 
elaborate design, block copolymers that form porous membranes,[149, 150] but high 
selectivity is rarely achieved. A more elegant approach is to induce the selectivity of 
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membranes by the insertion of membrane proteins. Selective transport of water and 
protons have been performed by the insertion of aquaporin[69] and gramicidin in 
polymeric membrane composed by PMOXA-b-PDMS-b-PMOXA triblock copolymer. The 
combination of polymeric vesicles with proteins including both enzymes and 
hydrophobic membrane proteins generate new complex nanosystems, such as 
nanoreactors,[63, 68, 80, 81]  used for biosensor development, or as new therapeutic 
and theragnostic agents.   
1.2. Hybrid nanosystems based on polymers and DNA 
DNA is a highly specific macromolecule that can be programmed to self-assemble into 
complex structures due to the free energy of base pair formation.[82, 83] The current 
technology is already able to virtually synthesize any DNA sequence, and amplify any 
DNA sequence from microscopic to macroscopic quantities by polymerase chain 
reaction (PCR). Another attractive feature of DNA is its ‘stiffness’ feature (length < 50 
nm), which corresponds to 150 base pairs in the double helix. Double-stranded DNA 
(dsDNA) behaves as a rather rigid and straight polymer chain below this size, and can be 
used as a rigid spacer between two tethered functional molecular components at each 
end.[84] In addition, the physicochemical stability of DNA is much higher than that of 
proteins. Hence, nanostructured materials constructed from DNA can be synthesized, 
processed, and stored under a broad range of environmental conditions without the 
requirements of special precautions to avoid decomposition of DNA materials. Moreover, 
nature provides a variety of highly specific enzymes which allow the processing of DNA 
materials with atomic precision.[85] The DNA molecules can be either cleaved 
specifically at a known site by restriction endonucleases, glued together by the sticky 
ends on each DNA to make one molecule, specifically modified to either 3’- or 5’- 
terminus by terminal deoxynucleotidyl transferase (TdT), and amplified from 
microscopic to macroscopic quantities by polymerase. For example, high molecular-
weight circular plasmid NA (pBR322, 4361 bp) was digested by a DNA restriction enzyme 
(Alw26I) into three dsDNA segments. The dsDNA segments could be ligated with dsDNA-
polymer conjugates by DNA ligase (Figure 1-11).[74]  
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Figure 1-11. Schematic representation of the extension of dsDNA-polymer conjugates by 
DNA ligase. [74] Reproduced with permission from ref. 74. Copyright 2011 Royal Society 
of Chemistry.   
 DNA has been combined with inorganic materials like gold nanoparticles[25, 87, 88] and 
small organic moieties like fluorescent dyes[89] for various applications, such as cancer 
detection and gene therapy.[82, 90-95, 152] In recent years, a new type of nucleic acid 
hybrid has emerged, which consists of synthetic oligonucleotides and organic 
polymers.[24, 75, 96] As a consequence of joining these two classes of materials in DNA-
polymer conjugates (DPCs), new materials preserving the features of DNA and exhibiting 
additional ones due to the presence of polymers are obtained. As various interactions 
existing in DPCs such as hydrophobic and electrostatic interactions, and the helix 
features of double strand DNA, nanostructures based on DPCs are able to self-assemble 
into diverse nanostructures including micelles and vesicular structures. These nano-
scaled DNA hybrid materials hold the promise for the programmable construction of 
functional materials and gene relative therapies, such as nanodevices, antisense, and 
aptamer therapeutic strategies.  
1.2.1. DNA-polymer conjugates  
Existing chemistry routes allow the versatile synthesis of DNA-polymers conjugates with 
a large choice from the composition, property, length, and architecture from both DNA 
and polymer point of view. A general approach to ligate DNA and polymers is by the 
reactions at the 5’- or 3’- terminus, due to the higher accessibility of these positions. In 
general, DNA used for the polymer conjugation is represented by synthetic 
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oligonucleotides (ODNs). ODNs are linked to either hydrophilic polymers or hydrophobic 
polymers depending on the desired application. The linkage of hydrophilic polymers to 
ODNs improves their aqueous stability and decrease immunogenicity, resulting in a 
reduction of the toxicity and the prolongation of in vivo circulation times. The most used 
hydrophilic polymer is PEG due to the uncharged, water-soluble, non-toxic, and non-
immunogenic nature.[97, 98] The combination of hydrophobic polymers with ODNs in 
general leads to self-assembly in aqueous solutions.[24, 96] The increase of size of ODN-
bearing structures is able to take full advantage of the EPR effect for passive DNA 
delivery.  
1.2.1.1. Synthesis for DNA-polymer conjugation 
Polymers are commonly connected to ODN sequences either in solution or on a solid 
support. The coupling reaction on a solid support can be used for achieving both water-
soluble and amphiphilic DNA–polymer conjugates (ADPCs) with relatively high yields.[20, 
99, 100] However, carrying out the coupling reaction between ODN sequence and 
hydrophobic polymer segments in solution results in low yields, because of the 
incompatibility between the two components. Recently, new approaches such as 
enzymatic reactions have been performed to obtain DPCs, especially for the ones with 
high DNA molecular weight.[74, 101] The pros and cons of different methods are 
discussed in the following sections.  
Solution Coupling. Solution coupling is the first approach for DNA-polymer conjugation. 
Four main coupling reactions in solution have been reported: amide bond formation, 
disulfide bond formation, Michael addition and click reaction (Figure 1-12).[99] In the 
first approach, the amino group of the ODN fragment reacts with the activated carboxyl 
group of the polymer and these two parts are linked by amide bond formation. The 
reaction conditions and activating agents are similar with that for peptide synthesis. 
N,N’-diisopropylcarbodiimide (DIC), N,N’-dicyclohexylcarbodiimide (DCC), N-
hydroxysuccinimide (NHS), and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) 
are the most used activating agents. In order to bind an ODN with a polymer by a 
disulfide linkage, both components are required to undergo a terminal thiol-
modification and the reaction is carried out in slightly alkaline conditions in an aqueous 
phase. In the case of Michael addition reaction, thiol-functionalized ODNs react with the 
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polymers containing maleimide or acrylic acid functional group at neutral pH. High yields 
of DNA–polymer conjugates can be obtained by using the approaches discussed above. 
But these approaches are only restricted for the coupling between ODNs and hydrophilic 
polymers, such as poly (ethylene oxide) (PEO)[76, 77] and PolyNIPAM[102, 103] due to 
poor solubility of DNA in organic solvents. In addition, the yield of the coupling reaction 
in solution is generally low due to the random coil feature of both single stranded DNA 
(ssDNA) and polymers in the solution, which leads to a low exposure of the end group 
for coupling reactions.[20] Moreover, the purification of DPCs from non-reacted DNA 
and polymers can be problematic due to the comparable molecular weight and 
hydrodynamic size of DNA-polymer conjugates compared with free DNA and polymers.    
 
Figure 1-12. Coupling methods for DPCs synthesis in solution.[99]  
Solid-phase synthesis. It has been mentioned above that the preparation of ADPCs by 
solution coupling is still not proficient due to the poor yields and the problematic 
purification. To overcome these synthetic difficulties, solid-phase synthesis has been 
employed and shows a higher yield comparing to solution coupling approach.[20, 99] 
ODNs are manufactured almost exclusively using automated solid-phase synthesis. All 
the potential reactive groups along the ODN fragment are protected during the 
synthesis. Therefore the ODN fragment immobilized on the bead is soluble in organic 
solvent. This feature helps the compatibility of ODNs and polymers in organic solvent. 
The protection of potentially reactive groups along the ODNs limits the side reactions, 
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improving the yield as well. In addition, the automation of solid-phase synthesis avoids 
performing tedious chemistry and purification steps.  
The coupling between ODNs and polymers by a solid-phase synthesis approach can be 
done by the three reactions mentioned above, as well. In addition, the polymers with 
phosphoramidite groups are able to couple to the detritylated 5’-hydroxyl-end of the 
ODN on the solid support using a DNA synthesizer directly and no modification of DNA is 
needed.[104] Phosphoramidite-polymer derivatives are synthesized by reacting 
hydroxyl-terminated polymers with phosphoramidite chloride. After cleavage from the 
resin and deprotection with a concentrated ammonia solution, ODN-based copolymers 
can be obtained. Several ADPCs such as DNA-block-polypropylene (DNA-b-PPO),[96] 
DNA-block-poly(2-alkyl-2-oxazoline),[75] poly(2-oxazoline)-graft-DNA[143] have been 
synthesized by solid-phase synthesis approach with high yields. For example, the 
synthesis of DNA-block-poly(2-alkyl-2-oxazoline) is shown in Figure 1-13.[75] However, 
the main drawback of ADPCs is that it is very hard to find a good solvent for both DNA 
and hydrophobic polymers due to the huge difference in polarity between the two 
components. Therefore, a successful synthesis of ADPCs cannot guarantee that they can 
dissolve or self-assemble in aqueous solution after deprotection. A latest study found 
that the complexation of hydrophobic contracts such as surfactants elevate the solubility 
of DNA in organic phase.[105] However, a careful design of the hydrophilic/hydrophobic 
ratios is still crucial for the preparation of ADPCs.   
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Figure 1-13. DNA-block-poly(2-alkyl-2-oxazoline) synthesized by solid-phase 
synthesis.[75] Reproduced with permission from ref. 75. Copyright 2013 WILEY-VCH 
Verlag GmbH & Co. KGaA.  
Enzymatic Reactions. The greatest disadvantage of the solid-phase synthesis approach is 
that it is only available for short length ODNs and polymer segments due to the limited 
diffusion of the reactants through the pores of the solid support and the exposure of the 
terminal groups. Recently, elegant molecular biology methods have been adapted to the 
synthesis of DNA–polymer conjugates in order to overcome this impediment. Herrmann 
and coworkers applied DNA PCR to synthesize DNA–polymers conjugates with longer 
DNA fragments (Figure 1-14).[101] The ODN-polymer conjugates acted as a primer and 
the plasmid pBR322 was used as a template for the PCR reaction to generate double-
stranded (ds) diblock copolymers with DNA fragments of extended length up to 1,578 bp. 
A total average molecular weight greater than 1,000 kDa and monodisperse nucleic acid 
chains could be achieved. The prolongation of DNA fragments on the conjugates can be 
done by the DNA polymerization catalyzed by TdT as well.[106] The DPCs with extremely 
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long DNA blocks were synthesized as well, based on the enzymatic restriction and 
ligation.[74] Large DNA fragments were obtained by the digestion of a circular plasmid 
DNA executed by a DNA restriction enzyme (Alw26I) and ligated to dsDNA-polymers 
conjugates with sticky ends by enzyme ligation.  
 
Figure 1-14. Schematic representation of the generation of DNA pentablock copolymers 
by PCR.[101] Reproduced with permission from ref. 101. Copyright 2009 American 
Chemical Society.   
1.2.1.2. Supramolecular assemblies of DNA-polymer conjugate 
It has already been mentioned above that ABPs containing both hydrophilic and 
hydrophobic segments self-assemble into various supramolecular structures such as 
micelles, vesicles, worms, and monolayers. Such superstructures can be used as delivery 
vehicles for therapeutic molecules, or act as the containers for catalytically active 
species. The ADPCs bring opportunities serving as containers or delivery vehicles for 
different applications.  Besides the automated and straightforward synthesis, DNA based 
self-assembled structures allow a convenient functionalization by the hybridization with 
complementary ssDNA.[107] In addition, dynamic assemblies can be obtained by the 
hybridization or enzymatic catalysis,[108, 109] which changes the balance between 
hydrophilicity and hydrophobicity in the structure and leads to a different morphology 
of the self-assembled structures. Moreover, DNA composing self-assembled structures 
exhibit high cellular uptake by different cell lines, and some ODN`s such as nucleic acid 
apatamers are able to specific bind to DNA and RNA, which make ADPCs highly 
promising for drug delivery, gene antisence and other gene therapy.[110, 111]  
A simple example of such supramolecular assemblies is the one-dimensional extension 
of DPCs. Triblock copolymer structures of the type polymer-block-DNA-block-polymer 
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are able to be formed by hybridization of two DNA-block-polymer with complementary 
sequences.[112] Large one-dimensional polymer assemblies were achieved by 
employing two DNA-block-polymer-block-DNA triblock polymers with complementary 
single strands.[113] The molecular weight could be easily controlled by the ratio of DNA-
hybrid monomers because the access of monomer efficiently induced chain termination.         
Besides extended one-dimensional assemblies, micellar morphologies have been 
obtained by DPCs. The first strategy is to form micellar structures led by the 
complexation between DNA and positively charged species. This approach is mainly 
adopted by DNA- hydrophilic polymer conjugates. For example, DNA-block-poly 
(ethylene glycol) (DNA-b-PEG) self-assembled to micellar structures by the complexation 
with positively charged peptide KALA.[114] The inner polyelectrolyte complex core is 
surrounded by the PEG chains constituting the corona, protecting the ODN from 
enzymatic degradation.  Another strategy is to build micellar structures by ADPCs. In this 
case, the assembly of the DPCs is driven by the polymer segments, which forms the 
hydrophobic core, while the DNA is present in the corona. Polystyrene (PS) and PPO 
have been used to conjugate with DNA and these ADPCs form homogeneous 
micelles.[115, 116]  Recently, vesicular structures assembled by ADPCs have been 
reported, as hydrophobic poly (butadiene) (PB) or poly (isobutylene) (PIB) coupled with 
a 12 nucleotide sequence.[117] Compared to the conventional block polymers, the self-
assembly of ADPCs is more complicated because different non-covalent interactions 
including hydrophobic, electrostatic interactions, and hydrogen bond formation are 
involved. A simpler way is assembling the structures based on the ABPs, and further 
modifying the surface of the structure by post functionalization. DNA with 
dibenzocyclooctyl group (DBCO) has been coupled to the chitosan nanoparticles with an 
azide group on the surface by a Cu-free click reaction.[118] The advantage of this 
strategy is DNA exposure to the environment, with no further influences on the self-
assembly behavior.      
Various morphologies assembled by DPCs have already been reported. Organic block 
polymers were combined with DPCs, which allows the combination of properties from 
both parts. Poly(polyethylene glycol)-block-poly (propylene)-block-poly(ethylene glycol) 
(PEG-b-PPO-b-PEG) composited with DNA-b-PPO formed a similar micellar structures to 
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DNA-block-poly (propylene) (DNA-b-PPO) alone (Figure 1-15).[119] The micelles can be 
cross-linked either at the periphery of the corona or within the core to protect them 
against disaggregation upon dilution and precipitation at low temperatures. In addition, 
mixed micelles formed by PEG-b-PPO-b-PEG and DNA-b-PPO provided the sequence 
specific recognition at the same time due to the DNA block. 
 
Figure 1-15. Schematic presentation of the mixed micelle architecture self-assembled by 
PEG-b-PPO-b-PEG and DNA-b-PPO.[119] Reproduced with permission from ref. 119. 
Copyright 2010 Royal Society of Chemistry. 
An advantage of assembled structures formed by DPCs is the ability to induce a specific 
morphology by the hybridization. It has been reported that micelles composed by DNA-
b-PPO can undergo a morphological transition from spherical to rod-like structures upon 
hybridization with long DNA sequences, while no effects on the micellar morphology 
was observed after hybridization with small single-stranded complementary 
sequences.[96] The application of DNAzyme and polymerases trigger the morphological 
transition of such assembled structures due to the change of DNA length and 
consequently the hydrophilic/hydrophobic ratio.[108]   
1.2.1.3. Applications of self-assembled structures based on DPCs 
Drug delivery vehicles. ADPC structures can be used for drug delivery due to the 
presence of their hydrophobic cores. Pyrene and anticancer drugs such as doxorubicin 
(Dox) have been successfully loaded into the micelles composed by ADPCs.[116, 120] 
ADPC-composed structures are superior due to the easy conjugation of different 
targeting moieties on the surface by simple hybridization. The “clicked” moieties allow a 
perfect control of the location depending on the conjugation of either 3’- or 5’-end of 
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ODNs. If a targeting moiety is connected to the 5’-end of ODN, it is present on the 
surface of micelles. If the conjugation is towards to the 3’-end of ODN, the targeting 
moiety is located inside of the DBC aggregates (Figure 1-16).[107] Folate has been 
conjugated to the micelle surface by the hybridization and high cellar uptake of folate 
modified micelles was observed.[120] The synthetic ODN corona has great 
biocompatibility and biodegradability, and also avoids immunological responses 
compared to plasmid DNA.[121] No toxicity of delivery vehicles composed by ADPCs was 
reported.[120] 
 
Figure 1-16. Modification of DPC micelles by hybridization with complementary ssDNA 
equipped with functional group either at the 5’- or at the 3’-ends.[107] Reproduced with 
permission from ref. 107. Copyright 2006 WILEY-VCH Verlag GmbH & Co. KgaA. 
ADPCs allow for control of the ratio between hydrophilic and hydrophobic blocks by 
enzymes, and the hybridization due to the DNA block, which results in the formation of 
diverse nanostructures, and facilitates the investigation of the relationship between 
geometry of nanostructures and cellular uptake. DNA-b-PPO micelles are able to form 
both spherical and rod-like nanostructures depending on the length of hybridized 
DNA.[109] The hybridization of DNA-b-PPO micelles with short complementary strands 
keeps the overall spherical shape of the aggregation, while rod-like micelles consisting of 
two parallel aligned double helices result when base pairing with long complementary 
strands are used. The rod-like aggregates show a higher extent of uptake than both ss 
and ds spherical micelles. 
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Nanostructures self-assembled by ADPCs show the same main drawbacks as other self-
assembled structures for in vivo applications, as they disassemble due to the dilution 
upon administration. For this reason, DNA-b-PPO system was blended with Pluronics, 
PEG-b-PPO-b-PEG, to stabilize the aggregation by crosslinking the hydrophobic 
cores.[119] The cross-linked nanostructures are much stable comparing to the one 
without crosslinking. Another approach to stabilize ADPC aggregates is to encapsulate 
the whole nanostructures in other nanocapsules. Micelles of DNA-b-PPO successfully act 
as the template for the formation of virus-like particles (Figure 1-17).[116] The Cowpea 
Chlorotic Mottle Virus (CCMV) coat protein dimers are able to attach and self-assemble 
into particles consisting of 90 and 120 proteins, respectively. Different hydrophilic and 
hydrophobic compounds have been loaded in the CCMV particle protected micelles. 
 
Figure 1-17. DPC micelles as the template for the formation of virus-like capsules and 
using for drug delivery.[116] Reproduced with permission from ref. 116. Copyright 2010 
American Chemical Society. 
Antisense therapy. Antisense ODNs are an important class of therapeutic molecules due 
to their ability to interact with their complementary target mRNA with high selectivity. 
The specific binding of ODN to target mRNA is able to block their expression and the 
production of undesirable proteins. To protect antisense ODNs against enzymatic 
degradation by cellular nucleases and promote their cellular uptake, antisense ODNs 
have been linked to polymers such as PEG and complexed with cationic molecules 
including KALA peptides, poly(l-lysine), polyethylenimine (PEI), and protamine to form 
complex micelles.[76, 114, 122] ODNs locate inside of the nanostructure to avoid the 
digestion by cellular nucleases. For example, antisense c-raf oligonucleotide-PEG 
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conjugates were complexed with PEI and self-assembled to form polyelectrolyte 
complex micelles with a diameter of approximately 70 nm in aqueous solution.[76] The 
complex micelles show a higher cellular uptake by A2780 cells than that of ODN alone 
and superior antiproliferative activity against ovarian cancer cells both in vitro and in 
vivo. 
Hydrophobic polymers have been conjugated to antisense ODNs to avoid the usage of 
cationic molecules, which have potential cell toxicity. Hydrophobic polymers drive the 
self-assembly of DPCs and form a hydrophobic core while hydrophilic antisense ODNs 
are exposed outside for the binding to mRNA. It has been observed that the dense 
packing of DNA in the micelle corona allows for hybridization of complementary 
oligonucleotides, while keeping the DNA protected from enzymatic degradation (Figure 
1-18).[24] Steric hindrance and the high local salt concentration surrounding the ODN 
corona, which prohibits the approach of cellular nucleases, are possible explanations of 
this behavior.[24, 25] Locked nucleic acids (LNAs) have been conjugated with a 
hydrophobic polymer and resulted in ADPCs that assemble into spherical micellar 
nanoparticles (LPA nanoparticles). LPA nanoparticles exhibit rapid uptake within 10 min 
across five different cell lines including human embryonic kidney cells. Treatment with 
antisense LPA nanoparticles significantly diminishes mRNA levels relative to endogenous 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA transcripts, which suggests 
efficient, sequence-specific binding of LPA nanoparticles with mRNA.  
 
Figure 1-18. Schematic of exonuclease resistance of DPC micelles.[24] Reproduced with 
permission from ref. 24. Copyright 2013 American Chemical Society. 
The unique self-recognition properties of DNA indicate DPCs are superior to other kinds 
of block copolymer assemblies, even though the studies and the developments of DPCs 
are still just beginning. DPCs form diverse architectures and the hybridization with 
complementary strands allows for easy modification and morphology transformation 
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under physiological conditions. In addition, high-density packing of ODNs in the 
nanoparticle shell renders DNA resistant to degradation by cellular nucleases. All these 
outstanding properties make DPCs ideal candidates for a new generation of smart 
biomaterials, capable of recognizing and responding to particular gene expression 
features. Multidisciplinary approaches from different fields will drive further evolution 
and realization of innovative concepts taking advantage of the unique properties of 
DPCs.     
1.3. Molecular recognition 
Molecular recognition drives highly specific interactions between molecules, and 
consequently contributes to biological recognition at the molecular level and the precise 
proceeding of numerous biological processes at the same time without any interruptions. 
In fact, molecular recognition is central to all biological processes including DNA 
replication and transcription, cellular signaling, enzyme catalysis, and so on.[123] 
Therefore, the understanding of the fundamental mechanisms of molecular recognition 
is crucial to understanding biology including the functions of proteins and DNA at the 
molecular level. 
1.3.1. Mechanism 
The highly specific interactions between substrates, which can be proteins, DNA, ligands, 
or many other molecules, rely on the perfect geometric fit between the “lock” molecule 
and “key” molecule, and the precise locational match for the formation of non-covalent 
bonds including hydrogen bonding, van der Waals forces, hydrophobic interactions, π-π 
stacking, metal coordination, electrostatic effects, and so on. The mechanism of 
molecular recognition was first suggested by Emil Fischer in 1894 and named the “lock-
and-key” model.[124] However, while this model explains the specificity of interaction 
between biomolecules, it neglects the fact that biomolecules, especially proteins, are 
inherently dynamic with a vast ensemble of conformations and fails to explain the 
stabilization of the transition state of substrates that enzymes achieve or enzymatic 
catalysis.  
A more favorable model for molecular recognition is the induced fit model suggested by 
Koshland, which considers biomolecules as flexible rather than geometrical rigid 
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structures.[27] Induced fit model suggests that the initial interaction between substrates 
is relatively weak, and the substrates undergo a continuous change the conformation 
until  the substrates are completely bound to each other (Figure 1-19, P1 transforms to 
P2L).[29] Here we use enzymes as examples. The binding of substrates to enzymes 
induce a conformational change of the enzymes and free energy is released from the 
formation of many weak interactions between the enzyme-substrate complexes. To 
maximize the release of free energy, the substrate has to be in its transition state to 
favor binding which lowers the activation energy and allows the reactants to proceed 
towards the product at a faster rate. This explains why enzymes have high catalytic 
performances.  
 
Figure 1-19. Thermodynamic cycle for molecular recognition involving induced fit or 
conformational selection.[29] Reproduced with permission from ref. 29. Copyright 2009 
Rights Managed by Nature Publishing Group.   
In 1999, Frauenfelder, Sligar and Wolynes first described the energy landscape of 
proteins, which led to the generation of the conformational selection model.[28] The 
energy landscape is a map of all possible conformations of a molecular entity in dynamic 
equilibrium. Therefore, in the conformational selection model, the conformation of 
molecules are dynamically fluctuating (P1 and P2) and the compatible conformation (P2) 
for the binding with substrate L pre-exists,[29] which has a constitutional difference with 
the induced fit model (Figure 1-19). The binding of substrate L to P2 induces the shift of 
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the equilibrium towards this state and consequently results in the “population shift”. 
Even though lots of efforts have been made to understand the mechanism of molecular 
recognition, so far no final conclusion, especially for proteins, has been reached.[125] 
The studies are also mainly restricted to binary systems, and very few expansions have 
been developed for polyphyletic systems. 
1.3.2. From molecular recognition to self-organization 
Molecular recognition relies on the molecular information stored in the interacting 
partners, such as hydrogen bonding arrays, sequences of donor and acceptor groups, ion 
coordination sites, etc. Each specific interaction occurring between partners is an 
intermolecular algorithm, directing the self-organization of molecules into complex 
matters. The specificity and the stability of the self-organization are based on the 
robustness of the molecular recognition. When the molecular recognition is sufficiently 
strong, more or less strict programming of the output species and “correct” 
constructions can be achieved. Biotin and streptavidin possess one of the strongest non-
covalent interactions in nature and have been used for the fabrication of various nano 
devices and sensors based on this strict recognition. Carbon nanotubes modified with 
biotin have been used as a nano detector for the binding of streptavidin.[31] The binding 
of streptavidin to the carbon nanotubes induces a charge-transfer reaction between 
them and the change of device characteristic. This nanodetector is extremely sensitive 
and promising for in-vivo applications (studying cell physiology, medical screening and 
diagnosis).[31]  Different inorganic nanoparticles such as gold nanorods and iron oxide 
nanoparticles are also organized by Biotin-streptavidin interactions targeting the 
applications for nanodevices.[32, 33, 151] By inspiration from nature, synthetic binding 
pairs such as NTA and His6, cyclodextrin and adamantine are also frequently adopted for 
the nanofabrication of diverse architectures and nanodevices. Self-assembly is 
considered as a simple collection and aggregation of components into a confined entity 
by non-covalent interactions, while self-organization is information-directed 
organization of specific molecules into certain structures under equilibrium conditions. 
The selectivity and robustness of the interactions ensure the correct expression and 
precise output of the structural instruments stored in molecules. 
32 
 
When several structural instructions (specific binding pairs) exist at the same time, multi 
subroutine self-organizations are displayed: (i) it may be that each instruction generates 
its own encoded output and directs one subprogram independently; (ii) it may present 
crossover and the subprograms operate in a combined fashion; (iii) it can also be that 
one of the instructions is dominant and impose its own output over the other one(s). 
The process of multiple well-defined supramolecular interactions in molecular-level is 
crucial for the development of complex chemical systems, as known by the execution of 
highly integrated functions taking place side by side in the assembly and operation of  
living cells. 
When the molecular recognition occurs only in a narrow range of conditions and are 
highly sensitive to internal factors (such as pKa) or external factors (such as 
concentrations and stoichiometries of the components), the system is unstable and may 
display a switching point between different assemblies. For example, pH can induce a 
morphology-shifting of DNA-b-poly(propylene oxide) assemblies from spherical micelles 
to nanofibers.[126] However, due to this sensitivity to the perturbations, the diversity 
and the adaptability are attributed into the self-organization process.  
1.4. Motivation and concept 
In this respect, we aim at the design and the construction of different hybrid 
nanosystems based on polymer/protein, polymer/DNA, and polymer/DNA/protein to 
understand biological interactions such as distance-dependent protein-protein 
interactions, mimic cell’s organization, such as multicompartmentalization, and achieve 
novel functionalities such as signal transduction. We designed polymers with specific 
structures and aim to control the self-organization of polymers and protein/DNA, or 
nanostructures such as DNA-functionalized polymersomes. To generate systems with 
higher complexity, diversity, and programmability, several algorithms (influence factors) 
are imputed in the systems and operated in a combined fashion within the self-
organization process. Molecular recognition acts as the main algorithm for the self-
organization. Internal factors such as the size and external factors such as pH and 
temperature as the co-algorithm are read and expressed within the same process in 
order to programmably control the architectures, interactions, functionalities, and so on. 
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Two hybrid systems are established in this thesis. First, we designe and synthesize tris-
nitrilotriacetic acid (trisNTA) functionalized polymers (PNTs) and use as polymeric 
scaffold for the binding of multiple his-tagged proteins. The molecular recognition 
between trisNTA on polymers and his tag on proteins ensures the specific connection 
between polymers and proteins with high stability under different conditions (pH 4). In 
addition, the distance between trisNTA binding sites on polymers and the size of his-
tagged molecules regulates the binding ability, the binding affinity, and protein-protein 
interactions of bound proteins in a combined manner. Moreover, the nature of the 
selected Me2+ connecting trisNTA and His tag and the distance between trisNTA binding 
sites on PNTs can influence the binding affinity between trisNTA on polymers and his-
tagged proteins, which can result in the switching of polymer-protein conjugates from 
static (stable) to dynamic (pH-responsive) state. PNT copolymers can serve as models for 
combining geometric topology with size requirements and mimicking biological systems. 
They are also promising as protein nanocarriers for protein therapy and other protein-
related applications. 
In the second system, we apply DNA as the algorithm to program the self-organization of 
binary polymersomes (compartments) to create multi-compartmentalized system. DNA 
is capable of controlling the spatial organization and the spatial distance between 
compartments due to the rigid nature of double-strand (<50 nm), while polymersomes 
as nano-scale cavities supply a robust and shielded encapsulation method of the active 
entities. The extension of the polymersome network can be programmably controlled by 
the average DNA coverage on vesicle surface, concentration and temperature. In 
addition, the size of polymersomes plays an important role in the assembly behavior and 
results in different architectures. The polymeric compartmentalized network system 
offers a new perspective onto evolution from unitary to binary/polyphyletic systems, 
with collective specific properties greater than of the individual building blocks, and 
serve as a platform for the generation of novel multi-functional, intelligent and complex 
systems and bio-devices. 
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2.1. Introduction 
A key challenge in life science research and protein engineering is to modify, conjugate, 
immobilize and label the proteins selectively, while preserving their specificity and 
activity.[1-4] Because the random conjugation might lead to a significant decrease of the 
proteins activity due to the blocking of the access to the active site and the alternation 
of the structure, specific binding is highly desired.[5, 6] One of the most commonly 
employed approach for site-specific protein modification targets the cysteine residues 
from protein structures, because it is less frequent in the structure of various 
proteins.[7-9] Nevertheless, very few proteins present only one cysteine residue. 
Besides, the insertion of free cysteins by genetic engineering increases the risk of 
incorrect disulfide formation and protein dimerization.[10] Specific binding based on the 
molecular recognition represents an alternative for protein modification. Various 
specific binders, including natural binders such as biotin,[11] antibodies,[12] and 
synthesized chelators such as NTA,[13] iminodiacetic acid (IDA),[14] are commonly 
applied for the protein labeling, modification and immobilization. NTA and its derivatives 
gained more interest due to their ability to bond specifically only to his tag, which 
commonly exists on the proteins for the binding affinity purification.[15, 16] The 
interaction between metal-ion-chelating NTA (NTA-Me2+), such as NTA-Cu2+ and NTA-
Ni2+, and his tag is stable, selective and switchable by competing agents such as 
imidazole and EDTA.[15, 17] The chelators containing multi-NTA exhibit an increased 
binding affinity towards his tag, especially trisNTA that shows the highest selectivity and 
affinity, 4 orders of magnitude higher comparing with NTA.[18] Moreover the 
interaction between trisNTA and His-tagged proteins is reversible in the presence of 
different agents. The presence of imidazole or EDTA can easily separate the His-tagged 
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proteins from trisNTA-Me2+ without disturbing the structure and activity of proteins.[18, 
19] Therefore, trisNTA is an ideal candidate for the binding of his-tagged proteins. 
Fluorescent-labeled trisNTA and trisNTA quantum dot conjugates have been already 
used for the labeling and tracking of individual his-tagged proteins in live cells.[20-22] 
TrisNTA functionalized poly(butadiene)-block-poly(ethylene oxide) binds to His6-eGFP 
without affecting its fluorescence.[23] However, to the best of our knowledge, the 
functionalization of polymers by trisNTA is limited to the terminal ends of the polymers 
and the applications of trisNTA-modified polymers remains at the simple conjugation 
between polymers and proteins.[23]  
Here, we have synthesized a library of novel poly (N-isopropylacrylamide-co-tris-
nitrilotriacetic acid acrylamide)s polymers (PNTs), and complexed them with Cu2+ to 
serve for conjugation of his-tagged molecules. The target is to create a flexible polymer 
based model and apply it for the investigation of protein-protein interactions as a 
function of intermolecular distance. More details are presented in Chapter 3. First, the 
polymers were fully characterized by 1H NMR and gel permeation chromatography (GPC). 
The amount of trisNTA in polymers was evaluated by 1H NMR and acid-base titration. 
The coordination of copper to the trisNTA pockets was characterized by fourier 
transform infrared spectroscopy (FTIR), UV-vis spectroscopy, and electron paramagnetic 
resonance (EPR). Then, the binding of His6 to trisNTA was proved and quantified by fast 
protein liquid chromatography (FPLC), FTIR, isothermal titration calorimetry (ITC) and 
EPR.   
 
Figure 2-1. Schematic representation of PNTs, which coordinate Cu2+, and further bind to 
sulforhodamine B labelled His6 (SRB-His6). 
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2.2. Results and discussion 
2.2.1. Synthesis and characterization 
Tert-butyl ester protected PNTs (3) were synthesized by free radical polymerization of N-
isopropylacrylamide (NIPAM) and t-butyl ester protected tris-nitrilotriacetic acid acrylate 
(prot-trisNTA) (2) using azobisisobutyronitrile (AIBN) as initiator (Scheme 2-1). 
PolyNIPAM was chosen due to its high hydrophilicity and biocompatibility. Molar ratios 
of prot-trisNTA and NIPAM in the range 1:99 and 10:90 were used for the 
polymerization in order to obtain polymers with different average distances between 
trisNTA binding sites (Table 2-1). 
Scheme 2-1. Synthesis of prot-trisNTA and PNT copolymers. 
 
Table 2-1. Polymerization of PNTs. Molecular mass and polydispersity.  
polymer 
code 
Polymerization of protected PNTs deprotection 
prot-trisNTA (mol%) Yield 
(%) 
GPC results Yield 
(%) 
Mnc 
(×104) in 
feed 
in 
polymera 
In 
polymerb 
Mn 
(×104) 
Mw/Mn 
PNT7 10.0 8.3 6.8 60 3.00 1.8 95 2.47 
PNT4 5.0 4.2 4.1 63 2.95 1.8 69 2.59 
PNT2 3.0 2.3 1.9 56 2.68 1.7 96 2.47 
PNT1 1.0 0.8 0.8 55 3.45 1.7 94 3.34 
PolyNIPAM 0 0 - 62 2.48 1.7 - - 
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a Calculated based on integration of the 1H NMR spectrum. b Evaluated by acid-base 
titration. c The values were calculated based on the molecular mass, and polymer degree 
of protected PNTs obtained by GPC and 1H NMR results, respectively. 
The structure of prot-trisNTA was first confirmed by 1H NMR (Figure 2-2). The peaks 
between δ=5.53 ppm and δ=6.26 ppm correspond to protons from acrylic groups. The 
peaks at δ=3.48, δ=3.43 and δ=3.38 ppm correspond to protons from cyclam and NTA 
scaffolds. The large peak at δ=1.42 and δ=1.38 ppm correspond to protons from tert-
butyl esters. The observed mass of 1630.1 for [MNa]+ by ESI-MS spectra was in 
agreement with the theoretical value of 1630.0. The formation of PNT copolymers with 
different trisNTA mol% was established by 1H NMR (Figure 2-3). The characteristic peaks 
of prot-trisNTA appear at δ=3.44 ppm, δ=3.50 ppm, δ=1.48 ppm and δ=1.45 ppm, while 
the NIPAM peaks at δ=4.00 ppm and δ=1.16 ppm correspond to protons on –CH– and 
methyl groups. trisNTA contents of 0.8 - 8.3 in all copolymers was calculated from the 
ratios between the integrals of the peaks at δ=3.44 ppm and δ=3.50 ppm (from trisNTA), 
and the peak at δ=4.00 ppm (from –CH– of NIPAM) (Figure 2-3).  
 
 
Figure 2-2. 1H NMR, 13C NMR and ESI-MS of prot-trisNTA. 
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Figure 2-3. 1H NMR spectra of PolyNIPAM and PNTs containing 2 mol% and 7 mol% of 
prot-trisNTA. 
1H NMR peaks at δ=1.43 ppm and δ=1.40 ppm (characteristic of tert-butyl ester groups) 
disappeared after the deprotection of the polymers, indicating a total deprotection 
(Figure 2-4). We used an acid-base titration to estimate the total trisNTA content (Table 
2-1). These values were slightly lower than those obtained from 1H NMR, because 1H 
NMR can induce some systematic errors in the estimation of the molar ratio of 
trisNTA/NIPAM repeating units in polymers, due to baseline distortion. Thus we used the 
trisNTA mol% values obtained from acid-base titration for subsequent calculations. 
 
Figure 2-4. 1H NMR spectrum of PNT7 after deprotection. 
2.2.2. Temperature and pH responsiveness 
It is important to understand the factors which might affect the binding ability, such as 
the stimuli-responsiveness of PNT copolymers. It’s already been well-known that 
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PolyNIPAM undergoes phase transition around 32 °C. Copolymerization of NIPAM with 
hydrophilic or hydrophobic monomers changes the hydrophilic/hydrophobic balance 
and results in a shift of phase transition temperature to a higher or lower temperature, 
respectively [24, 25]. The thermo-responsiveness of PolyNIPAM also becomes pH-
dependent after copolymerization with acrylic acid derivatives. Therefore, the phase 
transition of the library of PNT copolymers at different pH was assessed by UV-vis 
spectroscopy (Figure 2-5). In contrast to PolyNIPAM and copolymers composed of 
NIPAM and acrylic acid derivatives, such as poly (NIPAM-co-acrylic acid) (pKa=4.5),[26] all 
PNT polymers showed no phase transition at pH > 3, because of the low pKa values of 
NTA (1.9, 2.5 and 9.7).[27] 67% trisNTA units are ionized at pH > 3, resulting in a 
significant increase in hydrophilicity of the PNTs. At pH values < 2.3, below the pKa2 of 
NTA, tris-NTA is partly protonated and exhibits hydrophobicity, resulting in a phase 
transition for PNT2 and PNT4. PNT7 with 6.8 mol% trisNTA only showed 
thermoresponsive behavior at pH values < 1.8. A sharp phase transition for all five PNT 
copolymers was observed at pH 1.0. As the experiments were conducted in PBS buffer at 
room temperature, there was likely no aggregation of the PNTs copolymers. 
 
Figure 2-5. Absorbance dependence of temperature (5-70 °C) for PNT copolymers (1 
mg/mL) at pH 1-3. His6 binding behavior of trisNTA units from PNT copolymer.  
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2.2.3. Coordination of Cu2+ to PNT copolymers 
It has already been reported that Cu2+ can coordinate to trisNTA pockets and the binding 
stoichiometry between trsiNTA and Cu2+ is 1:3.[18] To investigate whether the 
conjugation of trisNTA to the polymers influences its coordination with Cu2+, FTIR 
experiments were first performed (Figure 2-6). The absorption band at 1723 cm-1 
assigned to C=O stretching vibration of carboxylic group on trisNTA, shifted to 1618 cm-1 
in the presence of Cu2+, indicating the coordination of Cu2+ to carboxylic groups.[28] The 
complete disappearance of the specific peak at 1723 cm-1 showed that all the carboxylic 
groups chelated Cu2+. For the trisNTA functionalized copolymers such as PNT7, a total 
shift of specific absorption band from 1633 cm-1 assigned to C=O stretching vibration of 
carboxylic group to 1627 cm-1 was observed as well, which proved that all the trisNTA on 
the polymers involved in the binding of Cu2+.    
 
Figure 2-6. FTIR spectra of trisNTA (black), trisNTA-Cu2+ (red), PNT7 (blue) and PNT7-
Cu2+(green). 
In addition, the binding of Cu2+ to the polymers was investigated by UV-vis spectroscopy 
(Figure 2-7). All copolymers showed similar UV-vis spectra and PNT2 was taken as a 
representative example. The coordination of PNT2 induced a shift of maximal 
absorbance of Cu2+ from 800 nm to 850 nm, in agreement with the data obtained from 
trisNTA-Cu2+ complex shown in Figure 2-7 as well. The absorbance intensity of Cu2+ 
increased as well after the coordination. The extinction coefficient of trisNTA-Cu2+ was 
determined as 143 M-1cm-1 by plotting the absorbance at 850 nm vs. its concentration. 
Because the polymer in low concentration doesn’t have absorbance around 850 nm, the 
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concentration of trisNTA-Cu2+ on polymers in solutions was determined by the extinction 
coefficient of trisNTA-Cu2+. As shown in Figure 2-8, the actual amount of trisNTA-Cu2+ on 
polymers was in good agreement with the theoretical value, suggesting that the binding 
between trisNTA and Cu2+ strictly implemented as 1:3, and no influence of the 
conjugation of polymers was observed for all PNT copolymers.    
 
Figure 2-7. UV-vis spectra of CuCl2 (black), CuCl2–His6 complex (red), PNT2-Cu
2+ complex 
(blue), PNT2-Cu2+ - His6 complex (green) and trisNTA-Cu
2+ complex (pink) in water at pH 
7. The concentration of CuCl2 is 0.9mM for all the samples. The molar ratio between 
CuCl2 and TrisNTA is 3:1.  
 
 
Figure 2-8. The theoretical (blue) and experimental (red) concentrations of trisNTA-Cu2+ 
in different trisNTA-containing copolymer aqueous solutions. The concentration of 
copolymers is 1.5 mg mL-1. The theoretical concentration was calculated by 1.5 × 
(polymer degree) × (trsiNTA molar ratio) × 3 × 1000 / (molecular weight of polymer).    
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2.2.4. Binding of His6 to PNT copolymers 
In order to evaluate the binding ability of Cu2+-loaded polymers to his-tagged molecules, 
His6 was initially chosen as the appropriate model because of its smaller size. The 
binding of His6 to the Cu
2+-loaded polymers was first confirmed by FTIR (Figure 2-9). The 
absorption bands of His6 at 1176 cm
-1 and 1124 cm-1 relate to ring vibration of imidazole, 
which shift to 1189 cm-1 and 1135 cm-1 after the coordination of Cu2+, respectively.[29] 
First, the presence of His6 was observed by its distinctive absorbance at 1176 cm
-1 and 
1124 cm-1 after the purification for both trisNTA-Cu2+ and PNT7-Cu2+ (Figure 2-9). The 
absorption bands of His6 at 1176 cm
-1 and 1124 cm-1 shifted upward as well after the 
presence of both trisNTA-Cu2+ and PNT7-Cu2+, indicating that His6 coordinated to the 
polymers through the coordination of Cu2+ ions.  
 
Figure 2-9. FTIR spectra of His6 and His6-Cu
2+ (a), trisNTA-Cu2+ and His6-Cu
2+-trisNTA (b), 
PNT7-Cu2+ and His6-Cu
2+-PNT7 (c), respectively.  
FPLC was performed to evaluate the binding ability of PNT copolymers to His6 and 
identify whether there is an unspecific binding between his6 and PNTs. Figure 2-10a 
showed a typically analytical chromatogram of Cu2+-loaded polymers. The polymer was 
52 
 
eluted after 1.5 mins and had almost no absorbance at 570 nm. The free sulforhodamine 
B-labeled His6 (SRB-His6) had a strong absorbance at 570 nm and was eluted later due to 
the smaller size comparing to PNTs (Figure 2-10c). After mixing Cu2+-PNT7 with SRB-His6, 
the analytical chromatogram showed two peaks when detected at 570 nm by UV-
detector, indicating that two SRB-His6 fractions were present in the solution (Figure 2-
10b). The first fraction is attributed to polymer-His6 conjugates, indicating by the 
overlapped location of PNT7’s elution peak alone (Figure 2-10a). The broad peak 
observed later belongs to the free SRB-His6. Based on the integral area of the two peaks 
shown in Figure 2-10b, the binding stoichiometry between trisNTA-Cu2+ on PNT7 and 
His6 was estimated at 1:0.8. The binding stoichiometry between His6 and trisNTA-Cu
2+ on 
PNT1, PNT2 and PNT4 were determined as well and the value remains close to 1:1 
(Figure 2-11). The relative low binding stoichiometry between trisNTA-Cu2+ on PNT7 
(1:0.8) and His6 is due to the decrease of the distance between trisNTA binding sites, 
which sterically hampers the binding of His6 to the polymer. The unspecific interaction 
between His6 and polymers were investigated by a chromatography analysis of 
PolyNIPAM incubated with Cu2+ and fluorescein-labeled His6 (FITC-His6). As shown in 
Figure 2-10e, only one peak was observed after 7 mins at 490nm, which suggested that 
there is no unspecific binding between His6 and the polymers. This proves that the 
binding of His6 to the PNTs are achieved by the specific interaction between trisNTA-Cu
2+ 
and His6. 
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Figure 2-10. Chromatograms of PNT7-Cu2+ (a), PNT7-Cu2+ with 1.5-fold molar excess of 
SRB-His6 (b), free SRB-His6 (c), and the comparison of PNT7-Cu
2+with SRB-His6-PNT7-Cu
2+ 
complex(d). Control experiments including PolyNIPAM incubated with 2-fold molar 
excess of Cu2+ and FITC-His6 (e) and PNT7 incubated with 2-fold molar excess of FITC-His6 
(f). 
 
Figure 2-11. Chromatograms of PNT1-Cu2+ (yellow), PNT2-Cu2+ (pink) and PNT4-Cu2+ 
(green) with 1.2-fold molar excess of SRB-His6. 
As shown above, the decrease of the distance between trisNTA binding sites decreases 
the binding stoichiometry between trisNTA-Cu2+ and His6. To confirm the influence of 
the distance between trisNTA binding sites to the binding stoichiometry and binding 
affinity, a series of ITC were performed (Figure 2-12). The complex formation is 
exothermic as expected for a reaction in which the coordination bonds are formed.[30] 
The stoichiometry between trisNTA-Cu2+ and His6 is 1:1, which agrees with results 
reported previouly (Table 2-2).[18] The conjugation of trisNTA to polymers doesn’t show 
an obvious influence to the binding stoichiometry between trisNTA-Cu2+ and His6 for 
PNT1, PNT2 and PNT4, but a decrease of the binding stoichiometry for PNT7 from 1:1 to 
1:0.79. This result agrees with the one obtained from FPLC. The slightly decrease for 
PNT7-Cu2+-His6 is due to steric hindrance determined by the decrease of the distance 
between trisNTA binding sites. The decrease of the distance between trisNTA binding 
sites reduces the distance among coordinated His6 and polymers, which may increase 
the noncovalent interactions in the system. This is reflected by the change of enthalpy 
(∆H°).[31, 32] For the PNT1-Cu2+-His6 and PNT2-Cu
2+-His6 complexes, the value of ∆H° 
are basically the same with the ∆H° value obtained from trisNTA-Cu2+-His6, which means 
∆H° is only determined by the coordination of His6 to trisNTA (Table 2-2). When the 
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distance between trisNTA binding sites is reduced, the enthalpy is decreasing and 
compensated by negative entropy (∆S°). The decrease of enthalpy and the loss of the 
entropy value suggested there are other interactions except the coordination of His6. A 
possible explanation is that the decrease of the distance between trisNTA binding sites 
increases the possibility of hydrogen bonding between His6 and polymers, which 
contributes to the ∆H° value additionaly.[33, 34] The hydrogen bond formation restricts 
the change of the conformation of the polymers, which may shield some of trisNTA 
binding sites and lead to a decrease of the binding stoichiometry. The binding affinity 
can be established by meaning dissociation constants (KD). A low KD suggests a strong 
non-covalent interaction. As shown in Table 2-2, the conjugation of trisNTA to the 
polymer doesn’t influence the binding affinity. The decrease of the distance between 
trisNTA binding sites induces a decrease of KD value, suggesting that the interaction 
between trisNTA-Cu2+ and His6 is more stable. This agrees with the pervious conclusion 
and an extra interaction between His6 and polymers enhances the stability between 
trisNTA-Cu2+ and His6.   
 
Figure 2-12. ITC thermograms (top) and titration curves (bottom) of TrisNTA-Cu2+ (a1), 
PNT1-Cu2+ (a2), PNT4-Cu2+ (a3), and PNT7-Cu2+ (a4) with His6, respectively. 
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Table 2-2. Binding stoichiometry (N), KD, ∆H° and ∆S° for the binding between trisNTA 
functionalized polymers and his-tagged molecules. 
 N KD (µM)
a 
∆H° 
(kcal/mol) 
∆S° 
(cal/mol/K) 
TrisNTA-Cu2+ 1 0.39 ± 0.03 -20.7 ± 0.3 His6 
PNT1-Cu2+ 0.98 ± 0.02 0.30 ± 0.02 -19.4 ± 0.2 -40.1 
PNT2-Cu2+ 0.856 ± 0.01 0.17 ± 0.01 -19.8 ± 0.2 -35.3 
PNT4-Cu2+ 1.01 ± 0.01 0.13 ± 0.01 -23.0 ± 0.1 -35.3 
PNT7-Cu2+ 0.79  ± 0.01 0.10 ± 0.01 -25.8 ± 0.2 -45.5 
A previous study reports that I28 immunoglobulin with two his tags was used to cross-
link copolymers composed by acrylamide and NTA methacrylate into hybrid hydrogels 
through the binding between his tags of proteins and metal-coordinated NTA.[35] To 
investigate whether single His6 can cross-link trisNTA functionalized copolymers, 
dynamic light scattering (DLS) was carried out with PNT1 and PNT7 before and after the 
complexation. As shown in Figure 2-13, the distribution of hydrodynamic radius of 
polymers are in the range of 3-4 nm, which agrees with the published value of 
polyNIPAM with similar degree of polymerization.[36] After complexation of Cu2+ and 
His6, no obvious changes of the hydrodynamic radius were observed. This suggests that 
no cross-binding happened between trisNTA-Cu2+ and His6, therefore no aggregation or 
self-assembled structure such as particles was observed.  
Figure 2-13. Distributions of the hydrodynamic radius of PNT1 (a), PNT7 (b) and the 
complexes in PBS buffer as measured by DLS at 25°C, scattering angle of 90°. 
EPR spectroscopy was used to identify the Cu2+ coordination sphere when complexed to 
trisNTA on PNT polymers, and after addition of His6, since the spectral parameters are 
known to change upon modification of the metal coordination sphere inside the NTA 
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pocket induced by complexation with His6.[37] Different model systems were studied 
and compared: CuCl2 in solution (a), and mixtures of Cu
2+ with PolyNIPAM, His6, with 
trisNTA (c), with PNT1 (g) and with both PNT1 and His6 (i) (Figure 2-14, and Table 2-3). 
The Cu2+ EPR spectrum in the presence of PolyNIPAM was similar to that of free Cu2+, 
which indicates that the metal is not coordinated by the polymer chain. In the presence 
of His6 and trisNTA two species were detected: one similar to free Cu
2+, and one with gz 
and Az values similar to those reported for the Cu
2+ complexes of these molecules.[23] In 
the case of Cu2+ complexation with PNT1 polymer only one species was detected (Figure 
2-14(g)) with spectral parameters indicative of tetragonal symmetry[38] and similar to 
those for the Cu2+ complexation of trisNTA;[23] thus the Cu2+ coordination sphere 
involves three carboxyl groups and one amine group. The value of g and A tensors 
indicate a tetragonal symmetry.[38] When His6 was added to Cu
2+: PNT1 the EPR 
spectrum changed significantly (Figure 2-14(i)). The signal was poorly resolved due to a 
significant broadening. The values of both g and hyperfine coupling differ from those 
observed for the Cu2+: PNT1 mixture, and are similar to the hyperfine coupling constants 
to those reported for Cu2+ dimers (Ax 27 G, Ay 38 G and Az 82 G).[39] The formation of 
the dimers is also supported by the signal recorded at half-field, which is typical for 
dimeric Cu2+ (Figure 2-15). A similar behavior was described for Cu2+: NTA: His6 mixtures, 
where the formation of Cu2+ dimers was proposed.[23] 
 
Figure 2-14. (a) X-band CW-EPR spectra of frozen solution in distilled water at 100 K 
together with their simulations using the EPR parameters indicated in Table 2-2: CuCl2 
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solution (a), and the related simulation of its EPR spectrum (b), Cu2+-trisNTA mixture (c) 
with the related simulation of the EPR spectrum (d), Cu2+-PNT1 mixture (g) with ithe 
related  simulation of EPR spectrum (h), Cu2+-PNT1: His6 mixture (i) with  the simulation 
of its EPR spectrum (j). (e) and (f) are individual contributions of paramagnetic species to 
the simulation (d). All EPR spectra are normalized for presentation means. 
 
Figure 2-15. Experimental X-band CW-EPR spectrum of a frozen solution of Cu2+-
PNT1:His6 mixture in water at half-field. 
Table 2-3. EPR spectral parameters for frozen solutions of Cu2+ in CuCl2, Cu
2+-trisNTA, 
Cu2+-His6, Cu
2+ mixing with PolyNIPAM, Cu2+-PNT1 and Cu2+-PNT1-His6 complexes. The 
hyperfine values are given for the 63Cu nucleus. 
 gx, gy gz |Ax|,|Ay|/G |Az|/G 
CuCl2 2.080  2.38          5  140 
Cu(Cl)2:PolyNIPAM 2.083  2.38  5  142  
Cu(Cl)2:His6 (3:1)  
 
Cu(OTf)2:His6 (1:5)
34 
2.082, 2.089  
2.082 
2.074 
2.42 
2.28 
2.37 
5 
5 
5 
115 
120 
105 
Cu(Cl)2:trisNTA (3:1) 
 
Cu(OTf)2:trisNTA (1:5)
34 
2.082, 2.090  
2.089, 2.100  
2.061 
2.41  
2.34  
2.302 
10, 15 
10, 5 
10  
120 
154 
120 
Cu(Cl)2:PNT1 2.068 2.30 10 154 
Cu(Cl)2:PNT1: His6 2.062, 2.080 2.35 30, 35 80 
2.3. Conclusion 
We have designed and synthesized a library of novel poly (N-isopropylacrylamide-co-tris-
nitrilotriacetic acid acrylamide)s bearing multi-trisNTA binding sites. PNT copolymers are 
1200 1400 1600 1800
Magnetic Field / G
Cu(Cl)
2
:PNT1:His
6
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able to chelate with Cu2+ in a stoichiometry of 1 to 3 and further conjugate with His6 
with high binding affinity. One His6 binding to one trisNTA on the polymers was 
observed for PNT1-PNT4 while a decrease of binding stoichiometry for PNT7 is due to 
the limited space and steric hindrance. The decrease of the distance between trisNTA 
bind sites favors the binding affinity of his6 to the polymers due to the intermolecular 
interactions, and results in the increase of ∆H° and the decrease of ∆S°.  
2.4. Experiment section  
Materials  
Materials. All chemicals were purchased from Sigma-Aldrich and used as received unless 
otherwise noted. N-isopropylacrylamide (NIPAM) and azobis(isobutyronitrile) (AIBN) was 
recrystallized twice from hexane and menthol, respectively. Hexahistidine was 
purchased from GenScript and his-tagged collagenase was purchased from Proteos 
Biotech.  
Synthesis and characterization of prot-trisNTA and PNT copolymers 
t-butyl ester protected tris-nitrilotriacetic acid acrylate (2). Chemical 1 was synthesized 
according to protocols published previously (Scheme 2-2).[40] Acryloyl chloride (335 mg, 
3.7 mmol) was added to a solution of 1 (4.11 g, 2.64 mmol) and N,N-
diisopropylethylamine (682 mg, 5.28 mmol) in 50 mL of  dichloromethane, cooled in an 
ice bath, then purged with N2 over night. The reaction mixture was washed with 
saturated NaHCO3 and brine sequentially. The organic phase was dried in anhydrous 
MgSO4. After removal of the solvent, the residue was isolated on silica gel using 
EtoAc/Hex (10/1) as eluent. A transparent oil was obtained in 91% yield.  1H NMR (400 
MHz, CDCl3); δ = 6.26-6.09 (m, 2H, CH2=CH-); 5.56-5.53 (d, 1H, CH2=CH-); 3.84-3.40 (br, 
15H, -N(CH2COOC(CH3)3)2 and -CHNCOOC(CH3)3); 3.4-3.3 (s, 16H, -CONCH2CH2CH2NCO- 
and -CONCH2CH2NCO-); 3.30-3.13 (br, 2H, -CO(CH2)4CH2NHCOCH=CH2); 2.86-2.46 (m, 6H, 
-COCH2CH2CH-); 2.46-2.16 (m, 2H, -COCH2(CH2)4NHCOCH=CH2); 2.15-1.69 (br, 10H, -
COCH2CH2CH- and -CONCH2CH2CH2NCO-); 1.69-1.48 (m, 6H, -
COCH2(CH2)3CH2NHCOCH=CH2); 1.48-1.05 (d, 81H, -N(CH2COOC(CH3)3)2 and -
CHNCOOC(CH3)3); 
13C NMR (400 MHz, CDCl3) δ = 24.5, 25.1, 26.3, 27.7, 28.0, 28.4, 28.7, 
32.4, 38.9, 47.2, 53.3, 53.5, 64.0, 80.2, 80.3, 80.4, 80.9, 81.1, 125.4, 131.3, 165.5, 170.2, 
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170.3,  171.7, 171.9, 173.0, 173.5; MS (ESI+, C82H142N8O23) Calculated mass: 1607.0 
Observed mass: 1630.1 [MNa]+ 
t-butyl ester-protected PNTs (3). t-butyl ester-protected PNTs containing various trisNTA 
contents were synthesized by free radical polymerization initiated by AIBN under inert 
gas. All polymerizations were carried out in DMF at 65 °C. The concentration of 
monomers was 1mol/L and the concentrations of initiator for PolyNIPAM and PNTs are 
2% based on the monomers ratio. The reaction time for PolyNIPAM, PNT1, PNT2 and 
PNT7 is 36 h, and PNT4 is 18 h. After cooling to room temperature, the polymer was 
dissolved in an excess of CHCl3 and loaded on a silica column chromatography eluted by 
CHCl3. A further purification was carried out by a precipitation from methanol solution 
into ether ester. 1H NMR (400 MHz, CDCl3); δ = 4.20-3.87 (br, -CONHCH(CH3)2 (NIPAM); 
3.84-3.43 (br, -N(CH2COOC(CH3)3)2 and -CHNCOOC(CH3)3); 3.43-3.30 (br, -
CONCH2CH2CH2NCO- and- CONCH2CH2NCO-); 3.30-3.01 (br, -CO(CH2)4CH2NHCO-); 2.80-
2.52 (br, COCH2CH2CH-); 2.52-2.41 (br, -COCH2(CH2)4NHCO-); 2.41-1.79 (br, -
COCH2CH2CH- and -CONCH2CH2CH2NCO-); 1.79-1.66 (s, -CO(CH2)5NHCO-); 1.54-1.33 (d, 
N(CH2COOC(CH3)3)2 and -CHNCOOC(CH3)3); 1.27-0.94 (br, -CONHCH(CH3)2 (NIPAM).  
Deprotected PNT copolymers (4). t-butyl ester-protected polymers were deprotected by 
dissolving them in an excess of TFA at 0 °C. After stirring for 4 h at room temperature, 
excess amount of MeOH was added and the solvent was evaporated in vacuum. The 
copolymers were then dialyzed (MWCO 3500-5000) against double-distilled water for 2 
days to remove small molecules.1H NMR (400 MHz, CDCl3); δ = 4.33-3.98 (br, -
N(CH2COOC(CH3)3)2 and -CHNCOOC(CH3)3); 3.98-3.79 (br, -CONHCH(CH3)2 (NIPAM); 3.79-
3.33 (br, -CONCH2CH2CH2NCO- and -CONCH2CH2NCO-); 3.28-3.04 (br, -
CO(CH2)4CH2NHCO-); 2.96-2.65 (br, COCH2CH2CH-); 2.56-2.35 (br, -COCH2(CH2)4NHCO-);  
2.35-2.11 (br, -COCH2CH2CH-); 2.11-1.86 (br, -CONCH2CH2CH2NCO-); 1.85-1.43 (br, -
COCH2(CH2)3CH2NHCO-); 1.32-0.92 (br, -CONHCH(CH3)2 (NIPAM).  
1H and 13C NMR spectra were recorded on Bruker DPX-NMR (400 MHz) instrument and 
chemical shifts are reported as δ values (ppm) relative to internal Me4Si. The molecular 
weight and molecular weight distribution were analyzed by gel permeation 
chromatography (GPC), which was carried out on an Agilent 1100 Series instrument 
equipped with Viscotek I-columns (I-GUARD-0478 (40 mm x 7.8 mm), I-MBHMW-3078 
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(300 mm x 7.8 mm, exclusion limit ˃ 10⋅106 g mol-1), and I-MBMMW-3078 (300 mm x 
7.8 mm, exclusion limit ˃ 10⋅106 g mol-1). N,N-Dimethylformamide (DMF) containing 20 
mM lithium bromide was used as mobile phase with a flow rate of 1.0 mL min-1 at 45 °C. 
Polystyrene standards were used for calibration. Acid-base titration was carried out to 
estimate the trisNTA content in polymers. The titration was performed by adding the 
0.01 M standard NaOH solution with a microburet to 1 mg/mL polymer aqueous solution. 
The pH vs the amount of NaOH was recorded and the concentration of carboxylic group 
in 1 mg/mL polymer aqueous solution was estimated. The trisNTA content in each 
polymer was calculated.  
 
 
 
 
 
 
 
 
 
 
 
Scheme 2-2. Synthesis of compound 15-[8,11-Bis-[4-(bis-tert-butoxycarbonylmethyl-
amino)-4-tert-butoxycarbonyl-butyryl]-4-(7-amino-hexanoyl)-1,4,8,11tetraaza-
cyclotetradec-1-yl]-2-(bis-tert-butoxycarbonylmethyl-amino)-5-oxo-pentanoic acid t-
butyl ester 
Copper chelation of the copolymers 
Respective polymers were incubated with a stoichiometric excess of copper chloride 
aqueous solution. The solution of polymer-Cu2+ complexes were adjusted to pH 7 and 
loaded onto an anion exchange column (HiTrap Q, GE Healthcare Life Sciences) to 
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remove the free Cu2+. A gradient of 0-500mM sodium chloride was used as eluent. The 
obtained solutions were desalted using a 10-kDa-Ultrafree centrifugal filter unit 
(Millipore Corporation), lyophilized, and re-dissolved in bidistilled water at a given 
concentration. The final pH of the complex solution was adjusted to 7. FTIR spectra were 
recorded on a Bruker Alpha FTIR spectrometer (Bruker Optic GmbH, Ettlingen, Germany) 
to prove the chelation of copper to the polymers. A prior lyophilization was performed 
before the FTIR measurements. UV-vis spectroscopy was carried out on a SpectraMax 
M5e Multi-Mode Microplate Reader. A standard curve by plotting the 850 nm-
absorbance of trisNTA-Cu2+ vs. its concentration was prepared. The concentration of 
trisNTA-Cu2+ in 1.5 mg mL-1 polymer aqueous solution was determined by the standard 
curve and the chelation efficiency was calculated. The concentration of bound Cu2+ was 
determined from the UV-vis spectra by using an extinction coefficient of 143 M-1cm-1 at 
850 nm, determined experimentally.  
Binding of hexahistidine to the polymer-Cu2+ complexes  
Cu2+-loaded polymers were equilibrated with 1.5-fold stoichiometric molar excess of 
SRB-His6 in PBS buffer at pH 7.4. The free SRB-His6 was removed by passing through a 
Hitrap desalting column (GE Healthcare Life Sciences), which was connected to a FPLC 
system. The elution was monitored at 290 nm and 570 nm, which are the maximal 
absorbance of polymers and SRB-His6, respectively. 
Electron paramagnetic resonance  
EPR measurements were performed on a Bruker CW EPR Elexsys-500 spectrometer 
equipped with a variable temperature unit. The spectra were recorded at 100 K with the 
following parameters: microwave power 10 mW, conversion time 61.12 ms, number of 
scans up to 100, resolution 2048 points, modulation amplitude in the range of 5 G, 
sweep width 1400 G. EPR spectra were simulated using the WINEPR Simphonia 
simulation package (Bruker); the fitting allowed the precise calculation of gyromagnetic 
tensor and hyperfine couplings values (with 5% standard error). The samples were 
prepared in distilled water at pH 7 keeping the copper concentration constant at 0.45 
mM in the salt form and also in the corresponding mixtures. Before measuring the 
samples were purged with nitrogen and the tubes were sealed with parafilm, in order to 
avoid line broadening due to the oxygen presence. 
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Investigation of polymer structures in solution 
The polymer structures in aqueous solution were investigated by DLS at 90° angle at 
room temperature with a commercial goniometer (ALV/CGS-8F, ALV Langen) equipped 
with a He:Ne linear polarized laser (JDS Uniphase, wavelength = 632.8 nm). An ALV-
5000/60X0 correlator was used to calculate the correlation function of the scattered 
light intensity which was analyzed by the CONTIN method. The concentration of 
polymers and the complexes were kept as 2 mg/mL.  
Microcalorimetry  
ITC was carried out using a VP-ITC microcalorimeter from MicroCal. For each experiment, 
the same batch of buffer or distilled water was used for all the sample preparation and 
dilution. Interaction constants characterizing the Cu2+-loaded polymers and His6 or his-
tagged proteins were determined by direct titration of His6 or his-tagged proteins to 
polymer solutions at pH 7.4 in PBS buffer at 25°C. The solution in the cell was stirred at 
300 rpm to ensure rapid mixing. The volume of sample cell and syringe are 1.4 mL and 
295 µL, respectively. Small aliquots of titrant (typically 10 µL) are successively injected 
into solution of the working cell with an adequate interval over 240 s to allow complete 
equilibration. The first injection is usually set to a volume of 2 µL because of possible 
dilution during the equilibration time preceding the measurement. The first injection 
was ignored in the analysis of the data. The heat change was monitored continuously 
upon addition of each injection of the titrant as a function of time.  
The stoichiometry value is equal to the value of the molar ratio for which the slope of 
the plot is steepest. The slope of the plot at this point gives the value of the association 
constant, KB , and the binding enthalpy ∆H° can be determined from the y-axis intercept 
of the curve. From the values for ∆H° and KB found from the plot, KD, ∆G° and ∆S° can be 
determined using the following equations:     
                                                       KD = 1/KB                                                                                (2) 
                                                       ∆G° = RT ln KD                                                                       (3) 
                                                       ∆S° = (∆H° - ∆G°)/T                                                              (4) 
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R is the ideal gas constant and T is the temperature at which the experiment was 
performed.  
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3. Combined study of molecular recognition and spatial constraints in 
protein binding and interactions using a polymer module 
Adapted with permission from J. Am. Chem. Soc., 2014, 136 (36), 12607–12614. 
Copyright 2014 American Chemical Society.   
 
3.1. Introduction 
Association and dissociation interactions/processes are fundamental to almost all the 
biological processes, such as DNA replication and transcription,[1-3] signaling 
transduciton,[4, 5] and molecular production,[6] simultaneously involving multiple 
molecules. The precise regulation of biological processes and the achievement of 
biological functions is based on accurate molecular recognition interactions and spatial 
constraints between molecules.[7-9] Molecular recognition, determined by the exact 
geometric match between interacting molecules and the formation of complementary 
noncovalent bonds,[10] plays an important role in specific interactions between 
molecules.[11, 12] In addition, the simultaneous interaction of multiple molecules is 
strongly dependent on spatial constraints when diverse binding sites of various ligands 
are located in the vicinity of each other. In nature, a large number of proteins work 
together in pairs, and the inter-protein distance influences their synergy.[13-15] An 
example is the synergy between TATA-binding protein and initiator elements. Decrease 
the distance induces stronger synergy and consequently higher activity.[16]  
Currently, the interactions and synergy of proteins can be successfully predicted by 
computer simulations,[17-19] while the influence of distance constraints on binding and 
activity of biomolecules has been reported in only very few cases.[16] In addition, 
current computer simulations do not account for variation of physical properties, such 
as entropy, that are known to be crucial for molecular recognition.[20-23] 
Nanostructures based on self-assembled DNA have been used to study inter-ligand 
distances resulting from the simultaneous binding of multiple ligands.[24, 25] However, 
DNA self-assembled structures behave as rigid scaffolds, which induce a decrease in 
binding due to spatial mismatches.[25] To the best of our knowledge, there are very few 
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model scaffolds that can specifically bind multiple proteins with controlled distances 
between binding sites, and none has used polymer-based scaffolds. 
Various polymers have been used for protein conjugation through different approaches, 
such as covalent bond formation,[26-28] or non-covalent interactions attributed to 
molecular recognition.[29-33] In particular, trisNTA functionalized polymers have been 
used to bind his-tagged proteins with multiple metal-NTA coordination pockets due to 
the high binding affinity.[34-44] As his tag normally is expressed on either the N- or C-
terminus of proteins, far away from their active centers, the binding does not influence 
their activities.[38, 45-47] For example, trisNTA functionalized poly(butadiene)-block-
poly(ethylene oxide) binds to his-tagged enhanced green fluorescent protein (His6-eGFP) 
without affecting its fluorescence,[38, 47] and his-tagged laccase preserved its activity 
when interacting with Ni2+-NTA functionalized surface.[46] However, to the best of our 
knowledge, the functionalization of polymers by trisNTA is limited to the terminal ends 
of the polymers.[47, 48] Therefore, polymer-his tagged protein interactions have been 
studied only in relation to their binding affinity via molecular recognition interactions at 
a single, specific metal-NTA pocket. An influence of distance between the NTA pockets 
on his-tagged proteins binding was only considered when NTA pockets were exposed at 
the surface of polymer vesicles.[38] 
Here, we have synthesized a library of novel PNT copolymers, and complexed them with 
Cu2+ as shown before. In the next step, PNTs is used to serve as flexible models to assess 
the combined effect of molecular recognition and spatial constraints in binding his-
tagged molecules ranging from small molecular mass molecules (< 1kDa) up to proteins 
(Figure 3-1). This library of PNTs provides different average distances between trisNTA 
sites, which can modulate the binding of multiple molecules as a function of their size. 
We selected His6, his-tagged enhanced yellow fluorescent protein (His6-eYFP) and his-
tagged collagenase G (His6-ColG) as model molecules because they provide a large range 
of sizes (from 1 to 11 nm). The binding of his-tagged molecules to trisNTA was analyzed 
by ITC. We investigated the binding affinity, and inter-molecular interactions of his-
tagged molecules bound to the polymers as a function of the specific local topology. Our 
polymers provide a dual topologic match at the molecular level involving both molecular 
recognition at trisNTA pockets, and steric effects regulated by the distance between the 
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trisNTA sites. In this way it is possible to get an insight into the fine details of binding 
affinities of molecules, which are regulated not only by attachment to a specific target, 
but also by spatial constraints. 
The concept of polymers serving as models for combined geometric topology with size 
requirements is expected to show the real binding capacity of molecules to a complex 
targeting configuration, which mimics biological systems in important details. 
PNT copolymers with high trisNTA mol% have a short average distance between trisNTA 
binding sites, and are expected to influence the binding ability and binding affinity 
between his-tagged molecules and trisNTA pockets, whereas PNT copolymers with low 
trisNTA mol% are expected to not influence the binding of His-tagged molecules. 
 
Figure 3-1. Schematic representation of PNTs, which coordinate Cu2+, and further bind to 
SRB-His6, His6-eYFP, and His6-ColG. 
3.2. Results and Discussion 
Reactivity ratio of comonomers and average distance between trisNTA binding sites 
Based on the monomer feed ratios and copolymer compositions (Table 3-1), the 
monomer reactivity ratio of trisNTA (rtrisNTA) and NIPAM (rNIPAM) were determined by 
Fineman-Ross method using 1H NMR data (Figure 3-2, 3-3, Equation 1).[67] The 
conversions of all copolymers were controlled below 18% and the copolymers 
compositions were calculated from the ratios between the integrals of the peaks at 
δ=3.44 ppm and δ=3.50 ppm (from trisNTA), and the peak at δ=4.00 ppm (from –CH– of 
NIPAM) from 1H NMR spectra (Figure 3-2). G values were plotted against H values to 
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yield a straight line with rtrisNTA as its slope and -rNIPAM as the intercept (Figure 3-3). The 
reactivity ratio of trisNTA and NIPAM were determined as 0.8 and 1.35, respectively.  
                                        𝐺 = 𝑟trisNTA𝐻 − 𝑟NIPAM                                                              (1) 
The variation of trisNTA mol% in polymer/in feed with the degree of conversion is shown 
in Figure S13. Even though rNIPAM is higher than rtrisNTA, trisNTA mol% in feeds only varied 
from 10 mol% to 13% when the degree of conversion increased from 0 to 0.62. 
Therefore, the difference of reactivity ratios of comonomers can’t obviously influence 
the trisNTA mol% in copolymers in our experimental conditions as also observed in 
Figure 3-4.  
As expected, trisNTA groups are statistically distributed on the polymer chains. We 
considered a homogeneous distribution of trisNTA groups on the polymer chain, and 
neglected possible statistical agglomeration due to the random character of 
polymerization.[53-55] 
Table 3-1. trisNTA mol% in feed and in copolymers, parameters of equations for 
copolymerization of trisNTA and NIPAM.  
Sample 
code 
ftrisNTA
a 
(mol%) 
FtrisNTA
b 
(mol%)  
fNIPAM 
(mol%) 
FNIPAM 
(mol%) 
fc Fd Ge Hf 
S1 5 4 95 96 0.053 0.042 -1.211 0.066 
S2 10 8 90 92 0.111 0.087 -1.167 0.142 
S3 30 25 70 75 0.429 0.333 -0.857 0.551 
S4 50 39 50 61 1.000 0.639 -0.564 1.564 
S5 70 66 30 34 2.333 1.941 1.131 2.805 
a trisNTA mol% in feed, b trisNTA mol% in copolymers, c f=ftrisNTA/fNIPAM, 
d F=FtrisNTA/FNIPAM, 
e G=f(F-1)/F, f H=f2/F 
A gas phase geometry of the PNT copolymers with the arrangement based on minimum 
energy conformation was built using the visualization program Avogadro. The yielded 
upper bound to the polymer length varying from 94.4 nm to 43.3 nm for PNT1-PNT7 
(Table 3-2).[68] Hence the upper bound to the distance between two successive trisNTA 
binding sites varies from 31.5 nm to 4.3 nm.  
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3.2.1. Influences to the protein binding ability  
To understand the influence of spatial constraints on the binding ability of molecules 
with high MW, we investigated the binding of two his-tagged proteins, His6-eYFP and 
His6-ColG to the PNT copolymers with different distance between the trisNTA binding 
sites. Binding of proteins to Cu2+-trisNTA sites was assessed in physiologic conditions in 
order to preserve the natural conformation of proteins.[49, 50] The dimensions of 
monomeric eYFP and monomeric ColG are 3 × 4 nm and 7 × 11.5 nm, respectively.[51, 
52] The average distances between the trisNTA-Cu2+ binding sites of PNTs was calculated 
by molecular dynamic calculations based on a minimum energy conformation. This 3D 
model describes in a first approximation the average distance between the trisNTA sites 
because repulsive forces associated to the trisNTA sites are expected to favor a Langevin 
dependence of elongation on force, and favor a stretch chain conformation. Compared 
to a normal random coil model of the polymer chain, the charges on PNTs associated to 
trisNTA sites determine that different chain conformations are no longer equally 
probable because they correspond to a different energy of the chain in the field 
produced by the electrical charges (Langevin dependence). Indeed, Zeta potential 
measurements proved the charged character of polymers in PBS buffer, due to the 
presence of metal-trisNTA sites (Table 3-3). Theoretical average distance values varied 
from 31.5 nm to 4.3 nm for PNT1-7 (Table 3-2). Note that the calculated average 
distance values are larger than the real distance between two neighboring trisNTA sites 
in solution due to the 3D conformation of PNTs. The average distance approaches the 
real distance value only when the trisNTA sites are close to each other, as in the case of 
PNT4 and PNT7.  
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Figure 3-2. 1H NMR spectra of copolymers composited with trisNTA and NIPAM. The 
trisNTA mol% in feed varied from 5% to 70%.  
 
Figure 3-3. Fineman-Ross plots for copolymerization of trisNTA and NIPAM. 
 
Figure 3-4. The variation of trisNTA mol% in copolymer/in feed with the degree of 
conversion. 
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Table 3-2. Length of polymer chain, trisNTA number per polymers and distances 
between trisNTA binding sites. 
 PNT1 PNT2 PNT4 PNT7 
polymer degree 276 182 168 127 
chain lengtha (nm) 94.4 65.9 41.4 43.4 
triNTA  number per polymer  2.2 3.5 6.9 8.6 
distances between binding sitesa (nm) 31.5 13.2 5.2 4.3 
a (distances between binding sites) (nm)= (chain length) (nm)/ (triNTA  number per 
polymer+1) 
Table 3-3. ζ potential of PNTs and Cu2+-PNTs in PBS buffer. 
ζ potential (mV) 
PNT1-Cu2+ PNT2-Cu2+ PNT4-Cu2+ PNT7-Cu2+ 
-4.4±0.3 -6.2±0.4 -8.3±0.7 -13.6±1.5 
 
To investigate the influence of spatial constraints on binding ability of his-tagged 
proteins to PNTs, we used ITC (Figure 3-5, 3-6). The highest binding stoichiometry for 
both His6-eYFP and His6-ColG (0.87 and 0.47) was determined for PNT1, which has the 
largest distance between trisNTA sites. Decreasing the distance between triNTA-Cu2+ 
groups had no influence on the binding stoichiometry of His6-eYFP, due to its relatively 
small size (3 × 4 nm), but evidently reduced the binding stoichiometry of His6-ColG from 
0.47 to 0.36. For PNT7, which has the smallest distance between trisNTA, a dramatic 
decrease in binding stoichiometry was observed for both His6-eYFP and His6-ColG (0.51 
and 0.18, respectively). This significant decrease was expected because of the 
inaccessibility of trisNTA-Cu2+ binding sites due to their close packing, which prevents 
coordination of high MW molecules. The low binding stoichiometry of His6-ColG to PNTs 
could be the consequence of His6-ColG dimer formation, which inhibits the binding to 
PNTs (Figure 3-7). An interesting observation is that proteins and polymers are able to 
arrange themselves to achieve maximal binding. When the average distance between 
trisNTA binding sites is decreased to 5.2 nm (PNT4), which is closer to the size of eYFP, 
the binding stoichiometry of the protein does not change. We attribute the binding 
stoichiometry, in the case of PNT4, to the flexibility of the polymer chain and a 3-D 
structure rearrangement, which allow the binding of eYFP even though their size is close 
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to the maximal average distance between the trisNTA sites. This is in agreement with 
previous reports, which indicated that polymers with multiple ligands are able to bind 
multiple proteins on each polymer chain.[45, 56] When the average distance decreases 
to the size of eYFP, as in the case of PNT7, the number of proteins bound to the polymer 
chain is not increased, as would have been expected by the increased number of 
trisNTA´s/polymer chain. We suppose that in this case the 3D conformation of PNT7 in 
solution induces spatial limitations, which do not favor a topologic match between 
trisNTA sites and eYFP. The binding stoichiometry of His6-ColG to PNT2 is only slightly 
higher than that to PNT4, due to the low number of ColG proteins/polymer chain, which 
prevents the distance constraints from playing a role in protein binding.  
PNTs copolymers possess higher binding capacity to small MW molecules than to large 
molecules, as expected. Although PNT7 has the highest trisNTA mol%, the binding 
capacity to his-tagged proteins is not higher than for PNT4 because of the spatial 
constraint (Table 3-4).   
 
Figure 3-5. Binding stoichiometry between trisNTA-Cu2+ groups in PNTs and His6, His6-
eYFP and His6-ColG. Stars indicate significance in two-tailed Student's t-test; *P<0.05, 
**P<0.005, ***P<0.0005. 
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Table 3-4. Average binding capacities of PNTs copolymers (per 100 repeat units). 
 His6 his-tagged eYFP his-tagged ColG 
PNT1 1 1 0 
PNT2 2 2 1 
PNT4 4 4 2 
PNT7 5 4 1 
 
 
Figure 3-6. ITC thermograms (top) and titration curves (bottom) of TrisNTA-Cu2+ (a1), 
PNT1-Cu2+ (a2), PNT4-Cu2+ (a3), and PNT7-Cu2+ (a4) with His6, respectively. Row b and 
row c represent the thermograms and titration curves of PNT1, PNT2, PNT4 and PNT7 
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with His6-eYFP and His6-ColG, respectively. The plots were fitted using the standard 
interaction model assuming a single type of binding sites. 
 
Figure 3-7. Native PAGE analysis of ColG (1, 2), NativeMarkTM Unstained Protein 
Standard (Novex) and atto488-ColG. 
3.2.2. Influences to the protein binding affinity 
High binding affinity is crucial in nature for the binding of multiple proteins. For example, 
Bcd protein is able to position at a distance close to 10 base pairs on DNA when the 
binding affinity is high, whereas the binding site arrangements of the Bcd protein 
decreases rapidly when the binding affinity is decreased.[53] Therefore, the binding 
affinity is an essential parameter for indicating the binding of multiple proteins, and for 
studying the effect of spatial constraints. We chose trisNTA for protein binding because 
of its high binding affinity for his tag and his-tagged proteins.[38, 45, 48, 54, 57] To 
investigate whether conjugation of trisNTA to polymers and the spatial constraint 
between the trisNTA sites affect the binding affinity of his-tagged molecules, we 
determined the KD values.  The KD values obtained for His6 bound to trisNTA on PNTs are 
similar to that obtained for trisNTA-Cu2+-His6 (Table 3-5), which suggests that the 
conjugation of polymer to trisNTA does not influence the binding affinity to His6. A 
higher KD (0.6±0.2 µM) value was reported for His6 bound to trisNTA-modified polymer 
vesicles, due to the presence of surrounding polyethylene oxide brushes at the surface 
of the polymer vesicles.[38]  Interestingly, the binding affinity of different his-tagged 
molecules to PNT1 was not affected by the structure or the size of his-tagged molecules, 
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but spatial constraint played an active role in the binding affinity between trisNTA and 
his-tagged molecules. When the distance between the binding sites was reduced, a 
decrease in KD was observed for all his-tagged molecules. This suggests hydrogen bond 
formation between his-tagged molecules which decreases their separation, and thus 
influences their binding.[45] It has been reported that the binding affinity of proteins 
can be enhanced when they are located closer to each other on a surface.[55, 58] PNTs 
have a higher binding affinity to his-tagged proteins compared to other trisNTA-
functionalized polymers,[47, 54] because Cu2+ was used as coordination ion instead of 
Ni2+, and it is known to favor stronger  binding than Ni2+.[38]  
Table 3-5. KD for the binding between trisNTA functionalized polymers and his-tagged 
molecules. 
 
KD (µM)
a 
 His6 His6-eYFP His6-ColG 
PNT1-Cu2+ 0.30±0.02 0.15±0.02 0.35±0.06 
PNT2-Cu2+ 0.17±0.01 0.26±0.03 0.26±0.03 
PNT4-Cu2+ 0.13±0.01 0.33±0.06 0.20±0.04 
PNT7-Cu2+ 0.10±0.01 0.07±0.01 0.20±0.04 
TrisNTA-Cu2+ 0.39±0.03   
a KD values presented in this paper were determined by ITC measurements.  
3.2.3. Spatial Constraints induce protein-protein interactions 
To get more information on the interactions between his-tagged molecules and PNTs, 
we assessed the change of ∆H° and ∆S°(Table 4).[59, 60] For PNT1-Cu2+-His6 and PNT2-
Cu2+-His6 complexes, the value of ∆H° is similar to that obtained for trisNTA-Cu
2+-His6 
(Table 3-6), suggesting that the coordination between trisNTA-Cu2+ and His6 is the only 
interaction when His6 binds PNTs copolymers. With decreasing distance between 
trisNTA binding sites, ∆H° increases, and ∆S° decreases, due to formation of hydrogen 
bonds between neighboring His6 units, and a conformation restriction of the polymer 
chain.[61, 62] Short distances and hydrogen bond formation between His6 units inhibit 
access to several trisNTA binding sites, and lead to decreases in binding stoichiometry 
for the case of PNT7 (as shown both by ITC and FPLC).  
The binding behavior between PNTs and his-tagged proteins is more complicated. When 
His6-eYFP was bound to PNTs, low ∆H° (3.6 kcal/mol), and positive ∆S° values (19.3 
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cal/mol/K) were obtained. No influence of the secondary structure of His6-eYFP was 
observed by circular dichroism (CD) spectroscopy after the coordination of PNTs (Figure 
3-8). A possible explanation to the positive ∆S° values is that His6 was not freely exposed, 
but interacted with eYFPs.[63, 64] The binding of His6 to PNTs affected the interaction 
between His6 and eYFP, and caused a total increase of ∆S°. The decrease in distance 
between trisNTA sites induced a decrease in ∆S°, due to restrictions in rotation and 
translation of the binding proteins.[65] When the distance between tris-NTA sites was 
further decreased (PNT7), the number of proteins bound to PNTs copolymers was 
unchanged (Table 3-4), and therefore ∆S° remained constant (Table 3-6). This indicates 
that no additional proteins are able to bind to the polymer due to the limited space, 
even though the number of trisNTA sites is increased.  
In contrast to PNT-Cu2+-eYFP complexes, His6-ColG binding to PNT1 is accompanied by 
an increase in ∆H° to a value of 31.7 kcal/mol, due to the formation of hydrogen bonds 
between PNTs and the protein molecules. The decrease in space between trisNTA sites 
induced an increase in ∆H° from 31.7 kcal/mol to 60.0 kcal/mol, which was compensated 
by a large decrease in ∆S° from -87.6 cal/mol/K to -177 cal/mol/K. The decrease in ∆S° is 
possibly the result of oligomerization of the proteins, as has been shown for the 
fibroblast growth factor 8b.[45] Oligomerization of proteins reduces the translational 
and rotational degrees of freedom, and induces a reduction in ∆S°. 
 
Figure 3-8. CD-spectra of eYFP and PNT4-Cu2+- eYFP in PBS buffer. 
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Table 3-6. ∆H° and ∆S° of interactions between trisNTA on PNTs and his-tagged 
molecules.   
 ∆H° (kcal/mol)a ∆S° (cal/mol/K)a 
 His6 His6-eYFP His6-ColG His6 His6-
eYFP 
His6-ColG 
TrisNTA-Cu2+ -20.7±0.3   -40.1   
PNT1-Cu2+ -19.4±0.2 -3.6±0.1 -31.7±1.8 -35.3 19.3 -87.7 
PNT2-Cu2+ -19.8±0.2 -4.7±0.1 -37.6±1 -35.3 14.3 -89.5 
PNT4-Cu2+ -23.0±0.1 -6.0±0.1 -42.9±1.7 -45.5 9.5 -123.0 
PNT7-Cu2+ -25.8±0.2 -6.8±0.1 -60.0±5.0 -54.4 9.9 -177.0 
3.3. Conclusion 
A library of PNT copolymers containing multi-trisNTA binding sites with different average 
distances between them were complexed with copper, and used as models to assess the 
combined effect of molecular recognition and spatial constraints on the binding of 
molecules ranging from small molecular mass compounds up to proteins. Small 
molecular mass molecules (His6) can easily access and bind to trisNTA sites of the 
polymers: a high binding ability of all PNT polymers was obtained, independent of the 
average distance between the tris-NTA sites. A different situation was found in the case 
of protein binding. His6-eYFP binds efficiently to PNTs only when the average distance 
between the trisNTA sites is larger than the protein size. The lowest binding 
stoichiometry was determined for interaction of His6-ColG with PNTs, due to the protein 
size (11 nm) and its possible dimerization. By controlling the amount of trisNTA on PNT 
polymers, we have efficiently controlled the binding stoichiometry, their affinity for 
selected his-tagged molecules, and their interactions in real conditions mimicking those 
encountered in biology.  
These novel polymers containing multi-trisNTA binding sites with different average 
spaces between them open a wide field of possible applications as scaffolds for multi-
binding of his-tagged proteins, or combination therapy. By selecting an appropriate PNT 
with a known average distance between the trisNTA sites and his-tagged proteins with a 
specific size, it is possible to predict the number of proteins bound per PNT chain, as well 
as their binding affinity. In addition, PNTs can be used to preorganize proteins to favor 
encapsulation of proteins inside polymeric vesicles and cellular uptake.    
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3.4. Experiment section 
Materials 
All chemicals were purchased from Sigma-Aldrich and used as received unless otherwise 
noted. His-tagged collagenase was purchased from Proteos Biotech. 
Protein expression and analysis 
eYFP expression. The expression of enhanced yellow fluorescent protein (eYFP) followed 
a previous publication.[66] The concentration was determined by UV-Vis spectroscopy, 
using an extinction coefficient ε(eYFP)513nm = 36500M
-1cm-1. The expressed eYFP has one 
His6 on N-terminal.  
PAGE analysis. Native PAGE was carried out using 4-12% Novex Tris-Glycine gels 
(Invitrogen) at 100V for 2h, using Tris-Glycine as running buffer. The gels were 
Coomassie stained with Simply Blue Safe Stain (Innitrogen). Gels were scanned by Gel 
DocTM EZ Imager (BIO-RAD). 
CD spectra were recorded using a spectral bandwidth of 1.5nm (AVIV) and 1nm 
(Chirascan) respectively, at 25 °C with a time constant of 5 s and a step resolution of 1 
nm. CD data are given as mean residual molar ellipticities (deg cm2 dmol-1). The spectra 
are the result of 2-4 accumulations. A quartz cell with a path length of 1 mm was used 
with solutions containing constant 4 µM of eYFP protein in PBS buffer. For the spectra in 
buffer the blank spectrum of the solution was subtracted.      
Collagenase G analysis. The structure of His6-ColG was confirmed by Native PAGE and 
the concentration of His6-ColG was determined by BCA protein assay. His6-ColG was 
fluorescently labeled by NHS-atto488 for the confirmation of structures. As shown in 
Figure 3-7, atto488-labled His6-ColG has only one band, but His6-ColG presents two 
bands. The band showing the same position as atto488-labled His6-ColG is very small and 
negligible. The molecular weight of His6-ColG shown on the gel is approximately double 
comparing to atto488-labled His6-ColG, which suggests His6-ColG mainly stays as a dimer 
in the solution and the fluorescent-labeled His6-ColG is monomeric due to the change of 
the chemical structure.  
ζ potential measurements of Cu2+-PNTs 
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The ζ potential of Cu2+-PNTs in PBS buffer was determined by measuring the direction 
and velocity of polymer movement in an applied electrical field using a Zetasizer Nano 
ZSP (Malvern Instrument). The zeta potential measured was reported as the average 
calculated from three readings. The concentration of Cu2+-PNTs is 1mg/mL. 
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4. A single polymer chain as a nanocarrier for multiple protein delivery 
with regulated pH responsiveness 
4.1. Introduction 
Protein therapeutics is of high importance in almost every field of medicine.[1] However, 
its functional applications are still in their infancy, as new applications are still being 
discovered. The high interest raised by protein therapeutics is mainly due to the highly 
specific actions of proteins, and their ability to regulate natural cell processes.[1, 2] 
There are still a number of challenges in the application of protein therapeutics that 
have to be overcome.[1, 3] Therapeutic proteins exhibit low stability, fast renal 
clearance, enzymatic degradation, and are frequently immunogenic.[4]  
In order to overcome these drawbacks, a combination of polymer science and protein 
therapeutics has been developed. One approach is the application of polymeric 
nanocarriers, such as polymersomes, for the delivery of proteins.[5-9] These 
nanocarriers have exhibited good protection and improved half-life of encapsulated 
proteins,[10] but unfortunately they often exhibit a low loading efficiency,[11, 12] and 
are often not rapidly eliminated from the body.[13]  
The most well-known approach for protein therapy is the conjugation of polymers, such 
as poly(ethylene glycol), to protect the protein and improve their stability, half-life, 
solubility, and reduce immunogenicity.[14-18] Polymer-protein conjugation for 
therapeutics has been developed for more than 40 years, and has led to several 
poly(ethylene glycol) conjugated proteins that are already on the market such as 
Pegloticase (Krystexxa®)[19] and Pegfilgrastim (Neulasta®)[20] for the treatments of 
chronic gout refractory and febrile neutropenia respectively. However, a number of 
deficiencies still exist that must be elegantly solved to create effective therapeutics. On 
one hand, the flexible polymer chains presented on the proteins generate a 
“conformational cloud”, which prevents interactions with blood components, enzymatic 
degradation, and fast renal clearance.[15, 21] On the other hand, this “conformational 
cloud” can obstruct normal protein-protein interactions, decreasing, or completely 
inhibiting the activity of the protein.[22, 23] To overcome this deficiency, stimuli-
responsive linkers are implemented to enable cleavage of the protein from the polymer 
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conjugate by a specific stimulus, reducing the influence of the “conformation cloud 
effect” created by the polymer chains.[24, 25] However, the toxicity of the linker must 
be kept in mind when designing the nanoparticle.[26, 27] 
Another disadvantage is that proteins are often covalently conjugated to polymers via 
lysine or cysteine residues. This results in random modification and heterogeneous 
conjugates.[28, 29] Site-specific modification of proteins is possible, but unfortunately 
often involves complicated modifications to achieve reactive sites on both the protein 
and polymer chains.[26, 30-32] Ultimately, an ideal polymer-protein conjugate needs to 
fulfill several requirements: 1) easy and versatile modification and conjugation 2) a 
linker that is stable in the bloodstream but cleavable in specific environments 3) 
polymers with a molecular weight lower than 40kDa, or biodegradable polymers that 
degrade to avoid accumulation after repeated administrations.[33]  
Currently, the main source of therapeutic proteins is the recombinant expression by 
E.coli, most commonly incorporating a His tag (His6) for easier purification. His6 also 
gives the benefit of site specific, and pH responsive binding to the metal-coordinated 
nitrilotriacetic acid (NTA-Men+).[34-36] Unfortunately, using NTA-Men+-His6 is still limited. 
Most systems are based on the presence of heavy metals, such as Cu2+ or Ni2+, in the 
NTA pocket to induce binding.[37] Repeated administrations of heavy metals can lead to 
their accumulation in the liver, kidney and spleen, and leading to organ damage.[38-41] 
In addition, neither of these two metals shows a high enough binding affinity for 
efficient polymer-protein conjugation (NTA-Cu2+-His6: log10K of 4.59 M
-1, NTA-Ni2+-His6: 
log10K of 3.76 M
-1).[42] To the best of our knowledge, there is only one study published 
recently using bisNTA-Ni2+-His6 for improved polymer-protein conjugation due to the 
increase of binding affinity compared with NTA-Ni2+-His6.[43] In addition, NTA-Me
n+ is 
capable of releasing His-tagged molecules when the pH is lower than 6,[44] but 
unfortunately, very few publications applied this chemistry for specific applications.[34]  
It is intrinsically difficult for non-covalent interactions, such as the chelation between 
NTA-Me2+ and His6-tagged proteins, to possess triggerable binding/release under mild 
biological conditions, but still exhibit high binding affinity and stability. Therefore, the 
successful design of a system combining both attributes would greatly advance protein 
therapeutics. 
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In previous chapters, we introduced poly (N-isopropylacrylamide-co-tris-nitrilotriacetic 
acid acrylamide)s (PNTn, where n represents the mol% of trisNTA on the polymer) 
containing Cu2+ for specific binding of His-tagged molecules. By increasing the trisNTA 
content in the polymer, (reducing the space between possible His-tagged binding sites) 
intermolecular interactions between bound His-tagged molecules were enhanced. 
Increasing the number of inter-protein interactions could stabilize the self-assembled 
structure, similar to many natural stabilized protein assemblies.[46-48]  
Here, PNTs are employed for a novel concept using single polymer chains as a 
nanocarrier for the simultaneous binding of multiple proteins with regulated pH 
responsiveness. Low molecular weight polymers were tested to ensure their full 
elimination from the body after pH-triggered release of a bound His-tagged protein.[14] 
For this study, His6-eYFP was chosen as a model molecule. PNTs with different average 
distances between trisNTA-Men+ binding sites were tested to incorporate the natural 
concept of increasing protein-protein interactions between His-tagged proteins to 
improve the stability of the conjugate. Three metal cations, Cu2+, Zn2+, Fe3+, were chosen 
as the coordination center in the trisNTA pocket to modulate the binding affinity of His-
tagged proteins to the polymer, and were assessed by ITC. Then their ability to 
reversibly bind based on changes in pH was analyzed by FPLC. Zn2+ and Fe3+ offer the 
possibility to reduce the inherent toxicity of the conjugated delivery system compared to 
Cu2+. By manipulating these two main factors, the distance between trisNTA-Men+ and 
the nature of the coordinated metal, the binding affinity between PNTs and His-tagged 
proteins and their pH responsiveness could be controlled. The protein stability before 
and after conjugation, as well as after pH mediated release, were measured by CD and 
fluorescence spectroscopy. The delivery of His-tagged molecules including His6-eYFP and 
His6 into living cells was investigated. 
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4.2. Results and Discussion 
4.2.1. Binding stoichiometry of His6-eYFP to PNTs coordinated with different metal 
cations 
PNT copolymers were coordinated with three different metal cations, Cu2+, Zn2+, or Fe3+, 
and the binding stoichiometry of His6-eYFP to the PNT-Me
n+ were assessed by ITC (Figure 
4-1). 
 
Figure 4-1. ITC thermograms (top) and titration curves (bottom) of PNT1-Zn2+ (a), PNT2-
Zn2+ (b), PNT4-Zn2+ (c), and PNT7-Zn2+ (d) with His6-eYFP, respectively. The plots were 
fitted using the standard interaction model assuming a single type of binding sites. 
trisNTA-Zn2+ on PNT copolymers efficiently bound to His6-eYFP with a binding 
stoichiometry approaching 1:1, when the average distance between trisNTA binding 
sites is larger than the size of His6-eYFP, as was the case for PNT1-PNT4, agreeing with 
previously published results for trisNTA-Cu2+ (Figure 4-2).[45] This stoichiometry is 
crucial for a well-defined polymer-protein conjugation and holds benefits over the 
heterogeneous conjugates often seen with modifying lysines as previously described.[28, 
49] trisNTA-Zn2+ showed the same binding stoichiometry to His6-eYFP as trisNTA-Cu
2+ 
copolymers, exemplified by both PNT4 polymers where a maximal 4 His6-eYFPs were 
able to bind per 100 repeat units of polymers (Table 4-1). However, even though PNT7 
has a higher content of trisNTA-Me2+ sites, a lower binding stoichiometry was observed 
(0.53 His6-eYFP to trisNTA-Me
2+ sites) due to steric hindrance.[45]  
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Figure 4-2. Binding stoichiometry between trisNTA-Me2+ in PNTn and His6-eYFP.  
Table 4-1. Average binding number of His6-eYFP per polymer chain.  
PNT1-Zn2+ PNT2-Zn2+ PNT4-Zn2+ PNT7-Zn2+ 
1 2 4 4 
In the case of PNTs containing trisNTA-Fe3+, no binding of His6-eYFP to the copolymers 
was observed by ITC even when high concentrations of His6-eYFP (180 µM) were added 
(data not shown). This suggests the interaction between trisNTA-Fe3+ and His6-eYFP is 
too weak for conjugating polymers with his-tagged proteins.  
4.2.2. Binding affinity of His6-eYFP to PNT-Me
2+ copolymers  
In addition to calculating the binding stoichiometry, the binding affinity of His6-eYFP to 
PNTs containing trisNTA-Zn2+ was determined. Similar to PNT-Cu2+ (0.09-0.39 µM), KD 
values for PNT-Zn2+-His6-eYFP depended on the average distance between trisNTA 
binding sites. When the distance was decreased from 31.5 nm to 4.3 nm (PNT1-Zn2+-
His6-eYFP and PNT7-Zn
2+-His6-eYFP, respectively), the KD values decreased from 1.35 ± 
0.12 µM to 0.46 ± 0.06 µM. Smaller binding site separation led to a higher local 
concentration of proteins which increased inter-protein interactions such as hydrogen 
bond formation and protein oligomerization.[50-52] These interactions can promote the 
stabilization of the whole polymer-protein conjugate. Thus, by controlling the 
coordination metal and distance between trisNTA binding sites, the amount of inter-
protein interactions and the KD of PNT-Me
2+-His6-eYFP can be regulated (1.35 ± 0.12 µM 
to 0.09 ± 0.03 µM, Figure 4-3).[50]  
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Figure 4-3. KD (M) for the binding between PNT-Zn
2+/Cu2+ and His6-eYFP. 
The binding affinity of NTA-Me2+ towards His-tagged proteins varies in the order 
Cu2+>Ni2+>Zn2+.[37] Therefore, Zn2+ is rarely used for NTA applications due to its poor 
binding affinity (log10K = 3.25 M
-1).[42] However, due to the multivalent interactions of 
trisNTA, the affinity of His6-eYFP for PNTn-Zn
2+ copolymers is greatly increased. This is 
exemplified by, at least, a 20, 130, and 420 fold decrease in KD for PNT containing 
trisNTA-Zn2+-His6-eYFP (1.35 ± 0.12 µM for PNT1-Zn
2+) compared to NTA-Cu2+-His6, NTA-
Ni2+-His6 and NTA-Zn
2+-His6, respectively.[42] The enhanced binding affinity between 
trisNTA-Me2+ and His6-eYFP suggested a higher stability of the protein-polymer 
conjugates compared with previously reported His6 and NTA-Ni
2+ (KD=41.6 µM) or 
bisNTA-Ni2+ (17.7 µM) conjugates.[43] 
4.2.3. Structure of PNT-Me2+-His6-eYFP conjugates and protein stability 
The structure of PNT-Me2+-His6-eYFP was first characterized by DLS. PNT1-Cu
2+/Zn2+ and 
PNT4-Cu2+/Zn2+ were chosen as representative polymers. The molar ratio between 
trisNTA and His6-eYFP was fixed at 2.2:1 for both PNT1 and PNT4. The average number 
of His6-eYFP per polymer chain on PNT1/PNT4 at this ratio was calculated as 1 and 3, 
respectively, and was independent of the metal used. The inter-protein interactions of 
His6-eYFP for the case of PNT1-Me
2+, at this binding molar ratio, can be neglected 
considering the low average number of His6-eYFP per PNT1-Me
2+, which is similar with 
conventional site-specific protein-polymer conjugate, binding one protein per polymer 
chain.[53-55]  
The DH of His6-eYFP and PNT4-Zn
2+ determined by DLS were 5.0 ± 0.9 nm and 5.8 ± 1.8 
nm, respectively (Figure 4-4). After binding, the diameter shifted to 13.1 ± 2.8 nm, 
similar to PNT4-Cu2+-His6-eYFP (data not shown). For His6-eYFP bound to PNT1-Zn
2+, the 
DH increased from 8.1 ± 2.5 nm for PNT1 alone to 9.7 ± 2.4 nm (Figure 4-5). The change 
in size between PNT1-Zn2+ and PNT4-Zn2+ after binding His6-eYFP can be explained by 
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the increased average number of proteins per polymer chain (3 for PNT4 and only 1 for 
PNT1). This data was supported by TEM, revealing structures with a diameter of 11.6± 
2.7 nm for PNT4-Zn2+-His6-eYFP (Figure 4-6).  
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Figure 4-4. Size distribution of His6-eYFP (a), PNT4-Zn
2+ (b) and PNT4-Zn2+-His6-eYFP (c).  
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Figure 4-5. Size distribution of PNT1-Zn2+ (a) and PNT1-Zn2+-His6-eYFP (b).  
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Figure 4-6. TEM image of PNT4-Zn2+-His6-eYFP. The scale bar is 100 nm.  
To address the question of whether the conjugation of polymers to proteins causes 
alterations in their secondary structure, His6-eYFP was characterized before and after 
polymer conjugation by CD spectroscopy. The far-UV CD spectrum of His6-eYFP and 
PNT4-Zn2+-His6-eYFP, showed that conjugation did not alter the protein structure (Figure 
4-7), agreeing with the previous published PNT-Cu2+ results. Also, the binding of PNT1-
Zn2+ to His6-eYFP did not alter the protein structure. 
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Figure 4-7. The far-UV CD spectra of His6-eYFP and PNT4-Zn
2+-His6-eYFP. 
4.2.4. PNT-Me2+-His6-eYFP stability in varying pH 
The stability of PNT-Me2+-His6-eYFP conjugates under various pH’s were investigated by 
FPLC. As shown in Figure 4-8, PNT4-Cu2+-His6-eYFP showed a higher stability than PNT1-
Cu2+-His6-eYFP at pH 7.4. The difference between PNT1-Zn
2+-His6-eYFP and PNT4-Zn
2+-
His6-eYFP was even more significant with 80.2% of His6-eYFP remaining complexed with 
PNT4-Zn2+, while only 46.6% of His6-eYFP remained bound with PNT1-Zn
2+. The higher 
stability of PNT4-Me2+-His6-eYFP compared to PNT1-Me
2+-His6-eYFP could be attributed 
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to a higher density of proteins per polymer chain that increased intermolecular 
interactions preventing the disassociation of the complex. This strategy is seen in nature 
to stabilize self-assembled structures by inter-protein interactions [46-48] and was used 
to compensate for the lower binding affinity of Zn2+ for His6 than Cu
2+ (Figure 4-8). By 
optimizing inter-protein interactions through decreasing space between trisNTA-Me2+ 
binding sites, PNT4-Zn2+-His6-eYFP remains more stable than PNT1-Cu
2+-His6-eYFP.  
Figure 4-8. Stability of PNT-Me2+-His6-eYFP conjugates at pH 7.4. (a) FPLC 
chromatograms of His6-eYFP and PNT1/4-Zn
2+-His6-eYFP. (b) The percentage of His6-eYFP 
bound with PNT1/4-Me2+. Stars indicate significance in two-tailed Student's t-test; 
*P<0.05, n=3.  
An attractive property of NTA-Me2+-His6 molecular recognition is the reversible binding 
at pH 6 [34]. Currently, no pH responsive investigations of trisNTA-Me2+-His6 have been 
shown. In order to investigate this, rhodamine B-labelled His6 (RB-His6) (which is strongly 
quenched when bound to Cu2+, and more stable than eYFP at lower pH)[56] was used. 
As shown in Figure 4-9c, the binding of trisNTA-Cu2+ to RB-His6 resulted in a significant 
decrease of fluorescent intensity from 570 to 60, remaining unchanged at pH values > 
3.3. The quenching of RB-His6 fluorescence after binding with trisNTA-Cu
2+ at pH 3.8 
(Figure 4-9c) is higher than the fluorescence shift of RB-His6 alone at the same pH (Figure 
4-9a), suggesting that RB-His6 remained unchanged after binding with trisNTA-Cu
2+. 
When the pH value dropped to 2.8, a significant increase of the fluorescence was 
observed, indicating the release of SRB-His6 from trisNTA-Cu
2+ complexes. PNT4-Cu2+-
His6 exhibited the same pH tolerance at pH > 3.5, suggesting that the presence of 
polymers does not significantly influence the binding stabilities at various pH values.  
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Figure 4-9. Fluorescence emission spectra of RB-His6 (a) conjugated with NTA-Cu
2+ (b), 
trisNTA-Cu2+ (c) and PNT4-Cu2+ (d) at different pH values.   
With the stability of PNT4-Cu2+-RB-His6 determined, pH stability of PNTn-Me
2+-His6-eYFP 
was investigated. PNT1-Cu2+ and PNT4-Cu2+ did not show a significant release of His6-
eYFP when the pH was changed from 7.4 to 6, but 53% and 52% of the conjugates 
disassociated at pH 5 (Figure 4-10). The higher percent of pH-triggered dissociation of 
PNT4-Cu2+-His6-eYFP compared with PNT4-Cu
2+-His6 (KD=0.13 µM)[45] was due to the 
higher KD. In contrast with PNT-Cu
2+, both PNT1-Zn2+ and PNT4-Zn2+ exhibited a more 
rapid dissociation. At pH 7.4 PNT1-Zn2+ had 53.4% dissociated while PNT4-Zn2+ remained 
bound. Decreasing the pH to 6.0 increased dissociation to 92% and 76%, respectively, 
with both being completely unbound at pH 5.0. The higher dissociation of PNT-Zn2+-His6-
eYFP compared with PNT-Cu2+-His6-eYFP at lower pH is attributed to the lower binding 
affinity (0.53-1.02 µM, 0.09-0.35 respectively). PNT-Cu2+ and His6-eYFP creates a stable 
conjugate, which is hard to protonate and dissociate. However, the affinity of PNT-Zn2+-
His6-eYFP is comparable to the acid dissociation constant of His6 (1 µM of Ka)[44] 
resulting in direct competition between protonation of the imidazole nitrogen and 
coordination with the conjugate, resulting in a higher rate of dissociation when the 
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proton concentration is increased. This can also explain the different pH responsiveness 
of His6-tagged molecules bound to NTA-Me
2+ or PNT-Me2+. 
 
Figure 4-10. Release of His6-eYFP from PNT1-Me
2+ (a) and PNT4-Me2+ (b) at different pH 
values.  All statistics were analysed by comparing samples to their respective protein-
polymer conjugate at pH 7.4. Stars indicate significance in two-tailed Student's t-test; 
*P<0.05, **P<0.005. 
To address the question of whether the reversible binding of PNT copolymers to His6-
eYFP influence its fluorescent property, His6-eYFP was characterized by fluorescence 
spectroscopy before and after polymer conjugation (Figure 4-11). When His6-eYFP was 
conjugated with PNT4-Zn2+, a decrease in fluorescence intensity was observed due to 
the chelation with Zn2+. After dissociation from PNT4-Zn2+ in acidic conditions (pH = 5 or 
6) and then buffered back to pH 7.4, the fluorescence of His6-eYFP recovered almost to 
its original value. The slight decrease of fluorescence intensity was due to short-term 
exposure to acidic condition which corresponds to literature precedence.[57] These 
results indicate that PNT copolymers are able to bind His6-eYFP at physiological pH 
causing a decrease in fluorescence, and release the loaded protein in acidic conditions. 
0
20
40
60
80
100
120
140
a
***
 PNT1-Cu2+-eYFP
 PNT1-Zn2+-eYFP
re
le
a
s
e
d
 e
Y
F
P
 (
%
)
pH
5.06.07.4
0
20
40
60
80
100
120
140
*
**
*
5.06.0
re
le
a
s
e
d
 e
Y
F
P
 (
%
)
pH
 PNT4-Cu2+-eYFP
 PNT4-Zn2+-eYFP
7.4
b
98 
 
520 540 560 580 600
0
100
200
300
400
500
600
700
 His
6
-eYFP
 PNT4-Zn
2+
-His
6
-eYFP
 released eYFP (pH 6.0      pH 7.4)
 released eYFP (pH 5.0      pH 7.4)
fl
u
o
re
s
c
e
n
c
e
 i
n
te
n
s
it
y
 (
a
.u
.)
wavelengh (nm)
b
 
Figure 4-11. The fluorescence emission spectra of His6-eYFP and PNT4-Zn
2+-His6-eYFP 
before and after release in acidic conditions. While reactions were run in acidic 
conditions, all samples were analysed at pH 7.4 in PBS. 
4.2.5. Delivery of PNT-Zn2+-His6-tagged molecules conjugates into living cells 
 
Figure 4-12. Toxicity evaluation of PNT4-Men+ copolymers on U87 cells using MTS assay. 
Errors bars represent the standard deviation (n=3). 
The cytotoxicity of PNT4-Men+ copolymers was evaluated by using the 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
(MTS) assay. While PNT4 copolymer showed low cytotoxicity (Figure 4-12), PNT4 
coordinated with Cu2+ led to an increase of the cytotoxicity with increasing PNT4-Cu2+ 
concentration. In contrast to PNT4-Cu2+, low toxicity was observed for PNT4-Zn2+ in all 
tested concentrations, suggesting that PNT4-Zn2+ can be used for in-vitro or in-vivo 
applications. 
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The cellular uptake of PNT4-Zn2+-His6-RB was first investigated. After incubating PNT4-
Zn2+-His6-RB with U87 glioblastoma cells for 24 hs, a significant cellular uptake of PNT4-
Zn2+-His6-RB was observed compared with His6-RB alone (Figure 4-13, red channel). To 
determine the cellular localization of PNT4-Zn2+-His6-RB, z-stack confocal images of 
PNT4-Zn2+-His6-RB treated U87 cells were obtained (Figure 4-14). Based on confocal 
fluorescence images it is apparent that His6-RB was distributed in the interior not on the 
surface of cells.  
 
Figure 4-13. CLSM images of U87 cells incubated with a) His6-RB and b) PNT4-Zn
2+-His6-
RB (scale bar = 20 μm).  
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Figure 4-14. Confocal fluorescence microscopy Z-stack montage for living U87 cells 
incubated with PNT4-Zn2+-His6-RB.  
In the next step, the cellular internalization of PNT4-Zn2+-His6-eYFP was investigated. No 
obvious cellular uptake of PNT4-Zn2+-His6-eYFP was observed compared with His6-eYFP 
alone (Figure 4-15). The distinct results comparing with PNT4-Zn2+-His6-RB can be due to 
the negative charged His6-eYFP (-6.3±3.0 mV). We are trying to conjugate targeting 
molecules such as TAT peptides on the PNT copolymers to promote the cellular uptake 
of proteins. It’s still on the process.      
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Figure 4-15. CLSM images of U87 cells incubated with a) His6-eYFP and b) PNT4-Zn
2+-
His6-eYFP (scale bar = 20 μm).  
4.3. Conclusion 
A robust and efficient method to conjugate multiple proteins on a single polymer chain 
using trisNTA-Me2+-His6 molecular recognition was designed. His6-eYFP was used as a 
model protein for binding PNT-Men+ copolymers. It was demonstrated that the nature of 
the Men+, and the distance between trisNTA binding sites on PNT copolymers enable 
great selectivity for the binding affinity and inter-protein interactions, leading to control 
of the stability and pH triggered release of the protein from the polymer. After complete 
release of His6-eYFP from PNT-Me
2+ copolymers at selective pH, the return of 
fluorescence suggested that the protein was intact and maintained its properties.  
The presented PNT copolymers in this work have many advantages as nanosystems for 
protein delivery because they: 1) have site-specific polymer conjugation to proteins; 2) 
have high stability of the conjugate in physiological condition while rapid dissociation in 
acid conditions (pH 6); 3) preserve protein structure and properties; 4) show low toxicity 
in vitro; 5) have low molecular weights and the polymers are expected to eliminate from 
the body; 6) allow the possibility to simultaneously bind multiple different proteins 
(combination of therapeutic, detection, and targeting proteins). In addition, the toxicity 
problem of NTA and its derivatives, which often incorporate toxic metals such as Ni2+ 
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and Cu2+ due to their high binding affinity, has been improved by using less toxic Zn2+. 
Moreover, PNT-Zn2+-His6-eYFP conjugates maintain high binding affinity (submicromolar) 
as well due to the multivalent binding (trisNTA) and inter-protein interactions.  
However, the properties of His-tagged molecules might affect the cellular uptake ability 
of their conjugates with PNT-Zn2+. More investigations are needed to fully understand 
the influence factors.    
4.4. Experimental section 
Materials. Copper(II) chloride, Zinc chloride, Iron(III) sulfate hydrate and Phosphate 
buffered saline (PBS) were purchased from Sigma-Aldrich and used as received. 
Rhodamine B labelled hexa-histidine was received as a gift from Dr. Pascal Tanner.  
Chelation of metal cations to PNTn copolymers. Respective PNTn copolymers were 
dissolved in 1 mM PBS buffer (pH 7.4). A stoichiometric excess of CuCl2, ZnCl2, or 
Fe2(SO4)3 was mixed with the respective PNTn solution and was purified on a HiTrap 
desalting column (5 mL, GE Healthcare Life Sciences) with PBS as the mobile phase.  
Protein analysis. Fluorescence of His6-eYFP (λex = 513 nm, λem = 524 nm) and polymer-
protein conjugates was investigated with a PerkinElmer LS55 fluorescence spectrometer 
(Waltham, Massachusetts, USA) at ambient temperature. 
Stability and pH responsiveness of PNT-Me2+-His6-eYFP conjugates. Fast protein liquid 
chromatography (FPLC) was used for the analysis of the stability and the pH 
responsiveness of PNT-Me2+-His6-eYFP conjugates. 250 µM His6-eYFP was incubated with 
a metal cation-coordinated PNT in PBS buffer with a molar ratio of 1:2.2 His6-
eYFP:trisNTA. The solution (500 µL) was loaded onto a Superdex 200 10/300 GL (Akta 
Prime system, Amersham Biosciences, measuring @ 513 nm), and eluted with a PBS 
mobile phase. For the investigation of pH responsiveness, the column was equilibrated 
with buffering power of PBS solution at pH 5.0 or 6.0. The sample was prepared in the 
same way as previously described, loaded onto the column and eluted with PBS solution 
at pH 5.0 or 6.0. The data were analyzed by Fityk software to calculate the integral area 
of the individual peaks. 
Structure of PNT-Me2+-His6-eYFP conjugates. The size of PNT-Me
2+-His6-eYFP conjugates 
were investigated by DLS with a Zetasizer Nano ZSP (Malvern Instruments Ltd., UK) at 
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25 °C in PBS buffer. The data were fit based on number distribution. The concentration 
of His6-eYFP was 20 µM and 1mL of solution was used for measurements.    
The negatively stained image of PNT4-Zn2+-His6-eYFP conjugates stained with 2% uranyl 
acetate was performed on a transmission electron microscope (Philips CM100) at an 
acceleration voltage of 80 kV. The size of the conjugates was analyzed using ImageJ 
software. 
Cell culture. Hela cells or U87 glioblastoma cells were maintained at 37 °C in a 5% CO2 
humidified atmosphere and were grown in Dulbecco's modified eagle medium (DMEM) 
with 10% fetal bovine serum (FBS), 100 units/mL penicillin, 100 μg/mL streptomycin and 
2 mM L-glutamine. 
Cell viability. Cytotoxicity testing was performed using the Promega CellTiter 96 
Aqueous Non-Radioactive Cell Proliferation (MTS) assay (Promega, USA) to determine 
the number of viable cells in culture. Hela and U87 cells were seeded in a 96-well plate 
the night before experiments at 0.5 × 104 and 1 × 104 cells/well in 100 µl, respectively. 
The day of the experiment, samples (10μL) containing different amount of PNT4-Me2+ 
(0-400 μg/mL), were added to the cells. Twenty-four hours later, 20 μL of MTS solution 
were added to each well and incubated for 3h at 37 °C. Cell viability was calculated by 
measuring the absorbance at 490 nm using a 96-well plate reader and plotted relative to 
untreated cells that were grown the same day in the same plate and assays were 
performed in triplicate. 
Cellular uptake. The U87 cells (3 × 104 cells in 0.3 mL medium) were seeded in 8-well 
ibidi chamber. After an overnight incubation, the cell culture medium was replaced with 
serum-free medium (0.14 mL). The PNT4-Zn2+-His6-eYFP conjugate, containing 30 µg of 
protein, or PNT4-Zn2+- RB-His6 with the same molar concentration were then added by 
dilution to the cell culture medium. After 4h incubation, the serum-free medium was 
carefully removed and replaced with medium containing 10% FBS (0.3 mL). The cells 
were incubated for 20 h more. Right before live cell imaging, the cell culture medium 
was replaced with an Opti-MEM solution. The imaging was performed on Zeiss 
microscope. Images were taken using a 40x water-immersion objective. Excitation was 
at 514 nm for YFP fluorescence and 543 nm for RB-His6. 
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5. Design and construct of DNA-functionalized polymersomes 
5.1. Introduction 
In 1996, spherical nucleic acids (SNAs) were first introduced by Prof. Chad Mirkin and 
defined as nanostructures typically synthesized from inorganic nanoparticle templates 
and DNA shells, which are immobilized on the surface  with high orientation.[1, 2] SNAs 
not only possesses the unique properties from both inorganic nanoparticle (e.g., 
electronic, luminescent, magnetic, plasmatic, catalytic, quenching) and DNA (e.g., 
information storage, molecular recognition), but also generate novel properties that are 
distinct from both sides. For example, linear nucleic acids do not enter cell without 
transfection agents such as cationic polymers, dendrimers, peptides,  or viruses, while 
SNAs are able to overcome this limitation and be rapidly taken up by 60 different cell 
types without any additional requirements.[3, 4] In addition, the densely packed DNA on 
the surface of the particle prevents their digestion by cellular nucleases.[5-7] SNAs have 
proven their potential in many important applications including intracellular detection, 
gene transfection, and therapeutic and gene regulation via antisense or siRNA 
pathways.[2, 8-11] In addition, these well-defined nanoparticles are able to create 
structures with high regulation in large scale by bottom-up nanofabrication for different 
purposes such as colloid crystallization,[12, 13] which opens a new way to 
programmably assemble the nanoparticles into microscopic materials.[14-18] 
One of many advantages for SNAs is that they are synthesized from readily available 
starting materials, which is ideal for applications requiring specific shape and structures. 
Moreover, all SNAs seem like they share the common properties and features such as 
rapid cellular uptake, independent of the structure and composition. Liposomal SNAs 
have been recently reported that they are able to enter ovarian adenocarcinoma cells in 
high quantities even after a short 1 h incubation time.[11] However, no significant 
uptake of free DNA with the same sequence was observed after 36 h incubation. In 
addition, liposomal SNAs exhibit high efficiency for both cellular transfection and gene 
regulation.[11] Even though liposomal SNAs show higher stability compared with naked 
liposomes, the stability is still unsatisfactory for in vivo applications. Polymersomes can 
be ideal replacements of liposomes due to their mechanical stability and 
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adaptability.[19-21] However, until now,  studies combining DNA and polymersomes has 
been rarely performed,[28] even though they are important for both theoretical 
developments and practical applications.   
In this chapter, different approaches for the construction of DNA-functionalized 
polymersomes are described. First, we tried to modify triblock copolymer, PMOXA-b-
PDMS-b-PMOXA, with DNA by both solution coupling and solid-phase coupling methods. 
The modification was investigated by gel electrophoresis and anion exchange 
chromatography. Second, DNA-functionalized polymersomes were self-assembled by a 
mixture of naked and DNA modified PMOXA-b-PDMS-b-PMOXA and the structure was 
characterized by TEM. The presence of DNA on the surface of the vesicle was evaluated 
by fluorescent correlation spectroscopy (FCS).  
In addition, we tried to construct DNA-functionalized polymersomes by in situ 
modification. Polymersomes were first pre-formed containing a mixture of PMOXA-b-
PDMS-b-PMOXA and PDMS-b-PMOXA with azide groups in different molar ratio. The 
structures of the vesicles were characterized by TEM and DLS. DNA-dibenzylcyclooctyne 
was subsequently used in order to couple DNA on the surface of the vesicle through 
strain-promoted azide–alkyne cycloaddition. The obtained DNA-functionalized 
polymersomes were analyzed by gel electrophoresis and the number of DNAs per vesicle 
was quantified by FCS.                 
5.2. Results and discussion 
5.2.1. Coupling DNA to the end of triblock copolymer by solid support synthesis 
We selected PMOXA-b-PDMS-b-PMOXA triblock copolymers as the constituent material 
for the polymersomes because it is capable of self-assembling into nanometer sized 
vesicular structures with high mechanical stability, good biocompatibility, and minimum 
toxicity.[22, 23] Compared to diblock copolymers, vesicles formed by triblock 
copolymers show an enhanced mechanical stability due to the stronger interdigitation 
and entanglement of the chains within the membranes.[23] PMOXA-b-PDMS-b-PMOXA 
(Mn: 6800 g/mol) was synthesized as previously published and the block ratio was 
calculated as 8:49:8 based on the 1H NMR results.[23] First, a 22 nucleotide-long 
sequence (5’-CCT CGC TCT GCT AAT CCT GTT A-3’, named as ssDNAa) was coupled to the 
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polymer by amide bond formation on a solid support (Scheme 5-1). We chose the solid-
phase coupling method because it shows higher reaction efficiency for non-hydrophilic 
polymers compared with the coupling reaction in solution.[24, 25] Hydroxyl-terminated 
PMOXA8-b-PDMS49-b-PMOXA8 was first reacted with maleic anhydride for the 
incorporation of the carboxyl group. The carboxyl terminal group of the polymers was 
further converted to a NHS ester then reacted with the amino group on the 5’-end of 
DNA, with the 3’-end anchored on a controlled pore glass (CpG) phosphoramidite solid 
support. After cleaverage from the CpG solid support and analysis by agarose gel 
electrophoresis, only one band was observed corresponding to the free ssDNAa, 
suggesting the coupling reaction wasn’t successful (Figure 5-1). Increasing the reaction 
time and the concentration didn’t show any improvement to the reaction (Data not 
shown).  
Scheme 5-1. Synthesis route of polymer-ssDNAa conjugate by amide bond formation on 
solid support. 
 
Figure 5-1. Gel analysis of polymer-ssDNAa conjugate (left) and ssDNAa (right). 
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Next, we tried to couple polymers to ssDNAa by phosphoramidite method, which 
showed a higher efficiency compared with amide bond formation method and no 
modification of DNA is required.[26, 27] Hydroxyl-terminated PMOXA8-b-PDMS49-b-
PMOXA8 was reacted with phosphoramidite chloride to yield the corresponding 
phosphoramidite-PMOXA8-b-PDMS49-b-PMOXA8-phosphoramidite derivatives (Scheme 
5-2). The presence of phosphoramidite on polymers is proved by the typical peak at 147 
ppm by 31P NMR (Figure 5-2). The activated polymers were then coupled to the 5’ end of 
the ssDNAa on a CpG solid support in dichloromethane (Scheme 5-2). However, no DNA-
polymer conjugate was detected by agarose gel after deprotection in the concentrated 
ammonia solution (data not shown). A possible reason is that the obtained ssDNAa-
polymer conjugates cannot dissolve in any solutions including aqueous solution, organic 
solvents and the mixtures, due to the huge difference between the polarity of polymer 
block and the one of DNA block, so no method can prove the presence.  
Scheme 5-2. Synthesis route of polymer-ssDNAa conjugate by phosphoramidite method 
on solid support. 
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Figure 5-2. 31P NMR spectrum of phosphoramidite-PMOXA8-b-PDMS49-b-PMOXA8- 
phosphoramidite. 
5.2.2. Coupling DNA to the end of triblock copolymer in solution  
As discussed above, ssDNAa-polymer conjugates might precipitate during the cleavage 
process in the concentrated ammonia solution and cannot be identified in the presence 
of CpG beads. To avoid this, coupling reactions were carried out in solution. The amide 
bond formation method was chosen because it has good efficiency in aqueous solution 
(Scheme 5-3). Carboxyl-end-functionalized PMOXA8-b-PDMS49-b-PMOXA8 was first 
dissolved in dimethylformamide (DMF) and activated by EDC and 1-
hydroxybenzotriazole hydrate (HoBt). ssDNAa aqueous solution was added subsequently 
and 2/1 of DMF/H2O (V/V) was used for to dissolve both polymers and DNA. The 
resulting conjugate was analyzed by agarose gel electrophoresis and anion exchange 
chromatography. The DNA coupled PMOXA8-b-PDMS49-b-PMOXA8 appeared as a 
discrete band in the gel and the electrophoretic mobility differed significantly from that 
of the DNA starting material (Figure 5-3a). Further structural analysis was performed by 
anion exchange chromatography (Figure 5-3b). A significantly different retention time 
was observed after the polymer conjugation due to the increase of the molecular weight 
and size. A 100% reaction yield was calculated based on gel analysis. To be sure that the 
polymer is covalently bound to ssDNAa, the conjugate was incubated in formamide 
solution or 2% triton solution at 95 °C for 10 mins in order to prevent hydrogen bond 
formation or hydrophobic interactions. The ssDNAa-polymer conjugate was then 
precipitated in cold isopropanol to remove the free polymer. The resulting conjugates 
were analyzed by electrophoresis and no change of the migration on the gel was 
observed (data not shown). As a control experiment, PMOXA8-b-PDMS49-b-PMOXA8 
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without a carboxyl group was used and reacted following the same procedure. Only free 
ssDNAa was observed after purification (Figure 5-4). Based on these results, we suppose 
that ssDNAa has been successfully conjugated to PMOXA8-b-PDMS49-b-PMOXA8. 
Complementary single-stranded DNA with a sequence (5’-TAA CAG GAT TAG CAG AGC 
GAG G-3’, named as ssDNAb) was conjugated to PMOXA8-b-PDMS49-b-PMOXA8 by the 
same procedure and the characterizations are shown in Figure 5-5. 
 
Scheme 5-3. Synthesis route of polymer-ssDNAa conjugate by amide bond formation in 
solution. 
 
Figure 5-3. Characterization of polymer-ssDNAa conjugate. (a) Gel analysis of polymer-
ssDNAa conjugate (left) and free ssDNAa (right); (b) chromatogram from analytical anion 
exchange chromatography: polymer-ssDNAa conjugate (red line) and free ssDNAa (blue 
dot). Buffer A: Tris-HCl (25mM). Buffer B: Tris-HCl (25mM)+NaCl (1M) 
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Figure 5-4. Gel analysis of a mixture of PMOXA8-b-PDMS49-b-PMOXA8 and ssDNAa (left) 
and ssDNAa (right). 
 
Figure 5-5. Characterization of polymer-ssDNAb conjugate. (a) gel analysis of polymer-
ssDNAb conjugate (left) and free ssDNAb (right); (b) chromatogram from analytical anion 
exchange chromatography: polymer-ssDNAb conjugate (red line) and free ssDNAb (blue 
dot). Buffer A: Tris-HCl (25mM). Buffer B: Tris-HCl (25mM)+NaCl (1M) 
5.2.3. Self-assembly of blended triblock copolymers with DNA-polymer conjugates 
The formation of polymersomes was achieved by the bulk film rehydration method 
using three different mixtures of PMOXA7-PDMS42-PMOXA7 with 2, 5, and 10 mol % of 
PMOXA8-b-PDMS49-b-PMOXA8-ssDNAa (polymer-ssDNAa conjugate). The self-assembled 
structures were investigated by TEM (Figure 5-6). Nice vesicular structures are observed 
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when the molar ratio of polymer-ssDNAa conjugate is lower than 10 % and the sample 
with 5 % of polymer-ssDNAa conjugate was used for further investigation. Two 
approaches were used to prove and quantify the ssDNAa on the polymersomes. First, 
atto550-labelled complementary single-stranded DNA (atto550-ssDNAb) was hybridized 
to the ssDNAa on the polymersomes at 37 °C.  The binding of atto550-ssDNAb on the 
polymersomes can be detected by FCS due to the change of the diffusion time. The 
number of ssDNAas per vesicle is determined by dividing the value of the molecular 
brightness of atto550-ssDNAb hybridized vesicles, expressed as counts per molecule 
(CPM), by the CPM of freely diffusing atto550-ssDNAb. No change of the diffusion time 
was observed by FCS after the hybridization and only free atto550-ssDNAb (τD = 120 µs) 
was detected, suggesting no ssDNAa on the polymersomes is available for hybridization. 
 
Figure 5-6. TEM images of polymersomes self-assembled by PMOXA7-PDMS42-PMOXA7 
mixed with 2 (a), 5 (b) and 10 % (c) of PMOXA8-b-PDMS49-b-PMOXA8-ssDNAa. The scale 
bar is 200 nm, 200nm, and 1000 nm, respectively. 
In another approach, we tried to fluorescently label ssDNAa on the polymersome by TdT. 
TdT is a template independent polymerase that catalyzes the addition of fluorescent-
labelled deoxynucleotides to the 3'-hydroxyl terminus of DNA molecules. The activity of 
TdT was first investigated and analyzed by agarose gel. As shown in Figure 5-7, the base 
pairs (bp) of DNA increased from 22 to 100 after 15 mins catalyzed by TdT.  When 
polymer-ssDNAa conjugates were mixed with TdT, the migration immediately shifted to 
22 bp, the same position with free ssDNAa, suggesting that ssDNAa was cleaved from 
the polymers. To avoid the influence of the other components in the TdT stock solution 
and TdT buffer, TdT was purified by centrifugal ultrafiltration and PBS was used for the 
reaction. However, the shift of the migration of polymer-ssDNAa conjugate to 22 bp was 
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still observed (Data not shown). We suppose that TdT can break the amide bond or 
some unknown interactions, which connect PMOXA8-b-PDMS49-b-PMOXA8 and ssDNAa 
together. The reason is still not clear up to now. 
 
Figure 5-7. TdT activity assessment by gel analysis. Polymerization of free ssDNAa (a) and 
polymer- ssDNAa conjugate (b) catalyzed by TdT after 15 mins and 50 mins.   
5.2.4. Construction of DNA-functionalized polymersomes by in situ modification  
As discussed above, the solubility of DNA-polymer conjugates cannot be predicted and 
some unknown interactions might exist between DNA and polymers. In order to avoid 
these problems, we were the first to apply in situ coupling of DNA on pre-formed 
polymersomes. A PMOXA-b-PDMS-b-PMOXA triblock polymer with a block ratio of 
7:42:7 [23] was selected as the constituent material for the polymersomes because it is 
capable of self-assembling into nanometer sized vesicular structures. Linking component 
poly(dimethylsiloxane)-b-poly(2-methyloxazoline) diblock copolymers modified with an 
azide group (PDMS-b-PMOXA-N3) at a block ratio of 65:32 [22] was used for further 
functionalization with DNA. PDMS65-PMOXA32-OH was converted to PDMS65-PMOXA32-
N3 by a two-step reaction (Scheme 5-4). As shown in Figure 5-8b, PDMS65-PMOXA32-N3 
has a longer hydrophilic PMOXA block compared to PMOXA7-PDMS42-PMOXA7. In this 
manner, the exposure of the azide group outside of the membrane for further reactions 
is promoted.  
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Scheme 5-4. Synthesis route of PDMS65-PMOXA32-N3. 
 
 
Figure 5-8. Construct DNA-functionalized polymersomes. (a) Schematic representation 
of polymersomes with azide groups on the surface, anchored with DBCO-ssDNAa and 
further hybridized with atto550-ssDNAb; (b) chemical structures of PMOXA7-b-PDMS42-
b-PMOXA7 and PDMS65-b-PMOXA32-N3; TEM images of P5-N3 (c), which was modified 
with ssDNAa (d) and subsequently hybridized with atto550-ssDNAb (e); (f) gel analysis of 
free ssDNAa (left) and P5-ssDNAa (right); (g) normalized autocorrelation curves from FCS 
data in PBS: free atto550-ssDNAb (blue) and atto550-ssDNAb hybridized P5-ssDNAa 
(red).     
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Polymersomes were obtained by the bulk rehydration approach using three different 
mixtures of PMOXA7-b-PDMS42-b-PMOXA7 with 0.25, 1, and 5 mol % of PDMS65-b-
PMOXA32-N3 (coded as P0.25-N3, P1-N3, P5-N3). TEM confirmed the formation of 
polymersomes (Figure 5-9). A morphology transition to micelles was observed when 
higher amounts of PDMS65-PMOXA32-N3 (>5 %) was used (Figure 5-9). The formed P5-N3 
have a DH of 180 ± 60 nm and no changes of DH were observed when the molar ratio of 
PDMS65-PMOXA32-N3 was decreased (Table 5-1). A larger diameter of 230 ± 60 nm for 
P5-N3 was determined from TEM images due to the collapse of polymersomes during 
the measurements.  
 
Figure 5-9. TEM images of polymersomes self-assembled by a mixture of PMOXA7-
PDMS42-PMOXA7 and PDMS65-PMOXA32-N3 with a molar ratio of 0.25% (A), 1% (B) 5% (C) 
and 10% (D). The scale bar is 200 nm, 200nm, 500 nm and 500 nm, respectively.  
Table 5-1. Reaction yields and sample characteristics: DH from DLS measurements, 
diameters (D) from TEM images and ξ potential.  
Sample code Yields (%) DLS DH (nm) TEM D (nm) 
ξ potential 
(mV) 
P5-N3 -- 180 ± 60 230 ± 60 -3.4 ± 1.1 
P5-ssDNAa 28 180 ± 60 220 ± 50 -9.2 ± 1.3 
P5-ssDNAb 27 180 ± 70 230 ± 50 -9.3 ± 0.7 
P1-N3 -- 180 ± 50 200 ± 40 -2.2 ± 2.3 
P1-ssDNAa 45 180 ± 60 220 ± 50 -6.0 ± 0.5 
P1-ssDNAb 59 170 ± 50 220 ± 50 -7.2 ± 0.4 
P0.25-N3 -- 180 ± 50 190 ± 40 -2.3 ± 2.1 
P0.25-ssDNAa 68 180 ± 60 180 ± 60 -3.7 ± 1.0 
P0.25-ssDNAb 96 180 ± 60 190 ± 40 -4.6 ± 1.5 
After the formation of polymersomes, a 22mer dibenzocyclooctyl-terminated DNA 
oligonucleotide (5’-CCT CGC TCT GCT AAT CCT GTT A-3’, named as DBCO-ssDNAa) was 
post-functionalized to the polymersomes through strain-promoted azide–alkyne 
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cycloaddition. The conjugation of ssDNAa to the polymersomes was proven by agarose 
electrophoresis analysis (Figure 5-8f). After the click reaction, two DNA bands could be 
distinguished. The band that did not migrate corresponded to the fraction of ssDNAa 
anchored on polymersomes. No influence of the polymersome structure and size was 
observed after DNA functionalization both by TEM and DLS (Figure 5-8d and Table 5-1). 
The coupling reaction of ssDNAa to polymersomes had a yield of 68 % for P0.25-N3, 
determined from DNA absorbance at 260 nm, decreased to 45 % for P1-N3 and 28 % for 
P5-N3. The lower yield obtained for P5-N3 is due to the higher density of azide groups at 
the surface leading to higher electrostatic and steric repulsion generated by coupled 
ssDNAa on the polymersomes (Table 5-1). The increasing electrostatic repulsion is 
indicated by a decrease of ξ potential value from -3.7 ± 1.0 mV for ssDNAa modified 
P0.25 (P0.25-ssDNAa) to -9.2 ± 1.3 mV for P5-ssDNAa in PBS buffer (Table 5-1). The 
reaction yield increased with the reaction time up to 3 days, and no increase in reaction 
yield could be observed over longer reaction times up to 10 days (Figure 5-10). In a 
similar manner, the complementary stranded ssDNA with DBCO group on 5’-end (5’-TAA 
CAG GAT TAG CAG AGC GAG G-3’, named DBCO-ssDNAb) was coupled to pre-formed 
polymersomes. The reaction yield ranged from 96 % for P0.25-N3, to 59 % and 27 % for 
P1-N3 and P5-N3. 
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Figure 5-10. The kinetics of the reaction between ssDNAa and azido-polymersomes. 
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Table 5-2. Characterization of DNA-functionalized polymersomes: diffusion time, 
number of DNA per vesicle and average surface coverage (σ).  
Sample code 
Diffusion time 
(µs) 
Count per 
molecule 
(kHz) 
Number of 
DNA per 
vesiclec 
 σd (10-3 nm-2) 
Atto550-ssDNAb 120 ± 0 20 ± 2 -- -- 
P5-ssDNAa-ssDNAb- 
Atto550a 
5270 ± 780 1905 ± 42 93 ± 2 0.9 
P1-ssDNAa-ssDNAb- 
Atto550 
3990 ± 590 690 ± 33 34 ± 2 0.3 
P0.25-ssDNAa-
ssDNAb- Atto550 
3970 ± 320 280 ± 16 14 ± 1 0.1 
Atto647N-ssDNAa 140 ± 0 15 ± 2 -- -- 
P5-ssDNAb-ssDNAa- 
Atto647Nb 
5090 ± 200 1844 ± 131 127 ± 9 1.2 
P1-ssDNAb-ssDNAa- 
Atto647N 
3650 ± 530 579 ± 41 40 ± 3 0.4 
P0.25-ssDNAb-
ssDNAa- Atto647N 
4070 ± 780 267 ± 29 18 ± 2 0.2 
P5-ssDNAa mixing 
with Atto647N-
ssDNAa 
6980 ± 1860 6 ± 2 0 0 
P5-N3 mixing with 
Atto550-ssDNAb 
3440 ± 1060 2 ± 0 0 0 
Liposomes [29]   39 1.2 
a Polymersomes with ssDNAa were hybridized by Atto550-ssDNAb. 
b Polymersomes with ssDNAb were hybridized by Atto647N-ssDNAa. 
c The number of DNA per vesicle was calculated by count per molecule of atto-DNA 
hybridizing vesicles divided by count per molecule of free atto-DNA molecules.  
d The σ value was calculated by number of DNA per vesicle/{4 × 3.14 × (radius of vesicle)2} 
× 1000 
In the next step, atto550-labelled complementary single-stranded DNA (atto550-ssDNAb) 
was hybridized to the ssDNAa on the polymersomes at 37 °C. The number of ssDNAa per 
vesicle was determined by FCS. The change in the diffusion time, from the value 
characteristic for free atto550-ssDNAb (τD = 120 µs) to a value of 5.3 ± 0.8 ms for 
atto550-ssDNAb hybridized P5-ssDNAa, indicated the successful hybridization of 
atto550-ssDNAb to ssDNAa on the polymersomes (Figure 5-8g). Assuming most of 
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ssDNAa on the polymersomes is involved in the hybridization, the average number of 
ssDNAa per polymersome of P5-ssDNAa, P1-ssDNAa, and P0.25-ssDNAa was determined 
as 93 ± 2, 34 ± 2 and 14 ± 1, corresponding to an average surface coverage density (σ) of 
≈0.9, 0.3, 0.1 strands per 1000 nm2 (Table 5-2). The σ value of polymersomes anchored 
with ssDNAb was determined as 1.2, 0.4 and 0.2 for P5-ssDNAb, P1-ssDNAb and P0.25-
ssDNAb using the same procedure. In control experiments, fluorescence-labelled DNA 
was incubated with non-functionalized polymersomes and polymersomes with non-
complementary stranded DNA. No nonspecific adhesion of DNA to the polymersomes 
was detected by FCS (Table 5-2). Considering the low amount of diblock copolymers 
used for polymersome formation and the similar chemical structure of diblock and 
triblock copolymers, no phase separation on the polymer membrane was taken into 
account and homogeneous distribution of DNA on the polymersome surface was 
expected.  
5.3. Conclusion 
In this chapter, three different strategies were used to construct DNA-functionalized 
polymersomes. First, the conjugation of PMOXA8-b-PDMS49-b-PMOXA8 with DNA was 
attempted by the solid-phase coupling method; however, no polymer-DNA conjugates 
were obtained. Polymer-DNA conjugation carried out in solution showed high reaction 
yield (100 %). However, it’s still not clear whether the polymer and DNA are conjugated 
covalently. These results indicate that the conventional methods are not suitable for 
constructing DNA-functionalized polymersomes, because the solubility of DNA-polymer 
conjugates cannot be predicted and some unknown interactions might exist between 
DNA and polymers.  
In addition, in situ coupling of DNA on formed polymersomes was achieved for the first 
time. The reaction yield was 28% - 96%, which decreased with the increase of DNA 
surface coverage on polymersomes due to electrostatic and steric repulsion. No change 
to the vesicle structures was observed after DNA conjugation to the vesicle surface. This 
method is able to extend to other structures for their DNA modifications.  
5.4. Experimental section  
Materials 
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All chemicals were purchased from Sigma-Aldrich and used as received unless otherwise 
noted. 50X TAE buffer was purchased from Applichem. All ODNs were purchased from 
Microsynth.  
Synthesis of HOOC-PMOXA8-b-PDMS49-b-PMOXA8-COOH  
HO-PMOXA8-b-PDMS49-b-PMOXA8-OH (150 mg, 0.022 mmol) synthesized according to 
the published procedure was first dissolved into 5 mL anhydrous chloroform, then 
succinic anhydride (6.5 mg, 0.066 mmol), 4-dimethylaminopyridine (1.32 mg, 0.011 
mmol) and triethylamine (8.7 mg, 0.088 mmol) were added. After deoxygenation by 
vacuum argon cycles, the mixture was further stirred for another 72 hs at RT. Finally, 140 
mg colorless solid product was obtained after the ultrafiltration with a yield of 93%.1H 
NMR (400 MHz, δ, CDCl3): 0 ppm (m, -Si(CH3)2), 0.54 ppm (m, -SiCH2), 1.31 ppm (m, -
SiCH2-CH2-CH2O-), 2.08-2.21 ppm (m, CH3-C=O), 3.40-3.60 ppm (m, -N-CH2-CH2-), 3.75 
ppm (t, -CH2-CH2-COOH).  
Coupling of ssDNAa to HOOC-PMOXA8-b-PDMS49-b-PMOXA8-COOH  
HOOC-PMOXA8-b-PDMS49-b-PMOXA8-COOH (170 mg, 0.025 mmol) was first reacted with 
EDC (9.6 mg, 0.05 mmol), HoBt (8.1 mg, 0.06 mmol) and N,N’-Diisopropylethylamine 
(DIPEA, 15.5 mg, 0.12 mmol) in dichloromethane (DCM) at RT under argon atmosphere 
for 3 h to obtain PMOXA8-b-PDMS49-b-PMOXA8 with NHS ester groups. ssDNAa, which 
5’-end is modified with amino group and the 3’-end is bound to CpG soild support, was 
subsequently added to the solution and the reaction was carried out for three days. EDC 
(4.8 mg, 0.025 mmol), HoBt (4 mg, 0.03 mmol) and DIPEA (8 mg, 0.06 mmol) were added 
three times per day to promote the reaction yield. The solid phase was purified by 
centrifuge and washed with DCM, ethanol and H2O for at least three times, respectively. 
Finally, the solid support and protecting groups were removed by treatment with 
concentrated ammonia for 16 h at 55 °C. The solid support was removed by centrifuge. 
After evaporation of ammonia, the conjugate was analyzed by gel electrophoresis.   
Synthesis of phosphoramidite-PMOXA8-b-PDMS49-b-PMOXA8-phosphoramidite 
HO-PMOXA8-b-PDMS49-b-PMOXA8-OH (300 mg, 0.08 mmol) was dissolved in dry DCM 
and reacted with N-diisopropyl-2-cyanoethyl-chlorophosphoramidite (189 mg, 0.8 mmol) 
in the presence of DIPEA (207 mg, 1.6 mmol) at RT under argon atmosphere for 2 h. The 
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crude product was dried and dissolved in ethyl acetate and extracted with Na2CO3 
solution, water (3x) and brine (3x). The solution was dried over MgSO4. After 
evaporation of the solvent the product was dried under high vacuum. (Yield: 99%) 31P 
NMR (400 MHz, CDCl3): 147 ppm. 1H NMR (400 MHz, δ, CDCl3): 0 ppm (m, -Si(CH3)2), 
0.54 ppm (m, -SiCH2), 1.31 ppm (m, -SiCH2-CH2-CH2O-), 2.08-2.21 ppm (m, CH3-C=O), 
2.62 ppm (NC-CH2-), 2.85 ppm ((CH3)2-CH-), 3.40-3.60 ppm (m, -N-CH2-CH2-), 3.75 ppm (t, 
-CH2-CH2-CO(O)-), 3.92 ppm (NC-CH2-CH2-).    
Coupling of ssDNAa to phosphoramidite-PMOXA8-b-PDMS49-b-PMOXA8-
phosphoramidite 
Phosphoramidite-PMOXA8-b-PDMS49-b-PMOXA8-phosphoramidite (1.1 mg, 0.16 mmol), 
ssDNAa anchored CpG solid support (0.001 mmol) and 0.3 M 5-(Ethylthiol)-1H-tetrazole 
was dissolved in DCM (4 mL) at RT under argon atmosphere for three days. The solid 
phase was purified by centrifuge and washed with DCM, ethanol and H2O for at least 
three times, respectively. Finally, the solid support and protecting groups were removed 
by treatment with concentrated ammonia for 16 h at 55 °C. The solid support was 
removed by centrifuge. After evaporation of ammonia, the conjugate was analyzed by 
gel electrophoresis.    
Synthesis of PDMS65-PMOXA32-N3 
Poly(dimethylsiloxane)-block-poly(2-methyl-2-oxazoline)-COOH. PDMS-b-PMOXA-OH 
(200 mg, 0.022 mmol) synthesized according to the published procedure was first 
dissolved into 5 mL anhydrous chloroform, then succinic anhydride (6.5 mg, 0.066 
mmol), 4-Dimethylaminopyridine (1.32 mg, 0.011 mmol) and triethylamine (8.7 mg, 
0.088 mmol) were added. After deoxygenation by vacuum argon cycles, the mixture was 
further stirred for another 72 hs at RT. Finally, 180 mg colorless solid product was 
obtained after the ultrafiltration with a yield of 90%. 1H NMR (400 MHz, δ, CDCl3): 0 ppm 
(m, -Si(CH3)2), 0.45 ppm (m, -SiCH2), 0.80 ppm (t, -CH3), 1.20 ppm (m, -CH2-CH2-), 1.50 
ppm (m, -SiCH2-CH2-CH2O-), 1.90-2.10 ppm (m, CH3-C=O), 2.40-2.60 ppm (m, -CH2-CH2-
COOH), 3.20-3.60 ppm (m, -CH2-O-CH2-CH2-N-CH2-CH2-).  
Poly(dimethylsiloxane)-block-poly(2-methyl-2-oxazoline)-N3. PDMS-b-PMOXA-COOH 
(100 mg, 0.011 mmol) was first dissolved into anhydrous chloroform, then 11-Azido-3, 6, 
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9-trioxaundecan-1-amine (11.80 mg, 0.055 mmol), N, N'-Dicyclohexylcarbodiimide (15.6 
mg, 0.078 mmol) and 4-Dimethylaminopyridine (1.2 mg, 0.01 mmol) were added. After 
deoxygenation, the mixture was stirred for another 48 h at RT. Finally, 86 mg colorless 
solid product was obtained after the ultrafiltration with a yield of 86%. 1H NMR (400 
MHz, δ, CDCl3): 0 ppm (m, -Si(CH3)2), 0.45 ppm (m, -SiCH2), 0.80 ppm (t, -CH3), 1.20 ppm 
(m, -CH2-CH2-), 1.50 ppm (b, -SiCH2-CH2-CH2O-), 2.0-2.20 ppm (m, CH3-C=O, OOC-CH2-
CH2-C(O)NH), 3.20-3.60 ppm (m, -CH2-O-CH2-CH2-N-CH2-CH2-, -C(O)NH-CH2-CH2-O-C2H4-
O-C2H4-O-C2H4-N3). 
Preparation of polymeric nanocompartments 
4 mg PMOXA7-PDMS42-PMOXA7 was dissolved with 427 µg, 85 µg, and 21 µg of PDMS65-
PMOXA32-N3 in 1 mL ethanol in a 5 mL round-bottom flask, and ethanol was removed on 
a rotary evaporator (100 mbar, 40 °C, 120 rpm). The thin polymer film was then 
rehydrated by adding 1 mL PBS buffer and stirred overnight. The yielded solution was 
extruded with an Avanti mini&extruder (Avanti Polar Lipids, Alabama, USA) through a 
200 nm or 50 nm diameter pore&size polycarbonate (PC) membrane for 15 times.  
Conjugation of ssDNA to the nanocompartments 
400 µL of 4 mg/ml azido-vesicles (45 µM azide moieties), corresponding to the sample 
P5-N3, was mixed with dibenzocyclooctyl-terminated DNA oligonucleotide (DBCO-
ssDNAa, 45 µM, 1 equivalent per azide moiety) in PBS buffer at 37 °C for 0.5, 2, 3, 4.5 
and 10 days. The sequences of all presented DNA oligonucleotides are supplied in 
supplementary Table S2. The unreacted DBCO-ssDNA was removed by size exclusion 
chromatography (Sepharose 2B column; 10 cm length). The yield of the reaction was 
determined based on the concentration of unreacted DBCO-ssDNAa measured by the 
UV absorbance at 260 nm (Figure S3). The conjugation of DBCO-ssDNAb to the azido-
vesicles (45 µM azide moieties) was performed following the above procedure and the 
reaction was carried out for 3 days.  
400 µL of 4 mg/ml azido-vesicles with lower amount of azide moieties (9 µM and 1.8 
µM), P1 and P0.25, were mixed with DBCO-ssDNAa/DBCO-ssDNAb (18 µM and 7.2 µM) 
at 37 °C for 3 days, respectively. The purification was carried out as mentioned above.    
Agarose electrophoresis analysis 
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Electrophoresis analysis was carried out using 5% agarose gel at 170 V for 34 mins, using 
TAE buffer as running buffer. The gels were stained with SYBR Gold nucleic acid gel 
staining (Invitrogen) and scanned by Gel DocTM EZ Imager (BIO-RAD). 
Fluorescence correlation spectroscopy (FCS) 
FCS measurements were performed on a confocal laser scanning microscope (Zeiss LSM 
510-META/Confocor2, Carl Zeiss, Jena, Germany). An Ar+ laser was used for 488 nm 
wavelength, a HeNe laser for 543 nm and a HeNe laser for 633 nm. The laser light was 
focused through a 40x C-Apochromat water immersion objective with a numeric 
aperture of 1.2 onto the sample and using the appropriate filter sets depending on the 
wavelength used. The fluorescent signal was recorded on an avalanche photodiode 
(APD). For each measurement and each fluorescent probe, the pinhole was calibrated 
for maximum count rate using free dye in PBS.  
The sample volumes were typically 5 µL. Fluorescent fluctuations over time were 
recorded for 30 x 10 s. The raw data was processed and analysed using ConfoCor3 
software. Autocorrelation curves were fitted by using a two-component model 
(equation 1). The diffusion times obtained for free atto550-ssDNAa and atto550-ssDNAa 
hybridized polymersomes were fixed in the fitting procedure. 
𝐺2𝑐𝑜𝑚𝑝(𝜏) = 1 +
1
𝑁
∙ (1 +
𝑇𝑡𝑟𝑖𝑝
1−𝑇𝑡𝑟𝑖𝑝
e
−
𝜏
𝜏𝑡𝑟𝑖𝑝) ∙ [
f1
(1+
𝜏
𝜏𝐷1
)(1+
𝜏
𝑆2𝜏𝐷1
)
1/2 +
f2
(1+
𝜏
𝜏𝐷2
)(1+
𝜏
𝑆2𝜏𝐷2
)
1/2]            
(1) 
Where 𝐺2𝑐𝑜𝑚𝑝(𝜏) is the two-component autocorrelation function, N is the number of 
particles, S the structural parameter, 𝑇𝑡𝑟𝑖𝑝 is the fraction of fluorophores in the triplet 
state, 𝜏𝑡𝑟𝑖𝑝 is the corresponding triplet time, f1 and f2 are the fraction of the particles of 
the corresponding component 1 or 2, 𝜏𝐷1  and 𝜏𝐷2  are the diffusion times of the 
corresponding component 1 or 2.  
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6. Spatially organizing polymersomes into multicompartmental systems  
6.1. Introduction 
The evolution of single or multicellular organisms benefited from the formation of 
membrane boundaries, separating life processes from non-living matter. The isolated 
compartments separated by intracellular membranes, called organelles, ensure not only 
the specificity, but also the efficiency of multiple reactions for each individual organelle 
to maintan all of the cells metabolism.[1] Mimicking the biological processes to design 
artificial cells and/or organelles is essential for synthetic biology and 
therapeutic/diagnostic applications.[2-7] Several outstanding achievements related to 
artificial cells/organelles have previously been reported.  Artificial cells or organelles 
based on lipid or polymer vesicles were endowed with cell-like functions, such as 
transport,[8] molecule synthesis,[9] self-replication,[10] signaling,[11] or energy 
production,[6] and were used as implants to compensate for defects in cellular functions. 
In most cases, artificial organelles are synthesized via ‘one-pot’ processes leading to 
vesicles capable of performing the basic function as the natural ones.[12] In the case of 
artificial cells the design approach is more complicated due to compartmentalization 
that represents the basic requirement for multi-step reaction process systems. The most 
common method to achieve compartmentalization is to encapsulate small vesicles into 
larger ones.[3, 13]  However, organelles in living cells often have their characteristic 
positions and spatial connections for molecular transport, such as proteins and lipids, to 
maintain and fulfill their functions.[14] Therefore, spatial organization and arrangement 
of compartments with different functions in a defined order is of great significance for 
mimicking the organization and metabolic pathway of living cells, even though it hasn’t 
been achieved yet so far.  
Bottom-up nanofabrication is an indispensable approach to position and organize 
diverse components into complex structures at the nanoscale level.[15, 16] Its 
realization is based on molecular recognition of individual building blocks (molecules, 
nanoparticles, or self-assembled structures) as found in nature.[15-18] Through the 
appropriate design of the molecular information stored in the building blocks, which 
determines the specificity,  robustness, and stimuli-responsiveness of the interactions, 
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direct and programmable control of the assembly process with minimal defects can be 
achieved.[19-21] DNA is the top choice for this target due to its unique molecular 
recognition properties, high information storage capacity, structural features, and ease 
of manipulation.[20-23] Building blocks with hollow structures are more promising for 
nanofabrication, because they are able to accommodate active entities (such as 
enzymes, DNA, etc)[24-26] to create hybrid systems with novel functions. Moreover, 
they are suitable to mimic cells and organelles, to replicate biological functions and/or 
processes.[10, 12, 27] Protein cages, such as ferritin and some bacterioviruses have been 
used for nanofabrication,[28-30] but they act more as templates than as building blocks 
due to their smaller size, leading to low encapsulation efficiency of specific 
molecules.[31] Lipid-based vesicular structures (liposomes) represent better candidates 
for nanofabrication, because they can be manipulated to have a certain size,[32] 
entrapment of active molecules,[33] and permeability (controlled by surface 
modification or by insertion of membrane proteins)[34]. Liposomes have been 
functionalized with DNA[35] or peptides[36] to induce aggregation by molecular 
recognition. Nevertheless, the aggregation scale is hard to control[35] and the stability 
of the structures is reduced due to membrane fusion occurring during the aggregation 
process.[36-38]  
In the previous chapter, we described the construction of DNA functionalized 
polymersomes. Here, we applied DNA as the algorithm to regulate the course of self-
organization of binary polymersomes (two distinct polymeric vesicles) to construct 
compartmentalized structures with spatial organization and connection. Polymersomes 
supply a robust and shielded encapsulation of active entities, while DNA is capable of 
controlling the spatial organization and distance between compartments due to the rigid 
nature of double-helix DNA (< 50 nm).[39] Opposed to aggregated lipid-based systems, 
the self-assembly scale can be modulated by tailoring the attractive forces between the 
DNA complementary strands and the repulsive steric and hydration forces  between 
polymer chains in proximity.  The size of the polymersomes, as the second algorithm, 
plays an important role in their assembly behavior and spatial organization due to the 
modulation of repulsive forces. In addition, the presence of DNA on polymer networks is 
expected to facilitate cellular uptake, promoting their in-vitro applications. The 
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polymeric compartmentalized network system described in this work offers a new 
perspective into the evolution from unitary to binary systems, with collective properties 
greater than the individual building blocks, which serve as a platform for the generation 
of novel, multi-functional, intelligent and complex systems and biodevices. 
6.2. Results and discussions 
6.2.1. Controllable self-assembly of DNA-functionalized polymeric nanocompartments 
After the functionalization of polymersomes with ssDNA, the potential to assemble the 
polymersomes into a network using DNA recognition was explored. The 
nanocompartments with complementary DNA strands were mixed in equal mass ratio. 
The formation of double-stranded DNA (dsDNA) resulted in an increase in particle size, 
which was monitored by DLS (Figure 6-1c,d). All the polymersomes with different σ value 
(average surface coverage density of ssDNA) undergo a rapid assembly based on the 
DNA recognition, and the network expands in time till reaching equilibrium. The DH of 
particles increased from 190 ± 60 nm (P5-ssDNAa alone) to 290 ± 90 nm (P5-ssDNAa-P5-
ssDNAb network) (Figure 6-1c). TEM images reveal the initiation and at equilibrium of 
the polymersome networks after 20 min and 6 h (Figure 6-1a,b). The formed networks 
were composed, in general, of 3 polymersomes, counted from TEM images. The small DH 
of the polymersome network compared to the expected value from aggregation number 
is due to the deformation and spatial rearrangement of polymersomes induced by the 
strong DNA interaction as observed in cryo-TEM images (Figure 6-2), which reveal the 
real structure of linked polymersomes in solution. Interestingly, the neutral liposomes 
(100 nm in diameter) with 39 single stranded DNAs (ssDNA) per polymersome and an σ 
value similar with the one of P5-ssDNAa or P5-ssDNAb (P5-ssDNAa/b), showed a 
continuous aggregation until precipitating from solution.[35] The distinct behavior of the 
polymersome assemblies compared with neutral liposomes is caused by the strong 
steric repulsion between polymer chains when in proximity of each other, hindering 
DNA hybridization. This strategy has been used to control the assembly of DNA-modified 
gold nanoparticles by grafting polymers on the surface.[40] The size of polymer network 
at equilibrium decreases with the σ value of polymersomes due to the weakening of 
attractive forces.  
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Figure 6-1. Self-assembly of DNA-functionalized polymersomes into network. The 
networking of polymersomes was monitored by TEM after 20 mins (a) and 6 hs (b). The 
scale bars are 500 nm and 1000 nm, respectively. The influence of σ value to the 
assembly process was investigated by recording the size change as a function of the time 
by DLS (c). P5ssDNAa-P5ssDNAb network was chosen as the model system for the 
evaluation of the influence of concentration, temperature and polymersome size to the 
polymersome assembly (d).  
 
Figure 6-2. Cryo-TEM image of polymersome network (P5-ssDNAa-P5-ssDNAb). The scale 
bar is 100 nm. 
The time course of polymersome assembly was well described by a double-exponential 
function (y = A1(1 - e
-k1t) + A2(1 - e
-k2t)) with a fast k1 and a slow k2 rate constants (Table 
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6-1), indicating two different periods existing in the assembly process. k1 corresponds to 
the rate constant for the initial period of the assembly, when ssDNA is free on the 
polymersome’s surface and the attractive force generated by the complementary 
ssDNAs is dominant. Both internal (σ value and size) and external factors (concentration 
and temperature) decide the k1 value. Increasing the σ value of polymersomes from 
P0.25-ssDNAa/b to P5-ssDNAa/b induced an increase of the k2 value from 5.0±0.1 s
-1 to 
10.0 ± 0.1 s-1 due to the rising of dsDNA duplex formation. By decreasing the 
polymersome diameter from 190 nm to 110 nm for P5-ssDNAa/b, k1 value dropped from 
5.0±0.1 s-1 to 0.3±0.1 s-1, even though the σ value was the same. The reduction of 
contact area between small polymersomes is the reason for a decreased number of 
ssDNA available for the dsDNA duplex formation. Lowering the concentration of 
polymers from 0.5 mg/mL to 0.1 mg/mL led to a decrease of both k1 and the aggregation 
size at equilibrium, while temperature influenced only the k1, but not the aggregation 
size. When the assembly entered the later period, a much lower rate constant of k2 was 
generated due to the reduction of the available number of ssDNA for hybridization. k2 
didn’t show a significant correlation with σ value, size, concentration, and temperature.  
Table 6-1. Rate constants for the growth of polymersome network.    
 
k1 (s
-1) k2 (10
-3 s-1) 
P5-ssDNAa-P5-ssDNAb, 0.5 mg/mL, 37 °C, 190 nm 10.0±0.1 9.7±0.8 
P1-ssDNAa-P1-ssDNAb, 0.5 mg/mL,  37 °C, 190 nm 5.0±0.1 9.6±1.2 
P0.25-ssDNAa-P0.25-ssDNAb, 0.5 mg/mL, 37 °C, 190 nm 5.0±0.1 10.7±1.0 
P5-ssDNAa-P5-ssDNAb, 0.1 mg/mL, 37 °C, 190 nm 10.0±0.1 10.6±1.5 
P5-ssDNAa-P5-ssDNAb, 0.1 mg/mL, 25°C, 190 nm 0.4±0.4 6.1±0.7 
P5-ssDNAa-P5-ssDNAb,0.1 mg/mL,  37 °C, 110 nm 0.3±0.1 7.8±1.3 
 
6.2.2. Spatial organization of DNA-functionalized polymeric nanocompartments 
In general, the organization of nanoparticles into nano-objects and nanomaterials is 
templated by various molecules or structures, which determines the sequence and 
spatial distance between individual blocks and the final geometrical structure.[17, 41] 
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Elaborate modulation of interparticle forces is possible to direct the assembly of 
nanoparticles,[42] while achieving well-defined spatial organization for individual blocks 
is still challenging. First, we tried to control the size of nanocompartments and aimed to 
regulate the assembled architectures dominated by the steric and repulsion forces 
generated by DNA-functionalized polymersomes.           
In order to investigate the influence of the size of polymersomes to their spatial 
organization, P5-ssDNAa/b were prepared with a diameter of either 230 ± 60 nm or 90 ± 
20 nm (determined by TEM). Atto488 and dy633 dyes were encapsulated in P5-ssDNAb 
and P5-ssDNAa (P5-ssDNAb-atto488, P5-ssDNAa-dy633) for the visualization.  Two 
distinct spatial organizations were observed by TEM and CLSM, based on the size 
combinations of polymersomes (Figure 6-3). An almost linear arrangement was obtained 
when 230 nm complementary polymersomes were mixed (Figure 6-3b,c). However, 
when nonequivalent sized polymersomes were combined, several 90 nm polymersomes 
hybridized onto the surface of each 230 nm polymersome resulting in a “satellite 
structure”, observed by TEM, CLSM (Figure 6-3d,e) and cryo-TEM (Figure 6-4). The 
diverse structures resulted by the different combination of various sized polymersomes 
is due to the effect of steric hinderance and charge repulsion between proximate 
polymersomes. Larger repulsion force generated between linked 230 nm polymersomes, 
causing them to distribute further apart. This leads to the reduction of available space 
for binding and results in a linear-like structure. Multiple small polymersomes can bind 
the surface of the large polymersome without being close enough in proximity to 
increase the repulsive energy. In addition, the electrostatic repulsive forces generated 
by the small polymersomes resulted in large separations between individual satellite 
structures, increasing the stability of multicompartmental structures. No large 
aggregation was observed by DLS for both linear-like and satellite-like structures (Figure 
6-5).   
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Figure 6-3. Self-organization of DNA-functionalized polymeric nanocompartments 
directed by the size of polymersomes. (a) Schematic presentation of distinct spatial 
organizations directed by the size of the polymersomes. TEM and CLSM images of linear 
structure (b and c) and satellite structure (d and e) self-organized by polymersomes. The 
scale bar for b image is 1000 nm, inset - 200 nm, for c - 2000 nm, inset -1000 nm, for d - 
1000 nm, inset - 100 nm and for e - 2000 nm, inset - 1000 nm.  
 
Figure 6-4. Cryo-TEM images of small polymersomes (a), big polymersomers (b) and the 
formed satellite-like structures. 
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Figure 6-5. Size distribution of linear-like structures (c) assembled by equivalent sized 
polymersomes (a, b) and satellite-like structures (f) assembled by larger polymersomes 
and smaller ones (d, e).  
In addition, we tried to control the spatial distance between compartments by the 
length of DNA on the polymersomes. P5 was modified with complimentary sequences of 
either 22 or 44 nucleotides and used for the construction of polymersome networks. 
Cryo-TEM was performed for the determination of the spatial distance between 
polymersomes (Figure 6-6). Cryo-TEM images showed polymersomes interacting via a 
gap with constant distance, corresponding to the formed dsDNA between 
polymersomes. The black spots between two connecting membranes are due to the 
phosphorous of DNA molecules, which have a stronger contrast.[43] The deformation of 
the membranes indicates a strong interaction between polymersomes.  
The distances between polymersomes sustained by 22mer dsDNA and 44mer dsDNA 
were determined as 8 ± 2 nm and 14 ± 2 nm by the analysis of cryo-TEM images (Figure 
6-6), which are slightly different with the theoretical values of 7.5 nm and 15 nm, 
respectively. These results suggest that the actual distance between polymersomes is 
not only decided by the length of DNA, but also influenced by interparticle forces. When 
polymersomes are located close to each other, repulsive forces including electrostatic, 
steric, and hydration repulsions dominate, and resulted in a larger distance compared 
with the theatrical value. In contrast, when the polymersomes are separated by a larger 
136 
 
distance, the influence of repulsive forces decreased. The observed lower distance 
compared with the theatrical dsDNA length can be due to the compression from 
polymersomes.  
 
Figure 6-6. Cryo-TEM images of polymersome networks sustained by 22mer (left) and 
44mer (right) dsDNA. The scale bar is 100 nm. 
In addition, intact polymersomes observed by cryo-TEM suggests that no membrane 
fusion occurs during the networking of polymersomes. To prove it, we probed the 
mixing of the aqueous vesicles content and leakage by employing a conventional 
membrane fusion assay using sulforhodamine B (SRB). In brief, 25 mM SRB was 
encapsulated in one vesicle population and PBS buffer alone was used for another 
vesicle population. SRB is self-quenched at 25 mM. Membrane fusion or the leakage of 
polymersomes leads to a decrease of SRB’s concentration, which can be observed by an 
increase of the fluorescence. As shown in Figure 6-7, no increase of the fluorescence 
was observed after polymersome networking after 5 days, suggesting polymersomes are 
highly stable during the assembly process.      
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Figure 6-7. Fluorescence spectroscopy of SRB encapsulated polymersomes after 
networking.    
6.2.3. Cellular internalization of polymersome network  
The 3D arrangement of DNA on spherical inorganic nanoparticles[44] and liposomes[45] 
was reported to significantly promote their cellular uptake due to the extracellular 
protein association on the particle surface,[46] inducing endocytosis.[47, 48] To examine 
the cellular uptake efficiency of DNA functionalized polymersomes and the 
polymersome network, a series of investigations were performed.  
First, the toxicity of P5 functionalized with complementary ssDNA strands and the 
formed polymer network was evaluated by a MTS assay in U87 glioblastoma cells (Figure 
6-8). Minimal in vitro cytotoxicity was observed for both P5-ssDNAa/b and polymersome 
networks after 24 h. This agrees with the reported lack in toxicity of PMOXA-b-PDMS-b-
PMOXA-based copolymers with different block lengths, as studied in various cell 
lines.[12, 49]  
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Figure 6-8. Cellular toxicity evaluation of 80 µg/ml DNA functionalized polymersomes 
and  polymersome network on U87 cells using MTS assay. Errors bars represent the 
standard deviation (n=3). 
Second, the stability of polymersome networks in cell media and in PBS as a control was 
assessed by DLS and FCS (Figure 6-9a, Table 6-2). After 24h of incubation, no significant 
difference in the size was observed by either technique, suggesting that the 
polymersome networks remain intact in cell culture media. This result was confirmed by 
TEM (Figure 6-9b).  
 
Figure 6-9. a) Normalized autocorrelation curves from FCS data: polymersome network 
formed by P5-ssDNAa/b in PBS (blue) and in cell media (red) after incubating for 24 h at 
37 °C; b) TEM image of polymersome network formed by P5-ssDNAa/b in cell media 
after incubating for 24 h at 37 °C. 
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Table 6-2. DH of polymersome network formed by P5-ssDNAa/b. The samples were 
incubated in PBS or cell media for 24 h at 37 °C before measurements.   
 DH (nm, FCS) DH (nm, DLS) 
In PBS 330 ± 30 250 ± 120 
in cell media 310 ± 70 290 ± 100 
Typically, high density of DNA on the surface of nanostructures is required to ensure the 
efficient cellular uptake.[44] The surface coverage of DNA on the presented 
polymersomes is much lower than for other reported systems.[46, 50] In order to 
examine the cellular uptake efficiency of DNA-functionalized polymersomes with 
different σ values (180 nm in diameter), dy633 encapsulated polymersomes were 
prepared. The extent of uptake of individual DNA functionalized polymersomes was 
measured by flow cytometry (Figure 6-10).  
After incubation of 40 µg/ml naked polymersomes (P0) and DNA-functionalized 
polymersomes (P0.25-ssDNAb, P1-ssDNAb and P5-ssDNAb) with U87 cells for 24 h, flow 
cytometry revealed that the cellular internalization of polymersomes is highly 
dependent on their σ values. The cells treated with P0 showed low uptake efficiency. 
Functionalization of polymersomes with DNA for the case of P0.25-ssDNAb (σ: 0.1×10-3 
nm-2) did not increase the uptake efficiency compared with P0. However, ~6-fold 
increase in fluorescent intensity for the case of P1-ssDNAb with σ value of 0.3×10-3 nm-2 
was observed compared with P0. Increasing the σ value to 0.9×10-3 nm-2 for P5-ssDNAb 
did not further enhance the cellular uptake. These results suggest that a low DNA 
surface coverage (σ: 0.3×10-3 nm-2) is sufficient to benefit the cellular uptake of 
nanostructures. 
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Figure 6-10. Flow cytometry results of U87 cells treated with naked polymersomes and 
DNA-functionalized polymersomes with different σ values, using untreated U87 cells as a 
control.   
In the next step, the cellular internalization of polymersome networks formed by P5-
ssDNAa/b was assessed by CLSM (Figure 6-11). P5-ssDNAa-dy633 and P5-ssDNAb-
atto488 were used for these experiments. Different combinations of polymersomes 
were added to the U87 cells and incubated for 24h. Low cellular internalization was 
observed for the mixture of P0-dy633 and P0-atto488 polymersomes (data not shown). 
Atto488 and dy633 contained polymersomes functionalized with ssDNA strands showed 
significantly higher uptake compared to P0. The confocal images of polymersome 
networks show internalization of both P5-ssDNAa-dy633 and P5-ssDNAb-atto488 (Figure 
6-11c, red and green channels) inside the cell cytoplasm with their evident colocalization. 
In contrast, polymersomes functionalized with non-complementary strands were 
randomly distributed and no evident colocalization was observed (Figure 6-11b). As a 
control P5ssDNAa-dy633 were mixed with P0-atto488 and incubated with cells resulting 
in significant uptake of P5ssDNAa-dy633 compared to P0-atto488 as shown in Figure 6-
11a. Flow cytometry confirmed the results obtained from CLSM (data not shown).  
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Figure 6-11. CLSM images of U87 cells incubated with a) P5ssDNAa-dy633 and P0-
atto488, b) P5ssDNAa-dy633 and P5ssDNAa-atto488, c) P5ssDNAa-dy633 and P5ssDNAb-
atto488 (scale bar = 20 μm).  
6.3. Conclusion 
We described, for the first time, polymersome networks formed by DNA hybridization. 
The kinetics and the self-assembly scale of polymersomes can be well controlled by both 
internal (σ value and size) and external factors (concentration and temperature). Spatial 
organization of polymersomes into linear- or satellite-like structures has been achieved 
by combining different sized polymersomes. The spatial distance between 
compartments was modulated as well by controlling the length of ssDNA on 
polymersomes.   
The presented polymersome network is highly promising for the fabrication of novel 
multi-functional, intelligent, and complex nanosystems because it supplies isolated 
multicompartments for individual active molecules with defined connections. In addition, 
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polymersome networks exhibit high cellular uptake abilities and stability, promoting 
their in-vitro applications.       
6.4. Experimental section  
Materials 
atto488 and dy633 were purchased from ATTO-TEC GmbH and Dyomics GmbH, 
respectively. 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium was purchased from Promega, USA.   
Preparation of DNA-functionalized polymeric nanocompartments 
Polymersomes was prepared as described previously. In order to encapsulate 
fluorescent probes in the vesicles, atto488 and DY-633 (2 mM in 1 mL PBS buffer) 
individually, were added for film rehydration. Non-encapsulated fluorescent dyes were 
separated from the encapsulated ones by size exclusion chromatography (Sepharose 2B 
column; 37 cm length).  
The functionalization of polymersomes with ssDNA was performed as described 
previously. The sequences  for 44mer ssDNAa and 44mer ssDNAb are 5'-CCT CGC TCT 
GCT AAT CCT GTT ACC TCG CTC TGC TAA TCC TGT TA-3' and 5'-TAA CAG GAT TAG CAG 
AGC GAG GTA ACA GGA TTA GCA GAG CGA GG-3', respectively.   
Kinetic analysis of vesicle assembly 
The measurements of DH of nanostructures were performed on a Zetasizer Nano ZSP 
(Malvern Instruments Ltd., UK) at 20 °C. The investigation of the kinetic of vesicle 
assembly was carried out by recoding the DH of particles as a function of time at 20°C 
and 37 °C. Then, DH of the nanostructures were plotted as a function of time by 
OriginPro 9.1G and the data was fitted by double-exponential function as shown in eq. 
1,2.  
                                                     𝑦 = 𝑦0 + 𝐴1 (1 − 𝑒−
𝑥
𝑡
1)
+ 𝐴2 (1 − 𝑒−
𝑥
𝑡
2)                             (1) 
                                                         𝑘1 =
1
𝑡
1
                           𝑘2 = 1/𝑡2                                        (2) 
y0 is the average DH of P5-ssDNAa and P5-ssDNAb. A1 and A2 are the corresponding 
number of traces. t1 and t2 represents the dwell times. k1 and k2 are the rate constant. 
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FCS and CLSM 
FCS measurements were performed on a confocal laser scanning microscope (Zeiss LSM 
510-META/Confocor2, Carl Zeiss, Jena, Germany). An Ar+ laser was used for 488 nm 
wavelength, and a HeNe laser for 633 nm. The laser light was focused through a 40x C-
Apochromat water immersion objective with a numeric aperture of 1.2 onto the sample 
and using the appropriate filter sets depending on the wavelength used. The fluorescent 
signal was recorded on an avalanche photodiode (APD). For each measurement and 
each fluorescent probe, the pinhole was calibrated for maximum count rate using free 
dye in PBS.  
The sample volumes were 5 µL. Fluorescent fluctuations over time were recorded for 10 
x 10 s. The raw data was processed and analysed using ConfoCor3 software. 
Autocorrelation curves were fitted by using a two-component model (equation 1). The 
diffusion times obtained for free dyes (atto488 and dy633) were fixed in the fitting 
procedure. 
𝐺2𝑐𝑜𝑚𝑝(𝜏) = 1 +
1
𝑁
∙ (1 +
𝑇𝑡𝑟𝑖𝑝
1−𝑇𝑡𝑟𝑖𝑝
e
−
𝜏
𝜏𝑡𝑟𝑖𝑝) ∙ [
f1
(1+
𝜏
𝜏𝐷1
)(1+
𝜏
𝑆2𝜏𝐷1
)
1/2 +
f2
(1+
𝜏
𝜏𝐷2
)(1+
𝜏
𝑆2𝜏𝐷2
)
1/2] (1) 
Where 𝐺2𝑐𝑜𝑚𝑝(𝜏) is the two-component autocorrelation function, N is the number of 
particles, S the structural parameter, 𝑇𝑡𝑟𝑖𝑝 is the fraction of fluorophores in the triplet 
state, 𝜏𝑡𝑟𝑖𝑝 is the corresponding triplet time, f1 and f2 are the fraction of the particles of 
the corresponding component 1 or 2, 𝜏𝐷1  and 𝜏𝐷2  are the diffusion times of the 
corresponding component 1 or 2.  
CLSM experiments were performed on a confocal laser scanning microscope (Zeiss LSM 
510-META/Confocor2, Carl Zeiss, Jena, Germany). For atto488 and dy633 containing 
polymersomes, a Argon-2 laser with λ = 488 nm (15 mW output), and a He-Ne laser with 
λ = 633 nm (15 mW output) was used. The laser output intensity was adjusted by 
changing the transmission in order to keep the laser intensity low. A main dichromatic 
beam splitter (HFT 488/543/633), a secondary dichroic beam splitter (NFT 545) and a 
low pass filter (LP 505) were used for 488 nm laser and a low pass filter (LP 650) in case 
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of the 633 laser. The light was focused on the sample using a C-Apochromat 40x water 
immersion objective (NA=1.2).  
Cell culture  
U87 glioblastoma cells were maintained at 37 °C in a 5% CO2 humidified atmosphere and 
were grown in DMEM with 10% FBS, 100 units/mL penicillin, 100 μg/mL streptomycin 
and 2 mM L-glutamine. 
Cell viability assay  
Cytotoxicity testing was performed using the Promega CellTiter 96 AQueous Non-
Radioactive Cell Proliferation MTS assay to determine the number of viable cells in 
culture. 104 U87 cells were cultured in a 96-well plate for 24 h prior to the experiment. 
P5-ssDNAa/b and polymersome networks (10 µl of 0.8 mg/ml)  were added to the cells 
and incubated for 24h at 37°C with 5% CO2. Next, a MTS mixture (20 μL/well)  was added 
to the cells and then incubated for 3 h. Cell viability was calculated by measuring the 
absorbance at 490 nm using a 96-well plate reader (Spectramax). Two internal controls 
were set up for each experiment: cells alone and medium alone. Background absorbance 
due to the non-specific reaction between test compounds and the MTS reagent was 
deducted from exposed cell values. Each experiment was performed in triplicate. 
Cellular uptake  
Freshly trypsinized U87 cells (3x104 cells in 300 µL cell culture medium) were seeded 
into 8-wells chamber 24h prior to the experiment. The cell culture medium was replaced 
with a cell culture medium without serum (130 µL) followed by addition of the polymer-
DNA conjugates prepared as described above (20 µl of 0.2 mg/ml). After 4h incubation, 
the cell culture medium was carefully removed and replaced with serum-containing 
medium (300 µL). The cells were incubated for 20 hs more. Right before live cell imaging, 
the cell culture medium was replaced with an Opti-MEM. The imaging was performed on 
Zeiss LSM 510-META/Confocor2, Carl Zeiss, Jena, Germany. Images were taken using a 
40x water-immersion objective. Excitations were at 488 nm and 633 nm for atto488 and 
dy633, respectively. Images were taken with the same acquisition settings for 
comparison purpose. 
Flow cytometry analysis  
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The U87 cells (105 cells/well) were plated into 24-well tissue culture plates 24 hours 
prior to treatment and subsequent flow cytometry analysis. After an overnight 
incubation, the cell culture medium was replaced with serum-free medium (0.44 mL) 
and the polymer-DNA conjugates prepared as described above (57 µl of 0.35 mg/ml), 
were added. After 4h incubation, the serum-free medium was carefully removed and 
replaced with 1 ml of medium containing 10% FBS. The cells were then let to grow 20h 
more in the incubator. The cells were then trypsinized with 200 μl of trypsin for 10 
minutes at 37 °C and 5% CO2. Following trypsinization, 800 μl PBS was added to the cells, 
gently mixed by pipetting and transfered in 1.5 mL microcentrifuge tubes. Cells were 
then pelleted by centrifugation at 300 RCF for five minutes. Subsequently, the media 
was aspirated and the pellet was resuspended in 200 μl cold PBS and put on ice until 
flow cytometry analysis. Cells were vortexed gently immediately prior to flow cytometry 
analysis. Flow cytometry analyses were carried out using a Canto II flow cytometer. 
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7. Summary and perspectives 
Hybrid nanosystems advance the developments of biochemistry, polymer chemistry and 
material science. Intelligent organization of diverse materials together brings the 
opportunities to combine all their properties and design new nanomaterials for as many 
as possible applications, such as diagnostic or therapeutic agents, sensing devices or 
nanotechonology. 
In this thesis, we described two hybrid nanosystems constructed by molecular 
recognition. First, we designed and synthesized novel trisNTA functionalized polymers 
for the binding of His-tagged molecules through the specific interaction between 
trisNTA-Me2+ and His6. PNT copolymers were used as models to mimic the complex 
targeting configuration in nature, and to investigate the correlation between geometric 
limitation and binding capacity in details. PNT copolymers exhibited many advantages 
for protein delivery. They site-specifically bound to multiple His-tagged protein per chain 
without the requirements for any modifications, and rapidly released the bound 
proteins in acid conditions. Low toxicity and no obvious influence to the properties of 
proteins were observed.  
In the second system, we designed and constructed multicompartmental systems self-
organized by binary polymersomes. The self-organization was achieved by the 
hybridization of ssDNA on the surface of polymersomes. The combination of different 
sized polymersomes resulted in linear-like or satellite-like structures. The length of 
ssDNA on the surface of polymersomes controlled the spatial distance between 
compartments. In addition, the multicompartmental systems exhibited high cellular 
uptake and stability.   
Afterward, these two hybrid nanosystems are expected to be promising in many 
interdisciplinary applications at the border between different research areas and 
technologies. PNT copolymers are able to combine various His-tagged proteins into one 
nanosystem with controllable distances, useful for the study of protein-protein 
interactions, protein synergy, as well as combination therapy. The design and the 
construction of polymeric multicompartmental systems with specific spatial organization 
will be promisingly used for complex nanobiomaterials. 
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10. Abbreviations 
αRIgG-biotin biotinylated goat antirabbit immunoglobulin 
∆H° standard enthalpy change 
∆S° standard entropy change 
τD diffusion time 
ε extinction coefficient 
σ average surface coverage density 
ABPs   amphiphilic block polymers 
ADPCs   amphiphilic DNA–polymer conjugates 
AIBN azobisisobutyronitrile 
APD avalanche photodiode 
AqpZ water-channel protein Aquaporin Z 
ATP adenosine triphosphate 
ATRP atom transfer radical polymerization 
APD avalanche photodiode 
BME   2-mercaptoethanol  
bp base pairs 
BSA bovine serum albumin  
CB[8]                                            macrocycle cucurbit[8]uri  
CCMV cowpea Chlorotic Mottle Virus  
CD circular dichroism 
cmc   critical micelle concentration 
DMEM Dulbecco's modified eagle medium 
CpG controlled pore glass 
CPM counts per molecule 
Cryo-TEM cryogenic transmission electron microscopy 
D diameter 
DBCO dibenzocyclooctyl group  
DCC    N,N’-dicyclohexylcarbodiimide 
DCM dichloromethane 
DH hydrodynamic diameter 
DIC N,N’-diisopropylcarbodiimide 
DIPEA N,N’-Diisopropylethylamine 
DLS dynamic light scattering 
DMF dimethylformamide 
DNA-b-PEG DNA-block-poly (ethylene glycol) 
DNA-b-PPO DNA-block-polypropylene 
ds double-stranded 
Dox doxorubicin 
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DPCs DNA-polymer conjugates 
dsDNA double-stranded DNA 
DTT dithiothreitol 
EDC 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide  
EDTA     ethylenediaminetetraacetic acid 
EPR electron paramagnetic resonance 
EPR effect enhanced permeability and retention effect 
ESI-MS electrospray ionisation mass spectrometry 
FBS fetal bovine serum 
FCS fluorescent correlation spectroscopy 
FDA Food and Drug Administration 
FITC-His6 fluorescein-labeled His6 
FPLC fast protein liquid chromatography 
FTIR fourier transform infrared spectroscopy 
F-Type ATPase ATP synthase 
GAPDH endogenous glyceraldehyde 3-phosphate dehydrogenase 
GPC gel permeation chromatography 
His6 His tag 
His6-eGFP his-tagged enhanced green fluorescent protein  
His6-eYFP his-tagged enhanced yellow fluorescent protein 
His6-ColG his-tagged collagenase G 
HoBt 1-hydroxybenzotriazole hydrate 
IDA iminodiacetic acid 
ITC isothermal titration calorimetry 
IgG immunoglobulin G 
k1 fast rate constant 
k2 slow rate constant 
KD dissociation constant 
LNA locked nucleic acid 
LPA nanoparticles Locked nucleic acid-polymer nanoparticles 
LPO lactoperoxidase 
Me2+ metal cations 
MTS 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium  
MV7 viologen 
MW molecular weight 
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NCS neocarzinostatin 
NHS N-hydroxysuccinimide 
NIPAM N-isopropylacrylamide 
Np8 naphthalene 
NTA nitrilotriacetic acid 
NTA-Men+ metal-coordinated nitrilotriacetic acid 
ODNs    oligonucleotides 
OmpF outer membrane protein F  
PB poly (butadiene)  
PBS buffer phosphate buffered saline 
PC pore&size polycarbonate 
PCR polymerase chain reaction  
PDIs polydispersities 
PEG poly(ethyleneglycol) 
PEG-b-PPO-b-PEG poly(polyethylene glycol)-block-poly (propylene)-block-
poly(ethylene glycol) 
PEGMA poly(ethylene glycol) methyl ether methacrylate 
PEI polyethylenimine  
PEO   poly (ethylene oxide)  
PGA poly(glutamic acid) 
PHPMA poly(N-(2-hydroxypropyl)methacrylamide)  
PIB poly (isobutylene) 
pKa acid dissociation constant 
PMOXA-b-PDMS-b-
PMOXA   
poly(2-methyloxazoline)-block-poly(dimethylsiloxane)-
block-poly(2-methyloxazoline) 
PNTs poly (N-isopropylacrylamide-co-tris-nitrilotriacetic acid 
acrylamide)s 
PolyNIPAM poly(N-isopropylacrylamide) 
PNTs poly (N-isopropylacrylamide-co-tris-nitrilotriacetic acid 
acrylamide)s polymers  
prot-trisNTA tert-butyl ester protected tris-nitrilotriacetic acid acrylate 
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PS polystyrene  
RAFT  reversible addition−fragmentation chain-transfer 
RB-His6 rhodamine B-labelled His6 
RT room temperature 
SMA styrene-co-maleic anhydride 
SNAs spherical nucleic acids 
SRB-His6 sulforhodamine B labelled His6 
SOD superoxide dismutase 
ssDNA single stranded DNA 
ssDNAa 5’-CCT CGC TCT GCT AAT CCT GTT A-3’ 
ssDNAb 5’-TAA CAG GAT TAG CAG AGC GAG G-3’ 
TEM transmission electron microscopy 
TdT terminal deoxynucleotidyl transferase 
TNF-α tumor necrosis factor-α 
TRAIL tumor necrosis factor-related apoptosis inducing ligand  
Tris-HCl tris hydrochloride 
trisNTA tris-nitrilotriacetic acid 
 
 
